- fields:
    HasMut: false
    Interactions: []
    PMCID: PMC1629034
    PMCXML: "<?xml version='1.0' encoding='utf-8'?>\n<!DOCTYPE pmc-articleset PUBLIC\
      \ \"-//PMC//DTD ARTICLE SET 2.0//EN\" \"http://www.pubmedcentral.nih.gov/pmcdoc/dtd/nlm_lib/articleset/nlm-articleset-2.0.dtd\"\
      >\n<pmc-articleset>\n <article xmlns:xlink=\"http://www.w3.org/1999/xlink\"\
      \ xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" article-type=\"research-article\"\
      >\n  <front>\n   <journal-meta>\n    <journal-id journal-id-type=\"nlm-ta\"\
      >\n     PLoS Biol\n    </journal-id>\n    <journal-id journal-id-type=\"publisher-id\"\
      >\n     pbio\n    </journal-id>\n    <journal-title>\n     PLoS Biology\n  \
      \  </journal-title>\n    <issn pub-type=\"ppub\">\n     1544-9173\n    </issn>\n\
      \    <issn pub-type=\"epub\">\n     1545-7885\n    </issn>\n    <publisher>\n\
      \     <publisher-name>\n      Public Library of Science\n     </publisher-name>\n\
      \     <publisher-loc>\n      San Francisco, USA\n     </publisher-loc>\n   \
      \ </publisher>\n   </journal-meta>\n   <article-meta>\n    <article-id pub-id-type=\"\
      pmc\">\n     1629034\n    </article-id>\n    <article-id pub-id-type=\"pmid\"\
      >\n     17076584\n    </article-id>\n    <article-id pub-id-type=\"doi\">\n\
      \     10.1371/journal.pbio.0040365\n    </article-id>\n    <article-id pub-id-type=\"\
      publisher-id\">\n     06-PLBI-RA-0202R4\n    </article-id>\n    <article-id\
      \ pub-id-type=\"sici\">\n     plbi-04-11-17\n    </article-id>\n    <article-categories>\n\
      \     <subj-group subj-group-type=\"heading\">\n      <subject>\n       Research\
      \ Article\n      </subject>\n     </subj-group>\n     <subj-group subj-group-type=\"\
      Discipline\">\n      <subject>\n       Cell Biology\n      </subject>\n    \
      \  <subject>\n       Virology\n      </subject>\n      <subject>\n       Diabetes/Endocrinology/Metabolism\n\
      \      </subject>\n      <subject>\n       HIV/AIDS\n      </subject>\n    \
      \  <subject>\n       Biochemistry\n      </subject>\n     </subj-group>\n  \
      \   <subj-group subj-group-type=\"System Taxonomy\">\n      <subject>\n    \
      \   Viruses\n      </subject>\n      <subject>\n       Homo (Human)\n      </subject>\n\
      \     </subj-group>\n    </article-categories>\n    <title-group>\n     <article-title>\n\
      \      Human Immunodeficiency Virus Impairs Reverse Cholesterol Transport from\
      \ Macrophages\n     </article-title>\n     <alt-title alt-title-type=\"running-head\"\
      >\n      HIV Impairs Cholesterol Efflux\n     </alt-title>\n    </title-group>\n\
      \    <contrib-group>\n     <contrib contrib-type=\"author\" equal-contrib=\"\
      yes\">\n      <name>\n       <surname>\n        Mujawar\n       </surname>\n\
      \       <given-names>\n        Zahedi\n       </given-names>\n      </name>\n\
      \      <xref rid=\"aff1\" ref-type=\"aff\">\n       1\n      </xref>\n     </contrib>\n\
      \     <contrib contrib-type=\"author\" equal-contrib=\"yes\">\n      <name>\n\
      \       <surname>\n        Rose\n       </surname>\n       <given-names>\n \
      \       Honor\n       </given-names>\n      </name>\n      <xref rid=\"aff2\"\
      \ ref-type=\"aff\">\n       2\n      </xref>\n     </contrib>\n     <contrib\
      \ contrib-type=\"author\">\n      <name>\n       <surname>\n        Morrow\n\
      \       </surname>\n       <given-names>\n        Matthew P\n       </given-names>\n\
      \      </name>\n      <xref rid=\"aff1\" ref-type=\"aff\">\n       1\n     \
      \ </xref>\n     </contrib>\n     <contrib contrib-type=\"author\">\n      <name>\n\
      \       <surname>\n        Pushkarsky\n       </surname>\n       <given-names>\n\
      \        Tatiana\n       </given-names>\n      </name>\n      <xref rid=\"aff1\"\
      \ ref-type=\"aff\">\n       1\n      </xref>\n     </contrib>\n     <contrib\
      \ contrib-type=\"author\">\n      <name>\n       <surname>\n        Dubrovsky\n\
      \       </surname>\n       <given-names>\n        Larisa\n       </given-names>\n\
      \      </name>\n      <xref rid=\"aff1\" ref-type=\"aff\">\n       1\n     \
      \ </xref>\n     </contrib>\n     <contrib contrib-type=\"author\">\n      <name>\n\
      \       <surname>\n        Mukhamedova\n       </surname>\n       <given-names>\n\
      \        Nigora\n       </given-names>\n      </name>\n      <xref rid=\"aff2\"\
      \ ref-type=\"aff\">\n       2\n      </xref>\n     </contrib>\n     <contrib\
      \ contrib-type=\"author\">\n      <name>\n       <surname>\n        Fu\n   \
      \    </surname>\n       <given-names>\n        Ying\n       </given-names>\n\
      \      </name>\n      <xref rid=\"aff2\" ref-type=\"aff\">\n       2\n     \
      \ </xref>\n     </contrib>\n     <contrib contrib-type=\"author\">\n      <name>\n\
      \       <surname>\n        Dart\n       </surname>\n       <given-names>\n \
      \       Anthony\n       </given-names>\n      </name>\n      <xref rid=\"aff2\"\
      \ ref-type=\"aff\">\n       2\n      </xref>\n     </contrib>\n     <contrib\
      \ contrib-type=\"author\">\n      <name>\n       <surname>\n        Orenstein\n\
      \       </surname>\n       <given-names>\n        Jan M\n       </given-names>\n\
      \      </name>\n      <xref rid=\"aff1\" ref-type=\"aff\">\n       1\n     \
      \ </xref>\n     </contrib>\n     <contrib contrib-type=\"author\">\n      <name>\n\
      \       <surname>\n        Bobryshev\n       </surname>\n       <given-names>\n\
      \        Yuri V\n       </given-names>\n      </name>\n      <xref rid=\"aff3\"\
      \ ref-type=\"aff\">\n       3\n      </xref>\n     </contrib>\n     <contrib\
      \ contrib-type=\"author\">\n      <name>\n       <surname>\n        Bukrinsky\n\
      \       </surname>\n       <given-names>\n        Michael\n       </given-names>\n\
      \      </name>\n      <xref rid=\"aff1\" ref-type=\"aff\">\n       1\n     \
      \ </xref>\n      <xref ref-type=\"corresp\" rid=\"cor1\">\n       &#x0002a;\n\
      \      </xref>\n     </contrib>\n     <contrib contrib-type=\"author\">\n  \
      \    <name>\n       <surname>\n        Sviridov\n       </surname>\n       <given-names>\n\
      \        Dmitri\n       </given-names>\n      </name>\n      <xref rid=\"aff2\"\
      \ ref-type=\"aff\">\n       2\n      </xref>\n     </contrib>\n    </contrib-group>\n\
      \    <aff id=\"aff1\">\n     <label>\n      1\n     </label>\n     The George\
      \ Washington University, Washington, District of Columbia, United States of\
      \ America\n    </aff>\n    <aff id=\"aff2\">\n     <label>\n      2\n     </label>\n\
      \     Baker Heart Research Institute, Melbourne, Victoria, Australia\n    </aff>\n\
      \    <aff id=\"aff3\">\n     <label>\n      3\n     </label>\n     University\
      \ of New South Wales, Sydney, New South Wales, Australia\n    </aff>\n    <contrib-group>\n\
      \     <contrib contrib-type=\"editor\">\n      <name>\n       <surname>\n  \
      \      Carr\n       </surname>\n       <given-names>\n        Andrew\n     \
      \  </given-names>\n      </name>\n      <role>\n       Academic Editor\n   \
      \   </role>\n      <xref rid=\"edit1\" ref-type=\"aff\">\n      </xref>\n  \
      \   </contrib>\n    </contrib-group>\n    <aff id=\"edit1\">\n     St. Vincent's\
      \ Hospital, Australia\n    </aff>\n    <author-notes>\n     <corresp id=\"cor1\"\
      >\n      &#x0002a; To whom correspondence should be addressed. E-mail:\n   \
      \   <email>\n       mtmmib&#x00040;gwumc.edu\n      </email>\n     </corresp>\n\
      \    </author-notes>\n    <pub-date pub-type=\"ppub\">\n     <month>\n     \
      \ 11\n     </month>\n     <year>\n      2006\n     </year>\n    </pub-date>\n\
      \    <pub-date pub-type=\"epub\">\n     <day>\n      31\n     </day>\n     <month>\n\
      \      10\n     </month>\n     <year>\n      2006\n     </year>\n    </pub-date>\n\
      \    <volume>\n     4\n    </volume>\n    <issue>\n     11\n    </issue>\n \
      \   <elocation-id>\n     e365\n    </elocation-id>\n    <history>\n     <date\
      \ date-type=\"received\">\n      <day>\n       6\n      </day>\n      <month>\n\
      \       2\n      </month>\n      <year>\n       2006\n      </year>\n     </date>\n\
      \     <date date-type=\"accepted\">\n      <day>\n       31\n      </day>\n\
      \      <month>\n       8\n      </month>\n      <year>\n       2006\n      </year>\n\
      \     </date>\n    </history>\n    <copyright-statement>\n     <bold>\n    \
      \  Copyright:\n     </bold>\n     &#x000a9; 2006 Mujawar et al. This is an open-access\
      \ article distributed under the terms of the Creative Commons Attribution License,\
      \ which permits unrestricted use, distribution, and reproduction in any medium,\
      \ provided the original author and source are credited.\n    </copyright-statement>\n\
      \    <copyright-year>\n     2006\n    </copyright-year>\n    <related-article\
      \ xlink:href=\"10.1371/journal.pbio.0040400\" related-article-type=\"companion\"\
      \ xlink:title=\"Synopsis\" vol=\"4\" page=\"e400\" id=\"N0x9b1b078N0x99a2530\"\
      \ ext-link-type=\"doi\">\n     <article-title>\n      HIV-Cholesterol Connection\
      \ Suggests a New Antiretroviral Strategy\n     </article-title>\n    </related-article>\n\
      \    <abstract>\n     <p>\n      Several steps of HIV-1 replication critically\
      \ depend on cholesterol. HIV infection is associated with profound changes in\
      \ lipid and lipoprotein metabolism and an increased risk of coronary artery\
      \ disease. Whereas numerous studies have investigated the role of anti-HIV drugs\
      \ in lipodystrophy and dyslipidemia, the effects of HIV infection on cellular\
      \ cholesterol metabolism remain uncharacterized. Here, we demonstrate that HIV-1\
      \ impairs ATP-binding cassette transporter A1 (ABCA1)-dependent cholesterol\
      \ efflux from human macrophages, a condition previously shown to be highly atherogenic.\
      \ In HIV-1&#x02013;infected cells, this effect was mediated by Nef. Transfection\
      \ of murine macrophages with\n      <italic>\n       Nef\n      </italic>\n\
      \      impaired cholesterol efflux from these cells. At least two mechanisms\
      \ were found to be responsible for this phenomenon: first, HIV infection and\
      \ transfection with\n      <italic>\n       Nef\n      </italic>\n      induced\
      \ post-transcriptional down-regulation of ABCA1; and second, Nef caused redistribution\
      \ of ABCA1 to the plasma membrane and inhibited internalization of apolipoprotein\
      \ A-I. Binding of Nef to ABCA1 was required for down-regulation and redistribution\
      \ of ABCA1. HIV-infected and\n      <italic>\n       Nef\n      </italic>\n\
      \      -transfected macrophages accumulated substantial amounts of lipids, thus\
      \ resembling foam cells. The contribution of HIV-infected macrophages to the\
      \ pathogenesis of atherosclerosis was supported by the presence of HIV-positive\
      \ foam cells in atherosclerotic plaques of HIV-infected patients. Stimulation\
      \ of cholesterol efflux from macrophages significantly reduced infectivity of\
      \ the virions produced by these cells, and this effect correlated with a decreased\
      \ amount of virion-associated cholesterol, suggesting that impairment of cholesterol\
      \ efflux is essential to ensure proper cholesterol content in nascent HIV particles.\
      \ These results reveal a previously unrecognized dysregulation of intracellular\
      \ lipid metabolism in HIV-infected macrophages and identify Nef and ABCA1 as\
      \ the key players responsible for this effect. Our findings have implications\
      \ for pathogenesis of both HIV disease and atherosclerosis, because they reveal\
      \ the role of cholesterol efflux impairment in HIV infectivity and suggest a\
      \ possible mechanism by which HIV infection of macrophages may contribute to\
      \ increased risk of atherosclerosis in HIV-infected patients.\n     </p>\n \
      \   </abstract>\n    <abstract abstract-type=\"toc\">\n     <p>\n      HIV1-Nef\
      \ impairs ABCA1-dependent cholesterol efflux from infected macrophages, promoting\
      \ the transformation of virally infected macrophages into foam cells (a condition\
      \ that may put HIV patients at risk for atherosclerosis).\n     </p>\n    </abstract>\n\
      \    <counts>\n     <page-count count=\"1\">\n     </page-count>\n    </counts>\n\
      \    <custom-meta-wrap>\n     <custom-meta>\n      <meta-name>\n       citation\n\
      \      </meta-name>\n      <meta-value>\n       Mujawar Z, Rose H, Morrow MP,\
      \ Pushkarsky T, Dubrovsky L, et al. (2006) Human immunodeficiency virus impairs\
      \ reverse cholesterol transport from macrophages. PLoS Biol 4(11): e365. DOI:\n\
      \       <ext-link ext-link-type=\"doi\" xlink:href=\"10.1371/journal.pbio.0040365\"\
      >\n        10.1371/journal.pbio.0040365\n       </ext-link>\n      </meta-value>\n\
      \     </custom-meta>\n    </custom-meta-wrap>\n   </article-meta>\n  </front>\n\
      \  <body>\n   <sec id=\"s1\">\n    <title>\n     Introduction\n    </title>\n\
      \    <p>\n     Macrophage cells and cholesterol play a central role in the pathogenesis\
      \ of two diseases, AIDS and atherosclerosis. Macrophages are among the main\
      \ targets of HIV in the body, and HIV assembly and budding, as well as infection\
      \ of new target cells, all depend on plasma membrane cholesterol. Depletion\
      \ of cellular cholesterol markedly and specifically reduces HIV-1 particle production\
      \ &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b001\">\n     \
      \ 1\n     </xref>\n     ,\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b002\"\
      >\n      2\n     </xref>\n     &#x0005d;, and cholesterol-sequestering drugs,\
      \ such as &#x003b2;-cyclodextrin, render the virus incompetent for cell entry\
      \ &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b003\">\n     \
      \ 3\n     </xref>\n     ,\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b004\"\
      >\n      4\n     </xref>\n     &#x0005d;. Therefore, regulating cholesterol\
      \ delivery to nascent virions would be highly beneficial for the virus. Some\
      \ clues to potential mechanisms that may be employed by HIV to achieve this\
      \ goal have been provided recently when it was demonstrated that HIV-1 accessory\
      \ protein Nef binds cholesterol and may deliver it to the site of virion assembly\
      \ at the plasma membrane &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b005\"\
      >\n      5\n     </xref>\n     &#x0005d;. However, little is known about the\
      \ relation of this mechanism to major cellular cholesterol trafficking pathways\
      \ and about the effect of HIV infection on lipid metabolism in the host cells.\n\
      \    </p>\n    <p>\n     Increased risk of atherosclerosis and coronary artery\
      \ disease (CAD) is a recognized clinical problem in HIV-infected patients &#x0005b;\n\
      \     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b006\">\n      6\n     </xref>\n\
      \     &#x02013;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b010\">\n \
      \     10\n     </xref>\n     &#x0005d;. A key element of atherosclerotic plaque\
      \ is formation of foam cells &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"\
      pbio-0040365-b011\">\n      11\n     </xref>\n     &#x0005d;, the majority of\
      \ which are macrophages overloaded with cholesterol. Foam cells undergo apoptosis,\
      \ necrosis, and calcification, and cholesterol released from foam cells forms\
      \ the lipid-rich core of the plaque. Interestingly, foam cells are less conducive\
      \ than macrophages to growth of certain pathogens, such as\n     <named-content\
      \ content-type=\"genus-species\">\n      Chlamydia pneumoniae\n     </named-content>\n\
      \     &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b012\">\n \
      \     12\n     </xref>\n     &#x0005d;, suggesting that they may contribute\
      \ to antibacterial response of the organism. One of the main causes of foam\
      \ cell formation and accumulation of cholesterol in the vessel wall may be dyslipidemia,\
      \ especially high levels of very low-density lipoprotein (VLDL) and low-density\
      \ lipoprotein (LDL), as well as low levels of high-density lipoprotein (HDL)\
      \ &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b013\">\n     \
      \ 13\n     </xref>\n     &#x0005d;, and/or impairment of intracellular cholesterol\
      \ metabolism. Dyslipidemia caused by antiretroviral drugs, in particular protease\
      \ inhibitors (PIs) &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b014\"\
      >\n      14\n     </xref>\n     &#x0005d;, is a known risk factor in pathogenesis\
      \ of CAD in HIV-infected patients. One mechanism of PI treatment&#x02013;dependent\
      \ dyslipidemia is inhibition of degradation of proteins involved in metabolism\
      \ of cholesterol and triglycerides, such as apolipoprotein B &#x0005b;\n   \
      \  <xref ref-type=\"bibr\" rid=\"pbio-0040365-b015\">\n      15\n     </xref>\n\
      \     &#x0005d; or the adipocyte determination- and differentiation-dependent\
      \ factor 1/sterol regulatory element binding protein 1 &#x0005b;\n     <xref\
      \ ref-type=\"bibr\" rid=\"pbio-0040365-b016\">\n      16\n     </xref>\n   \
      \  &#x0005d;. In addition to causing dyslipidemia, PIs may contribute to initiation\
      \ of atherosclerosis by affecting intracellular metabolism of cholesterol via\
      \ up-regulation of the scavenger receptor CD36 and the subsequent accumulation\
      \ of sterol in macrophages &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b017\"\
      >\n      17\n     </xref>\n     &#x0005d;. Therefore, PIs affect both extra-\
      \ and intracellular pathways of cholesterol metabolism and are likely an important\
      \ factor in pathogenesis of atherosclerosis in HIV-infected patients. However,\
      \ a number of clinical reports found a correlation between heart disease and\
      \ HIV viral load, and detected an increased risk of CAD in patients not treated\
      \ with PIs or even in drug-naive HIV-infected individuals &#x0005b;\n     <xref\
      \ ref-type=\"bibr\" rid=\"pbio-0040365-b018\">\n      18\n     </xref>\n   \
      \  ,\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b019\">\n      19\n  \
      \   </xref>\n     &#x0005d;. Recent results support the role of HIV infection\
      \ as an independent risk factor of CAD &#x0005b;\n     <xref ref-type=\"bibr\"\
      \ rid=\"pbio-0040365-b007\">\n      7\n     </xref>\n     ,\n     <xref ref-type=\"\
      bibr\" rid=\"pbio-0040365-b009\">\n      9\n     </xref>\n     ,\n     <xref\
      \ ref-type=\"bibr\" rid=\"pbio-0040365-b010\">\n      10\n     </xref>\n   \
      \  ,\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b020\">\n      20\n  \
      \   </xref>\n     &#x02013;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b022\"\
      >\n      22\n     </xref>\n     &#x0005d;, but the mechanisms of this atherogenic\
      \ effect of HIV remain unknown.\n    </p>\n    <p>\n     In this report, we\
      \ identify one such mechanism. We show that HIV, via its accessory protein Nef,\
      \ affects normal function of ATP-binding cassette transporter A1 (ABCA1) and\
      \ consequently impairs cholesterol efflux from infected macrophages. Previous\
      \ studies demonstrated the key role of ABCA1 in reverse cholesterol transport\
      \ and found that functional mutations in ABCA1 cause Tangier disease, which\
      \ is characterized by severe HDL deficiency, accumulation of sterols in tissue\
      \ macrophages, and accelerated atherosclerosis &#x0005b;\n     <xref ref-type=\"\
      bibr\" rid=\"pbio-0040365-b023\">\n      23\n     </xref>\n     &#x0005d;. The\
      \ effect of HIV-1 on ABCA1 is consistent with ABCA1 inhibition described for\
      \ viral &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b024\">\n\
      \      24\n     </xref>\n     &#x0005d; and bacterial &#x0005b;\n     <xref\
      \ ref-type=\"bibr\" rid=\"pbio-0040365-b025\">\n      25\n     </xref>\n   \
      \  &#x0005d; infections; however, the mechanism of impairment is unique for\
      \ HIV. As a result of ABCA1 inhibition, HIV-infected macrophages accumulate\
      \ lipids and transform into foam cells, a step that may contribute to the increased\
      \ risk of atherosclerotic plaque formation. Our results also suggest that cholesterol\
      \ efflux impairment may be a mechanism that ensures access of nascent virions\
      \ to intracellular cholesterol, which is critical for HIV infectivity. Therefore,\
      \ pharmacological stimulation of cholesterol efflux may be considered as a novel\
      \ anti-HIV therapeutic strategy.\n    </p>\n   </sec>\n   <sec id=\"s2\">\n\
      \    <title>\n     Results\n    </title>\n   </sec>\n   <sec id=\"s2a\">\n \
      \   <title>\n     Impairment of Cholesterol Efflux in HIV-Infected Macrophages\n\
      \    </title>\n    <p>\n     Cholesterol efflux is a pathway for removing excessive\
      \ cholesterol from cells to extracellular acceptors. It is the first step of\
      \ reverse cholesterol transport, and it plays a key role in maintaining cell\
      \ cholesterol homeostasis. Impairment of cholesterol efflux leads to accumulation\
      \ of intracellular cholesterol &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"\
      pbio-0040365-b026\">\n      26\n     </xref>\n     &#x0005d; and development\
      \ of atherosclerosis in animal models &#x0005b;\n     <xref ref-type=\"bibr\"\
      \ rid=\"pbio-0040365-b027\">\n      27\n     </xref>\n     &#x0005d; and in\
      \ humans &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b028\">\n\
      \      28\n     </xref>\n     ,\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b029\"\
      >\n      29\n     </xref>\n     &#x0005d;. Analysis of cholesterol efflux from\
      \ monocyte-derived macrophages infected in vitro with HIV-1 ADA &#x0005b;\n\
      \     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b030\">\n      30\n     </xref>\n\
      \     &#x0005d; demonstrated a substantial inhibition of apolipoprotein A-I\
      \ (apoA-I)-specific efflux (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g001\"\
      >\n      Figure 1\n     </xref>\n     A). A similar effect was observed in macrophages\
      \ infected with two primary macrophage-tropic HIV-1 strains, Yu-2 and 92US660,\
      \ indicating that impairment of cholesterol efflux is a general feature of HIV-1\
      \ replication in macrophages (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g001\"\
      >\n      Figure 1\n     </xref>\n     A). The level of cholesterol efflux inhibition\
      \ correlated with the level of virus replication (\n     <xref ref-type=\"fig\"\
      \ rid=\"pbio-0040365-g001\">\n      Figure 1\n     </xref>\n     A). Importantly,\
      \ at the time of analysis (21 d after infection), 80&#x00025;&#x02013;90&#x00025;\
      \ of the cells infected with ADA and Yu-2 viruses were p24\n     <sup>\n   \
      \   &#x0002b;\n     </sup>\n     (only 20&#x00025; of the cells infected with\
      \ 92US660 strain were p24\n     <sup>\n      &#x0002b;\n     </sup>\n     at\
      \ that time), indicating that reverse transcription (RT) values in these infections\
      \ reflected the amount of virus produced per cell and that cholesterol efflux\
      \ impairment depended on the level of virus protein expression.\n    </p>\n\
      \   </sec>\n   <sec id=\"s2b\">\n    <title>\n     Nef Is Critical for Cholesterol\
      \ Efflux Impairment\n    </title>\n    <p>\n     Previous studies demonstrated\
      \ that the HIV-1 protein Nef can directly bind cholesterol and suggested that\
      \ in CD4\n     <sup>\n      &#x0002b;\n     </sup>\n     T cells, Nef may be\
      \ involved in transporting cholesterol to the sites of HIV assembly at the plasma\
      \ membrane &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b005\"\
      >\n      5\n     </xref>\n     &#x0005d;. To test the role of Nef in the observed\
      \ impairment of cholesterol efflux from macrophages, we infected macrophages\
      \ with HIV-1 SF2 constructs carrying a mutated or a functional\n     <italic>\n\
      \      Nef\n     </italic>\n     gene. To ensure similar levels of infection,\
      \ the constructs were pseudotyped by the glycoprotein of vesicular stomatitis\
      \ virus (VSV-G), which targets HIV-1 entry to an endocytic pathway, thus eliminating\
      \ the requirement for Nef in the early steps of infection &#x0005b;\n     <xref\
      \ ref-type=\"bibr\" rid=\"pbio-0040365-b031\">\n      31\n     </xref>\n   \
      \  &#x0005d;. Under these one-cycle replication conditions, both viruses infected\
      \ about 40&#x00025; of cells and produced similar levels of p24 (\n     <xref\
      \ ref-type=\"fig\" rid=\"pbio-0040365-g001\">\n      Figure 1\n     </xref>\n\
      \     B). Cholesterol efflux to apoA-I was substantially reduced in the culture\
      \ infected with the Nef-positive virus (wild type &#x0005b;WT&#x0005d;), whereas\
      \ in the culture infected with Nef-deficient virus (&#x00394;Nef), it was similar\
      \ to the level observed in uninfected cells (\n     <xref ref-type=\"fig\" rid=\"\
      pbio-0040365-g001\">\n      Figure 1\n     </xref>\n     B). This result indicates\
      \ that Nef is necessary for HIV-mediated impairment of cholesterol efflux.\n\
      \    </p>\n    <p>\n     To determine whether Nef is sufficient for the observed\
      \ effect, we transiently transfected murine macrophages RAW 264.7 with constructs\
      \ expressing SF2-derived Nef and stimulated ABCA1 expression in these cells\
      \ by liver X receptor (LXR) agonist TO-901317. Cholesterol efflux to apoA-I\
      \ from\n     <italic>\n      Nef\n     </italic>\n     -transfected RAW 264.7\
      \ macrophages was significantly reduced (by more than 50&#x00025;) compared\
      \ to cells transfected with an empty vector (mock transfection) (\n     <xref\
      \ ref-type=\"fig\" rid=\"pbio-0040365-g001\">\n      Figure 1\n     </xref>\n\
      \     C). This result indicates that expression of Nef is sufficient to impair\
      \ cholesterol efflux from macrophages. Interestingly, Nef mutant Nef.G2A, defective\
      \ in myristoylation and membrane localization &#x0005b;\n     <xref ref-type=\"\
      bibr\" rid=\"pbio-0040365-b005\">\n      5\n     </xref>\n     &#x0005d;, was\
      \ not effective in impairing cholesterol efflux (\n     <xref ref-type=\"fig\"\
      \ rid=\"pbio-0040365-g001\">\n      Figure 1\n     </xref>\n     C) despite\
      \ levels of expression being similar to that of WT Nef (\n     <xref ref-type=\"\
      fig\" rid=\"pbio-0040365-g001\">\n      Figure 1\n     </xref>\n     D). Cholesterol\
      \ efflux impairment in Nef-transfected RAW cells was less than in HIV-infected\
      \ macrophages, likely due to differences between these cell types.\n    </p>\n\
      \   </sec>\n   <sec id=\"s2c\">\n    <title>\n     Nef Specifically Targets\
      \ ABCA1-Dependent Cholesterol Efflux\n    </title>\n    <p>\n     Specific efflux\
      \ of cholesterol from cells is mediated by the members of the family of ATP-binding\
      \ cassette (ABC) transporters. The ABCA1 transporter is responsible for lipidation\
      \ of lipid-poor apoA-I with cellular lipids &#x0005b;\n     <xref ref-type=\"\
      bibr\" rid=\"pbio-0040365-b032\">\n      32\n     </xref>\n     &#x0005d;, whereas\
      \ ABCG1 controls efflux to mature HDL &#x0005b;\n     <xref ref-type=\"bibr\"\
      \ rid=\"pbio-0040365-b033\">\n      33\n     </xref>\n     &#x0005d;. Our finding\
      \ that Nef inhibits cholesterol efflux to apoA-I (\n     <xref ref-type=\"fig\"\
      \ rid=\"pbio-0040365-g001\">\n      Figure 1\n     </xref>\n     ) suggests\
      \ that ABCA1 may be the specific target of Nef. Consistent with this notion,\
      \ cholesterol efflux to HDL (controlled by ABCG1) from HIV-infected macrophages\
      \ was not significantly impaired (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g002\"\
      >\n      Figure 2\n     </xref>\n     A). Furthermore, phospholipid efflux,\
      \ which is dependent on ABCA1 &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"\
      pbio-0040365-b034\">\n      34\n     </xref>\n     &#x0005d;, from\n     <italic>\n\
      \      Nef\n     </italic>\n     -transfected RAW 264.7 macrophages was reduced\
      \ (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g002\">\n      Figure 2\n\
      \     </xref>\n     B), similar to the effect of Nef on cholesterol efflux (\n\
      \     <xref ref-type=\"fig\" rid=\"pbio-0040365-g001\">\n      Figure 1\n  \
      \   </xref>\n     C). In addition, Nef did not affect cholesterol efflux from\
      \ RAW 264.7 cells in which ABCA1 expression was not stimulated (\n     <xref\
      \ ref-type=\"fig\" rid=\"pbio-0040365-g002\">\n      Figure 2\n     </xref>\n\
      \     C) and consequently was very low.\n    </p>\n    <p>\n     The notion\
      \ that ABCA1-mediated efflux is the target of Nef was further supported by experiments\
      \ in HeLa cells, which do not express ABC transporters and have very low background\
      \ cholesterol efflux to apoA-I &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"\
      pbio-0040365-b035\">\n      35\n     </xref>\n     &#x0005d;. Consistent with\
      \ a previous report &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b036\"\
      >\n      36\n     </xref>\n     &#x0005d;, transfection of HeLa cells with\n\
      \     <italic>\n      ABCA1\n     </italic>\n     significantly enhanced cholesterol\
      \ efflux to apoA-I, whereas co-transfection with\n     <italic>\n      Nef\n\
      \     </italic>\n     derived from SF2 or LAI strains of HIV-1 brought the efflux\
      \ back to the level observed in mock-transfected cells (\n     <xref ref-type=\"\
      fig\" rid=\"pbio-0040365-g002\">\n      Figure 2\n     </xref>\n     D). Importantly,\
      \ NefLAI, which was expressed to higher levels than NefSF2 (\n     <xref ref-type=\"\
      fig\" rid=\"pbio-0040365-g002\">\n      Figure 2\n     </xref>\n     D), was\
      \ more effective also in cholesterol efflux impairment. A similar experiment\
      \ testing the effect of Nef on ABCG1-directed cholesterol efflux showed stimulation\
      \ of cholesterol efflux to HDL after transfection of HeLa cells with ABCG1,\
      \ but did not reveal significant inhibition by Nef (\n     <xref ref-type=\"\
      fig\" rid=\"pbio-0040365-g002\">\n      Figure 2\n     </xref>\n     E). Therefore,\
      \ we conclude that Nef specifically targets ABCA1-dependent cholesterol efflux.\n\
      \    </p>\n   </sec>\n   <sec id=\"s2d\">\n    <title>\n     Nef Down-Regulates\
      \ ABCA1\n    </title>\n    <p>\n     Since ABCA1 appears to be the target of\
      \ Nef, we tested ABCA1 abundance (by Western blotting) and transcription (by\
      \ real-time RT-PCR) in HIV-infected human macrophages and\n     <italic>\n \
      \     Nef\n     </italic>\n     -transfected RAW 264.7 cells. Analysis of ABCA1\
      \ in macrophages at the peak of HIV-1 ADA replication showed a substantial decrease\
      \ of ABCA1 abundance (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g003\"\
      >\n      Figure 3\n     </xref>\n     A). Importantly, abundance of two other\
      \ proteins involved in cholesterol efflux to HDL, ABCG1 and scavenger receptor\
      \ B1 (SR-B1), was not affected by HIV infection (\n     <xref ref-type=\"fig\"\
      \ rid=\"pbio-0040365-g003\">\n      Figure 3\n     </xref>\n     A), consistent\
      \ with specific targeting of the ABCA1-dependent pathway by the virus. A similar\
      \ phenomenon was observed in Nef-transfected RAW 264.7 macrophages, although\
      \ the effect was less pronounced (approximately 50&#x00025; reduction in ABCA1\
      \ abundance when assessed by densitometry of the Western blot) (\n     <xref\
      \ ref-type=\"fig\" rid=\"pbio-0040365-g003\">\n      Figure 3\n     </xref>\n\
      \     B). The Nef.G2A mutant, which was inactive in cholesterol efflux impairment\
      \ (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g001\">\n      Figure 1\n\
      \     </xref>\n     C), was also inactive in depleting ABCA1. RT-PCR analysis\
      \ revealed a significant increase of ABCA1 mRNA in HIV-infected (\n     <xref\
      \ ref-type=\"fig\" rid=\"pbio-0040365-g003\">\n      Figure 3\n     </xref>\n\
      \     C) or Nef-transfected (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g003\"\
      >\n      Figure 3\n     </xref>\n     D) cells, which likely reflects a compensatory\
      \ response for the loss of ABCA1 &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"\
      pbio-0040365-b037\">\n      37\n     </xref>\n     &#x0005d;. This observation\
      \ rules out a suppressive effect of Nef on ABCA1 transcription and suggests\
      \ a post-transcriptional down-regulation of ABCA1 by Nef. Therefore, down-regulation\
      \ of ABCA1 is one of the mechanisms responsible for impairment of cholesterol\
      \ efflux by HIV-1.\n    </p>\n   </sec>\n   <sec id=\"s2e\">\n    <title>\n\
      \     Nef Alters Intracellular Distribution of ABCA1\n    </title>\n    <p>\n\
      \     Although down-regulation of ABCA1 alone would account for a substantial\
      \ part of the inhibition of cholesterol efflux, we further found that intracellular\
      \ distribution of ABCA1 was also affected by HIV infection. Recent reports established\
      \ that ABCA1 resides both on the plasma membrane and in endocytic vesicles &#x0005b;\n\
      \     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b036\">\n      36\n     </xref>\n\
      \     &#x0005d;, and demonstrated the role of endosomal ABCA1 and trafficking\
      \ of ABCA1 between endosomes and plasma membrane in the apoA-I&#x02013;mediated\
      \ efflux of cellular lipids from the endosomal compartment &#x0005b;\n     <xref\
      \ ref-type=\"bibr\" rid=\"pbio-0040365-b038\">\n      38\n     </xref>\n   \
      \  ,\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b039\">\n      39\n  \
      \   </xref>\n     &#x0005d;.\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g004\"\
      >\n      Figure 4\n     </xref>\n     A and\n     <xref ref-type=\"fig\" rid=\"\
      pbio-0040365-g004\">\n      4\n     </xref>\n     B show p24 staining, and\n\
      \     <xref ref-type=\"fig\" rid=\"pbio-0040365-g004\">\n      Figure 4\n  \
      \   </xref>\n     C and\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g004\"\
      >\n      4\n     </xref>\n     D show ABCA1 distribution in human macrophages\
      \ infected with &#x00394;Nef and Nef-expressing HIV-1, respectively. Consistent\
      \ with the findings of Neufeld and colleagues &#x0005b;\n     <xref ref-type=\"\
      bibr\" rid=\"pbio-0040365-b036\">\n      36\n     </xref>\n     &#x0005d;, ABCA1\
      \ was distributed evenly between the cytoplasm and the plasma membrane in human\
      \ macrophages either uninfected (unpublished data) or infected with &#x00394;Nef\
      \ HIV-1 (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g004\">\n      Figure\
      \ 4\n     </xref>\n     C), as well as in mock-transfected murine RAW 264.7\
      \ cells (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g004\">\n      Figure\
      \ 4\n     </xref>\n     E). It appears that in macrophages infected with Nef-expressing\
      \ HIV-1, ABCA1 was re-localized to the cell periphery (p24\n     <sup>\n   \
      \   &#x0002b;\n     </sup>\n     cells in\n     <xref ref-type=\"fig\" rid=\"\
      pbio-0040365-g004\">\n      Figure 4\n     </xref>\n     D). This re-localization\
      \ of ABCA1 to the plasma membrane was even more pronounced in Nef-transfected\
      \ murine macrophages RAW 264.7 (compare\n     <xref ref-type=\"fig\" rid=\"\
      pbio-0040365-g004\">\n      Figure 4\n     </xref>\n     E and\n     <xref ref-type=\"\
      fig\" rid=\"pbio-0040365-g004\">\n      4\n     </xref>\n     F). No re-localization\
      \ of ABCA1 was observed in macrophages transfected with Nef.G2A (\n     <xref\
      \ ref-type=\"fig\" rid=\"pbio-0040365-g004\">\n      Figure 4\n     </xref>\n\
      \     G). Therefore, Nef expression induces re-localization of ABCA1, which\
      \ requires myristoylation of Nef.\n    </p>\n    <p>\n     Previous studies\
      \ demonstrated that apoA-I specifically binds to ABCA1 at the cell surface &#x0005b;\n\
      \     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b040\">\n      40\n     </xref>\n\
      \     &#x02013;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b042\">\n \
      \     42\n     </xref>\n     &#x0005d;. It was also suggested that trafficking\
      \ of apoA-I to intracellular cholesterol pools correlates with trafficking of\
      \ ABCA1 &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b039\">\n\
      \      39\n     </xref>\n     ,\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b043\"\
      >\n      43\n     </xref>\n     &#x0005d;. Consistent with re-localization of\
      \ ABCA1 to the plasma membrane, the specific binding of &#x0005b;\n     <sup>\n\
      \      125\n     </sup>\n     I&#x0005d;apoA-I to Nef-transfected RAW 264.7\
      \ macrophages was increased (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g004\"\
      >\n      Figure 4\n     </xref>\n     H, left panel). However, internalization\
      \ of &#x0005b;\n     <sup>\n      125\n     </sup>\n     I&#x0005d;apoA-I was\
      \ almost completely blocked, supporting the model whereby Nef impairs intracellular\
      \ trafficking of ABCA1 (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g004\"\
      >\n      Figure 4\n     </xref>\n     H, right panel). Degradation of &#x0005b;\n\
      \     <sup>\n      125\n     </sup>\n     I&#x0005d;apoA-I was negligible and\
      \ was not affected by Nef (unpublished data).\n    </p>\n    <p>\n     Therefore,\
      \ Nef-dependent changes in intracellular distribution of ABCA1 may be another\
      \ mechanism responsible for impairment of cholesterol efflux.\n    </p>\n  \
      \ </sec>\n   <sec id=\"s2f\">\n    <title>\n     Nef Interacts with ABCA1\n\
      \    </title>\n    <p>\n     Nef has been shown to modulate expression of several\
      \ trans-membrane proteins. In some cases (e.g., with CD4 or major histocompatibility\
      \ complex &#x0005b;MHC&#x0005d; I) Nef down-regulates the protein, and in some\
      \ (e.g., with invariant chain of MHC class II or with dendritic cell-specific\
      \ ICAM-3-grabbing nonintegrin &#x0005b;DC-SIGN&#x0005d;), it up-regulates the\
      \ protein's surface expression (&#x0005b;\n     <xref ref-type=\"bibr\" rid=\"\
      pbio-0040365-b044\">\n      44\n     </xref>\n     &#x0005d; and references\
      \ therein). Some of these effects, including down-regulation of CD4 &#x0005b;\n\
      \     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b045\">\n      45\n     </xref>\n\
      \     &#x0005d; and MHC I &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b046\"\
      >\n      46\n     </xref>\n     &#x0005d;, have been shown to depend on an interaction\
      \ between Nef and the target protein. We therefore tested whether Nef interacts\
      \ with ABCA1. HeLa cells were co-transfected with Nef or Nef.G2A and FLAG-tagged\
      \ ABCA1, ABCA1 was immunoprecipitated using anti-FLAG antibody, and immunoprecipitates\
      \ were analyzed for co-precipitation of Nef. This analysis revealed that Nef\
      \ co-precipitated with ABCA1, whereas Nef.G2A did not (\n     <xref ref-type=\"\
      fig\" rid=\"pbio-0040365-g005\">\n      Figure 5\n     </xref>\n     A, upper\
      \ panel) despite equally high expression of the two forms of Nef (\n     <xref\
      \ ref-type=\"fig\" rid=\"pbio-0040365-g005\">\n      Figure 5\n     </xref>\n\
      \     A lower panel). We conclude that Nef can interact with ABCA1, and this\
      \ interaction requires myristoylation of Nef and correlates with the ability\
      \ of Nef to impair cholesterol efflux. The Nef-specific signal observed in this\
      \ experiment required high-level expression of participating proteins, likely\
      \ due to the transitory nature of Nef interaction with ABCA1.\n    </p>\n  \
      \  <p>\n     Interaction between ABCA1 and Nef at the plasma membrane was supported\
      \ by confocal microscopy, which demonstrated co-localization of Nef and ABCA1\
      \ in RAW 264.7 cells transfected with Nef.wt-expressing vector (\n     <xref\
      \ ref-type=\"fig\" rid=\"pbio-0040365-g005\">\n      Figure 5\n     </xref>\n\
      \     B). No co-localization was observed between ABCA1 and Nef.G2A (\n    \
      \ <xref ref-type=\"fig\" rid=\"pbio-0040365-g005\">\n      Figure 5\n     </xref>\n\
      \     B). This visual analysis was reinforced by an analytical quantification\
      \ presented in\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g005\">\n   \
      \   Figure 5\n     </xref>\n     C. Indeed, both ABCA1 and the WT Nef proteins\
      \ are found at the cell periphery, and their co-localization is indicated by\
      \ overlapping green and blue peaks at either end of the graph. Moreover, both\
      \ colors peak and valley in tandem, suggesting a correlation in subcellular\
      \ localization of ABCA1 and WT Nef. No such correlation is observed in ABCA1\
      \ and Nef.G2A distribution. Taken together, these results suggest that interaction\
      \ between ABCA1 and Nef occurs at the cell plasma membrane.\n    </p>\n    <p>\n\
      \     Therefore, both re-localization and down-modulation of ABCA1 depend on\
      \ its interaction with Nef, which in turn requires myristoylation and membrane\
      \ localization of Nef.\n    </p>\n   </sec>\n   <sec id=\"s2g\">\n    <title>\n\
      \     HIV-Infected Macrophages Transform into Foam Cells\n    </title>\n   \
      \ <p>\n     To determine whether impairment of cholesterol efflux by HIV-1 infection\
      \ leads to cholesterol accumulation and foam cell formation, we loaded macrophages\
      \ (uninfected or infected with Nef-expressing or &#x00394;Nef HIV-1) with lipids\
      \ by incubating with acetylated LDL (AcLDL) in the presence of apoA-I and stained\
      \ cellular lipids with Oil Red O (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g006\"\
      >\n      Figure 6\n     </xref>\n     ). This experiment revealed formation\
      \ of typical lipid-rich cells in cultures infected with Nef-expressing HIV-1,\
      \ whereas uninfected cells or macrophages infected with &#x00394;Nef virus accumulated\
      \ substantially less cholesterol (compare\n     <xref ref-type=\"fig\" rid=\"\
      pbio-0040365-g006\">\n      Figure 6\n     </xref>\n     A,\n     <xref ref-type=\"\
      fig\" rid=\"pbio-0040365-g006\">\n      6\n     </xref>\n     B, and 6C). Analysis\
      \ by transmission electron microscopy revealed more lipid vacuoles (arrows in\n\
      \     <xref ref-type=\"fig\" rid=\"pbio-0040365-g006\">\n      Figure 6\n  \
      \   </xref>\n     E) in macrophages infected with Nef-expressing HIV-1 than\
      \ in uninfected cells or cells infected with &#x00394;Nef HIV-1 (compare\n \
      \    <xref ref-type=\"fig\" rid=\"pbio-0040365-g006\">\n      Figure 6\n   \
      \  </xref>\n     D,\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g006\">\n\
      \      6\n     </xref>\n     E, and 6F). Cholesterol loading of RAW 264.7 macrophages\
      \ transfected with Nef also led to accumulation of significantly larger amounts\
      \ of lipids when compared to cells transfected with an empty vector (compare\n\
      \     <xref ref-type=\"fig\" rid=\"pbio-0040365-g006\">\n      Figure 6\n  \
      \   </xref>\n     H and\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g006\"\
      >\n      6\n     </xref>\n     I). In addition, Nef-transfected RAW 264.7 macrophages\
      \ demonstrated accelerated cholesteryl ester synthesis, especially when cells\
      \ were loaded with AcLDL (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g006\"\
      >\n      Figure 6\n     </xref>\n     G). Enhanced synthesis of cholesteryl\
      \ esters is a sensitive indicator of accumulation of cholesterol inside the\
      \ cells and a key element of foam cell formation.\n    </p>\n    <p>\n     Measurements\
      \ of cholesterol mass confirmed substantially higher cholesteryl ester content\
      \ in Nef-transfected RAW 264.7 macrophages compared to mock-transfected cells\
      \ (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g007\">\n      Figure 7\n\
      \     </xref>\n     A); there was also more free cholesterol in the transfected\
      \ macrophages (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g007\">\n  \
      \    Figure 7\n     </xref>\n     B). Synthesis of triglycerides was not affected\
      \ (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g007\">\n      Figure 7\n\
      \     </xref>\n     C), indicating that increased cholesteryl ester synthesis\
      \ and content is a consequence of increased concentration of cholesterol rather\
      \ than of fatty acids. The increased cholesterol content in Nef-transfected\
      \ cells was not caused by differences in AcLDL uptake, as the latter was similar\
      \ between Nef-transfected and mock-transfected cells (\n     <xref ref-type=\"\
      fig\" rid=\"pbio-0040365-g007\">\n      Figure 7\n     </xref>\n     D). To\
      \ accommodate the increasing amounts of cholesteryl esters, cells would require\
      \ an additional amount of phospholipids, and, indeed, the efflux of phospholipids\
      \ was inhibited (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g002\">\n\
      \      Figure 2\n     </xref>\n     A), whereas phospholipid synthesis was accelerated\
      \ in Nef-transfected cells (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g007\"\
      >\n      Figure 7\n     </xref>\n     E). Taken together, these results indicate\
      \ that HIV-1 infection, via Nef expression, impairs reverse cholesterol transport\
      \ in macrophages and leads to accumulation of lipids and formation of foam cells.\n\
      \    </p>\n   </sec>\n   <sec id=\"s2h\">\n    <title>\n     HIV-Positive Foam\
      \ Cells in Atherosclerotic Plaques of HIV-Infected Patients\n    </title>\n\
      \    <p>\n     Our finding that HIV-1 infection of macrophages impairs cholesterol\
      \ efflux from these cells suggests that HIV-infected macrophages may potentially\
      \ contribute to the development of atherosclerotic plaques, especially when\
      \ combined with dyslipidemia found in PI-treated patients. Immunostaining of\
      \ sections of atherosclerotic plaques obtained from highly active antiretroviral\
      \ therapy (HAART)-treated HIV-infected patients demonstrated the presence of\
      \ p24\n     <sup>\n      &#x0002b;\n     </sup>\n     macrophages (\n     <xref\
      \ ref-type=\"fig\" rid=\"pbio-0040365-g008\">\n      Figure 8\n     </xref>\n\
      \     A,\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g008\">\n      8\n\
      \     </xref>\n     B,\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g008\"\
      >\n      8\n     </xref>\n     E, and 8F). In areas surrounding lipid cores,\
      \ some p24\n     <sup>\n      &#x0002b;\n     </sup>\n     cells displayed a\
      \ typical foam cell appearance (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g008\"\
      >\n      Figure 8\n     </xref>\n     B). Analysis of parallel consecutive sections\
      \ stained with anti-CD68 showed that these p24\n     <sup>\n      &#x0002b;\n\
      \     </sup>\n     cells were located in areas composed of CD68\n     <sup>\n\
      \      &#x0002b;\n     </sup>\n     cells (\n     <xref ref-type=\"fig\" rid=\"\
      pbio-0040365-g008\">\n      Figure 8\n     </xref>\n     C), indicating the\
      \ macrophage nature of p24\n     <sup>\n      &#x0002b;\n     </sup>\n     foam\
      \ cells. Double immunostaining confirmed this notion by demonstrating the association\
      \ of p24 staining with CD68\n     <sup>\n      &#x0002b;\n     </sup>\n    \
      \ macrophages and macrophage foam cells (\n     <xref ref-type=\"fig\" rid=\"\
      pbio-0040365-g008\">\n      Figure 8\n     </xref>\n     E and\n     <xref ref-type=\"\
      fig\" rid=\"pbio-0040365-g008\">\n      8\n     </xref>\n     F). These findings\
      \ indicate that HIV-infected, cholesterol-loaded macrophages are present in\
      \ the atherosclerotic plaque and therefore may potentially be involved in pathophysiological\
      \ events leading to the development of atherosclerosis.\n    </p>\n   </sec>\n\
      \   <sec id=\"s2i\">\n    <title>\n     Active Cholesterol Efflux Reduces Infectivity\
      \ of HIV Virions\n    </title>\n    <p>\n     To determine whether impairment\
      \ of cholesterol efflux has a role in HIV biology, we compared infectivity of\
      \ HIV virions produced from monocyte-derived macrophages stimulated or not with\
      \ an LXR agonist, TO-901317. We hypothesized that if impairment of cholesterol\
      \ efflux is a specific mechanism to increase HIV replication, then agents counteracting\
      \ this effect should have anti-HIV activity. LXR agonists up-regulate expression\
      \ of ABCA1 at a transcriptional level and stimulate cholesterol efflux from\
      \ various cell types, including human monocyte-derived macrophages (&#x0005b;\n\
      \     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b047\">\n      47\n     </xref>\n\
      \     &#x0005d; and\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g009\">\n\
      \      Figure 9\n     </xref>\n     A). When added to HIV-infected macrophages\
      \ at day 7 after infection and kept with cells for another 7 d (to allow ABCA1\
      \ to accumulate and overcome Nef-mediated inhibition), LXR agonist prevented\
      \ the impairment of cholesterol efflux by HIV-1 infection (\n     <xref ref-type=\"\
      fig\" rid=\"pbio-0040365-g009\">\n      Figure 9\n     </xref>\n     A); in\
      \ fact, cholesterol efflux from TO-901317&#x02013;treated HIV-infected macrophages\
      \ was similar to efflux from uninfected cells stimulated with the LXR agonist.\
      \ The lack of HIV-specific reduction of cholesterol efflux is likely due to\
      \ overproduction of ABCA1, which exceeds production of Nef. Virions were collected\
      \ from TO-901317&#x02013;treated and untreated cells, adjusted according to\
      \ p24 content, and analyzed for infectivity using indicator P4-CCR5 cells. This\
      \ analysis revealed a substantial reduction (by about 80&#x00025;) of infectivity\
      \ of virions produced from macrophages treated with LXR agonist (\n     <xref\
      \ ref-type=\"fig\" rid=\"pbio-0040365-g009\">\n      Figure 9\n     </xref>\n\
      \     B). Interestingly, protein composition of the virions produced from LXR\
      \ agonist&#x02013;treated and untreated cells was very similar (unpublished\
      \ data), whereas virion-associated cholesterol was significantly diminished\
      \ in virions produced from TO-901317&#x02013;treated macrophages (\n     <xref\
      \ ref-type=\"fig\" rid=\"pbio-0040365-g009\">\n      Figure 9\n     </xref>\n\
      \     C). These results suggest that stimulation of cellular cholesterol efflux\
      \ may be an effective approach to suppressing HIV replication.\n    </p>\n \
      \  </sec>\n   <sec id=\"s3\">\n    <title>\n     Discussion\n    </title>\n\
      \    <p>\n     Results presented in this report demonstrate that HIV-1, via\
      \ the accessory protein Nef, impairs cholesterol efflux from macrophages. This\
      \ finding can be interpreted as a virus-mediated switch of cholesterol trafficking\
      \ from physiological efflux to virus-controlled transport, thus reducing the\
      \ ability of a cell to export excessive cholesterol. Given that availability\
      \ of cholesterol is critical for HIV assembly and infectivity &#x0005b;\n  \
      \   <xref ref-type=\"bibr\" rid=\"pbio-0040365-b048\">\n      48\n     </xref>\n\
      \     &#x0005d;, it is physiologically sensible for the virus to take over control\
      \ of intracellular cholesterol metabolism.\n    </p>\n    <p>\n     A previous\
      \ report demonstrated that Nef binds cholesterol and may deliver it to nascent\
      \ virions &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b005\"\
      >\n      5\n     </xref>\n     &#x0005d;. Our study suggests that Nef-mediated\
      \ impairment of cholesterol efflux is another mechanism ensuring efficient delivery\
      \ of cholesterol to HIV. Importantly, this mechanism may be a necessary component\
      \ of the above-mentioned Nef-mediated transport of cholesterol to virions. Indeed,\
      \ prevention of cholesterol efflux impairment by LXR agonist reduces virion-associated\
      \ cholesterol without interfering with Nef incorporation into the virions (unpublished\
      \ data). Reduction of virion-associated cholesterol correlates with lower virion\
      \ infectivity (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g009\">\n  \
      \    Figure 9\n     </xref>\n     B and\n     <xref ref-type=\"fig\" rid=\"\
      pbio-0040365-g009\">\n      9\n     </xref>\n     C).\n    </p>\n    <p>\n \
      \    Our results demonstrate that Nef specifically targets ABCA1. Indeed, Nef\
      \ did not suppress cholesterol efflux in cells lacking ABCA1 (HeLa cells or\
      \ non-activated RAW 264.7 cells), but did so in ABCA1-expressing cells, such\
      \ as RAW 264.7 cells stimulated with an LXR agonist, HeLa cells transfected\
      \ with ABCA1, and differentiated human macrophages. Furthermore, Nef did not\
      \ suppress cholesterol efflux from ABCG1-transfected HeLa cells (\n     <xref\
      \ ref-type=\"fig\" rid=\"pbio-0040365-g002\">\n      Figure 2\n     </xref>\n\
      \     E). These findings and the fact that Nef can interact with ABCA1 (\n \
      \    <xref ref-type=\"fig\" rid=\"pbio-0040365-g005\">\n      Figure 5\n   \
      \  </xref>\n     A) suggest that there is an interplay between Nef and ABCA1\
      \ in an HIV-infected cell. The end result of this interplay would depend on\
      \ relative levels of expression of Nef and ABCA1. Consistent with this suggestion,\
      \ overexpression of Nef from the cytomegalovirus (CMV) promoter inhibits ABCA1-mediated\
      \ cholesterol efflux stimulated with the LXR agonist (\n     <xref ref-type=\"\
      fig\" rid=\"pbio-0040365-g001\">\n      Figure 1\n     </xref>\n     C), whereas\
      \ levels of Nef expressed from the HIV LTR are insufficient to suppress LXR\
      \ agonist-stimulated cholesterol efflux in HIV-infected macrophages (\n    \
      \ <xref ref-type=\"fig\" rid=\"pbio-0040365-g009\">\n      Figure 9\n     </xref>\n\
      \     A). As a result, HIV infectivity is reduced in LXR agonist-stimulated\
      \ cells (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g009\">\n      Figure\
      \ 9\n     </xref>\n     B). Therefore, drugs stimulating cholesterol efflux\
      \ may provide a dual benefit to HIV-infected patients by limiting HIV replication\
      \ and reducing the risk of atherosclerosis.\n    </p>\n    <p>\n     Our studies\
      \ show that cholesterol efflux impairment is a conserved feature of HIV-1 Nef.\
      \ Indeed, we show this phenomenon using three R5 (ADA, Yu-2, and 92US660) and\
      \ two X4 (SF2 and LAI) HIV-1 isolates. We demonstrate that HIV-1 Nef impairs\
      \ cholesterol efflux by at least two mechanisms: it reduces ABCA1 abundance,\
      \ and it causes intracellular re-distribution of ABCA1. These two mechanisms\
      \ may be related, as they both depend on interaction between Nef and ABCA1 (\n\
      \     <xref ref-type=\"fig\" rid=\"pbio-0040365-g003\">\n      Figures 3\n \
      \    </xref>\n     &#x02013;\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g005\"\
      >\n      5\n     </xref>\n     ). For example, a block to intracellular trafficking\
      \ of ABCA1 may re-target this protein to a degradation pathway. Alternatively,\
      \ ABCA1 re-distribution and down-regulation may be two independent effects of\
      \ Nef, both contributing to impairment of cholesterol efflux. Indeed, several\
      \ recent reports demonstrated a role of ABCA1 trafficking between late endosomes\
      \ and the cell surface in cholesterol efflux from endosomal compartment &#x0005b;\n\
      \     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b036\">\n      36\n     </xref>\n\
      \     ,\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b038\">\n      38\n\
      \     </xref>\n     ,\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b039\"\
      >\n      39\n     </xref>\n     ,\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b049\"\
      >\n      49\n     </xref>\n     &#x0005d;. The effects of Nef on ABCA1 distribution\
      \ and apoA-I binding and internalization are similar to the effects of cyclosporin\
      \ A &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b043\">\n   \
      \   43\n     </xref>\n     &#x0005d; or deletion of the PEST sequence in ABCA1\
      \ &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b039\">\n     \
      \ 39\n     </xref>\n     &#x0005d;, both of which inhibit efflux of cholesterol\
      \ from late endosomes. Therefore, both down-regulation of ABCA1 and its intracellular\
      \ re-distribution can independently contribute to cholesterol efflux impairment\
      \ observed in HIV-infected cells. Interestingly, Nef alone had less effect on\
      \ ABCA1 abundance than HIV-1 infection (compare\n     <xref ref-type=\"fig\"\
      \ rid=\"pbio-0040365-g003\">\n      Figure 3\n     </xref>\n     A and\n   \
      \  <xref ref-type=\"fig\" rid=\"pbio-0040365-g003\">\n      3\n     </xref>\n\
      \     B), however, it had a more profound effect on the sequestration of ABCA1\
      \ at the plasma membrane (compare\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g004\"\
      >\n      Figure 4\n     </xref>\n     D and\n     <xref ref-type=\"fig\" rid=\"\
      pbio-0040365-g004\">\n      4\n     </xref>\n     F). Although this result may\
      \ be due to differences between the cell types in which these analyses were\
      \ performed (primary human macrophages for HIV infection and murine macrophage\
      \ cell line RAW 264.7 for\n     <italic>\n      Nef\n     </italic>\n     transfection),\
      \ it is also possible that the primary effect of Nef is to sequester ABCA1 at\
      \ the plasma membrane, and some other HIV protein may cooperate with Nef to\
      \ stimulate down-regulation of sequestered ABCA1.\n    </p>\n    <p>\n     The\
      \ exact molecular mechanisms responsible for the effect of Nef on intracellular\
      \ trafficking and abundance of ABCA1 are yet to be fully investigated. Nef is\
      \ known to regulate expression of several transmembrane proteins, including\
      \ CD4 &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b045\">\n \
      \     45\n     </xref>\n     &#x0005d;, MHC I &#x0005b;\n     <xref ref-type=\"\
      bibr\" rid=\"pbio-0040365-b050\">\n      50\n     </xref>\n     &#x0005d;, MHC\
      \ II &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b050\">\n  \
      \    50\n     </xref>\n     &#x0005d;, CD28 &#x0005b;\n     <xref ref-type=\"\
      bibr\" rid=\"pbio-0040365-b051\">\n      51\n     </xref>\n     &#x0005d;, and\
      \ DC-SIGN &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b052\"\
      >\n      52\n     </xref>\n     &#x0005d;. In most cases, Nef mediates internalization\
      \ and degradation of the receptor &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"\
      pbio-0040365-b053\">\n      53\n     </xref>\n     &#x0005d;, but in some cases\
      \ (e.g., with DC-SIGN or invariant chain of MHC II), it up-regulates the cell\
      \ surface expression of the protein. These effects are consistent with our findings\
      \ showing ABCA1 re-localization and down-regulation, which may involve mechanisms\
      \ similar to those described for Nef interactions with other proteins. It is\
      \ worth noting that few of the above-mentioned studies showed co-immunoprecipitation\
      \ of Nef with a target protein from HIV-infected cells, consistent with our\
      \ inability to pull down Nef and ABCA1 from HIV-infected macrophages. This may\
      \ be due to a transitory nature of Nef&#x02013;ABCA1 interaction and low-level\
      \ expression of these proteins. Analysis of this interaction in cells overexpressing\
      \ both proteins demonstrated a critical role of Nef myristoylation (\n     <xref\
      \ ref-type=\"fig\" rid=\"pbio-0040365-g005\">\n      Figure 5\n     </xref>\n\
      \     A). This fatty acid may either be directly involved in binding of Nef\
      \ to ABCA1, similar to the role that farnesylation of the yeast pheromone a-factor\
      \ plays in its interaction with the yeast ABC transporter Ste6 &#x0005b;\n \
      \    <xref ref-type=\"bibr\" rid=\"pbio-0040365-b054\">\n      54\n     </xref>\n\
      \     &#x0005d;, or it may regulate Nef&#x02013;ABCA1 interaction indirectly\
      \ by targeting Nef to the plasma membrane. Further analysis of the mechanisms\
      \ by which Nef affects ABCA1 function would require understanding of the molecular\
      \ events that regulate intracellular trafficking and degradation of ABCA1 in\
      \ uninfected cells, which is incompletely characterized and is a subject of\
      \ the ongoing studies.\n    </p>\n    <p>\n     The results of this study have\
      \ potential implications for understanding pathogenesis of CAD in HIV-infected\
      \ patients. These patients have a mildly elevated risk of CAD &#x0005b;\n  \
      \   <xref ref-type=\"bibr\" rid=\"pbio-0040365-b055\">\n      55\n     </xref>\n\
      \     &#x0005d;, which is sharply raised by treatment with certain PIs &#x0005b;\n\
      \     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b007\">\n      7\n     </xref>\n\
      \     ,\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b009\">\n      9\n\
      \     </xref>\n     ,\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b014\"\
      >\n      14\n     </xref>\n     ,\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b019\"\
      >\n      19\n     </xref>\n     &#x0005d;. Increased risk of CAD after treatment\
      \ with PIs led to the assumption that PIs and/or dyslipidemia are the primary\
      \ source of development of atherosclerosis in HIV patients. Results presented\
      \ in this report suggest that HIV-induced impairment of cholesterol efflux from\
      \ macrophages may be another important contributor to the pathogenesis of CAD.\
      \ Indeed, inactivation of ABCA1 in macrophages of hyperlipidemic mice significantly\
      \ increased development of atherosclerosis &#x0005b;\n     <xref ref-type=\"\
      bibr\" rid=\"pbio-0040365-b027\">\n      27\n     </xref>\n     &#x0005d;, and\
      \ genetic mutation inactivating ABCA1 in humans leads to Tangier disease, one\
      \ of the characteristic features of which is an increased risk of CAD &#x0005b;\n\
      \     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b028\">\n      28\n     </xref>\n\
      \     &#x0005d;. Impairment of reverse cholesterol transport mediated by down-regulation\
      \ of ABCA1 has been described for bacterial infections and has been linked to\
      \ pathogenesis of atherosclerosis (reviewed in &#x0005b;\n     <xref ref-type=\"\
      bibr\" rid=\"pbio-0040365-b056\">\n      56\n     </xref>\n     &#x0005d;).\
      \ In the case of HIV infection, this mechanism would have only a mild atherogenic\
      \ effect or not at all on the background of hypocholesterolemia characteristic\
      \ for untreated HIV-1 infection &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"\
      pbio-0040365-b055\">\n      55\n     </xref>\n     ,\n     <xref ref-type=\"\
      bibr\" rid=\"pbio-0040365-b057\">\n      57\n     </xref>\n     &#x0005d;. Treatment\
      \ of HIV-infected patients with HAART causes a sharp rise of triglyceride-rich\
      \ VLDL, resulting in enhanced lipid uptake and foam cell formation &#x0005b;\n\
      \     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b058\">\n      58\n     </xref>\n\
      \     &#x0005d;, and small dense LDL &#x0005b;\n     <xref ref-type=\"bibr\"\
      \ rid=\"pbio-0040365-b059\">\n      59\n     </xref>\n     ,\n     <xref ref-type=\"\
      bibr\" rid=\"pbio-0040365-b060\">\n      60\n     </xref>\n     &#x0005d;, which\
      \ is particularly susceptible to oxidation &#x0005b;\n     <xref ref-type=\"\
      bibr\" rid=\"pbio-0040365-b061\">\n      61\n     </xref>\n     &#x0005d;, is\
      \ more able to infiltrate the subendothelial space, and is a risk factor for\
      \ CAD &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b062\">\n \
      \     62\n     </xref>\n     &#x0005d;. A combination of these effects of HAART\
      \ and impairment of cholesterol efflux by HIV (which prevents compensatory removal\
      \ of excessive cholesterol) would result in a greatly enhanced accumulation\
      \ of cholesterol in HIV-infected macrophages and would potentially further increase\
      \ the risk of development of atherosclerosis. It should be noted that HIV-infected\
      \ macrophages, unlike T cells, survive for extended periods of time and are\
      \ considered long-term reservoirs of HIV-1 &#x0005b;\n     <xref ref-type=\"\
      bibr\" rid=\"pbio-0040365-b063\">\n      63\n     </xref>\n     &#x0005d;. As\
      \ a result, infected macrophages persist, at least for some time, in HAART-treated\
      \ patients, when conditions favor development of atherosclerotic plaques. We\
      \ can speculate that these macrophages may contribute to initiation of atherosclerotic\
      \ plaque formation, which then proceeds even in the absence of newly infected\
      \ cells. This mechanism is consistent with the presence of HIV-infected macrophages\
      \ in atherosclerotic plaques of HAART-treated patients observed in our study\
      \ (\n     <xref ref-type=\"fig\" rid=\"pbio-0040365-g008\">\n      Figure 8\n\
      \     </xref>\n     ). However, further in vivo and clinical studies are required\
      \ to evaluate the contribution of the impairment of reverse cholesterol transport\
      \ to the risk of atherosclerosis in HIV patients.\n    </p>\n    <p>\n     Findings\
      \ presented in this report provide an example of how viruses may interfere with\
      \ cellular cholesterol metabolism and may potentially affect the risk of atherosclerosis.\
      \ This example may be not unique to HIV. Other viruses (such as Herpes virus\
      \ or CMV) were found in atherosclerotic plaques and were epidemiologically associated\
      \ with elevated risk of development of atherosclerosis &#x0005b;\n     <xref\
      \ ref-type=\"bibr\" rid=\"pbio-0040365-b064\">\n      64\n     </xref>\n   \
      \  &#x02013;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b066\">\n    \
      \  66\n     </xref>\n     &#x0005d;. Future studies will determine whether these\
      \ viruses cause disturbances in cholesterol metabolism similar to those found\
      \ in this report. In support of this possibility, several reports demonstrated\
      \ that bacterial and viral pathogens may modulate macrophage cholesterol efflux\
      \ by down-regulating ABC transporters via LXR-dependent &#x0005b;\n     <xref\
      \ ref-type=\"bibr\" rid=\"pbio-0040365-b024\">\n      24\n     </xref>\n   \
      \  &#x0005d; and LXR-independent &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"\
      pbio-0040365-b025\">\n      25\n     </xref>\n     &#x0005d; pathways. The first\
      \ pathway is engaged after activation of Toll-like receptors by invading viruses\
      \ or bacteria. The second pathway involves the negative effect of bacterial\
      \ endotoxin on ABCA1 mRNA levels in macrophages &#x0005b;\n     <xref ref-type=\"\
      bibr\" rid=\"pbio-0040365-b025\">\n      25\n     </xref>\n     &#x0005d;. Both\
      \ pathways promote conversion of macrophages into foam cells, which may acquire\
      \ resistance to pathogen, but retain their atherogenic properties &#x0005b;\n\
      \     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b012\">\n      12\n     </xref>\n\
      \     &#x0005d;. Therefore, the effect on reverse cholesterol transport may\
      \ be a common feature of viral and bacterial infection of macrophages, although\
      \ mechanisms involved are likely unique for each infection.\n    </p>\n   </sec>\n\
      \   <sec sec-type=\"materials|methods\" id=\"s4\">\n    <title>\n     Materials\
      \ and Methods\n    </title>\n   </sec>\n   <sec id=\"s4a\">\n    <title>\n \
      \    Human monocyte-derived macrophage cultures.\n    </title>\n    <p>\n  \
      \   Monocyte-derived macrophages were prepared from peripheral blood mononuclear\
      \ cells of normal donors using adherence to plastic, and differentiated in the\
      \ presence of macrophage colony-stimulating factor essentially as previously\
      \ described &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b067\"\
      >\n      67\n     </xref>\n     &#x0005d;. No stimulation with LXR agonist was\
      \ performed unless indicated.\n    </p>\n   </sec>\n   <sec id=\"s4b\">\n  \
      \  <title>\n     Antibodies.\n    </title>\n    <p>\n     The following antibodies\
      \ were used for Western blotting: rabbit polyclonal anti-ABCA1 (Novus Biologicals,\
      \ Littleton, Colorado, United States), rabbit polyclonal and mouse monoclonal\
      \ anti-Nef (AIDS Research and Reference Reagent Program), rabbit polyclonal\
      \ anti-ABCG1 (Novus Biologicals), rabbit polyclonal anti-SR-B1 (Novus Biologicals),\
      \ and mouse monoclonal anti-&#x003b2;-actin (Sigma, St. Louis, Missouri, United\
      \ States).\n    </p>\n   </sec>\n   <sec id=\"s4c\">\n    <title>\n     Viruses\
      \ and infections.\n    </title>\n    <p>\n     Macrophage-tropic HIV-1 strains\
      \ Yu-2 and 92US660 were obtained from the National Institutes of Health (NIH)\
      \ AIDS Research and Reference Reagent Program. VSV-G&#x02013;pseudotyped HIV-1\
      \ was prepared by co-transfecting HEK 293T cells with Env-deficient HIV-1 infectious\
      \ clones &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b005\">\n\
      \      5\n     </xref>\n     &#x0005d; and VSV-G-expressing plasmid pHEF-VSVG\
      \ &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b068\">\n     \
      \ 68\n     </xref>\n     &#x0005d;. All infections were performed using 3.5\
      \ &#x000d7; 10\n     <sup>\n      6\n     </sup>\n     cpm of RT activity per\
      \ 10\n     <sup>\n      6\n     </sup>\n     cells.\n    </p>\n   </sec>\n \
      \  <sec id=\"s4d\">\n    <title>\n     FACS analysis of HIV-infected macrophages.\n\
      \    </title>\n    <p>\n     To determine the percentage of HIV-infected cells,\
      \ HIV-infected macrophages were detached from the plate, fixed in 4&#x00025;\
      \ formalin/PBS, permeabilized using Becton-Dickinson permeabilization/washing\
      \ solution (15 min at 4 &#x000b0;C), and incubated with PE-conjugated anti-p24\
      \ monoclonal antibodies (mAb) or isotype control IgG for 30 min at 4 &#x000b0;C.\
      \ After washing, cells were analyzed on a FACScan flow cytometer (Becton-Dickinson,\
      \ Palo Alto, California, United States).\n    </p>\n   </sec>\n   <sec id=\"\
      s4e\">\n    <title>\n     Transfection.\n    </title>\n    <p>\n     RAW 264.7\
      \ mouse macrophage cells were transiently transfected using the DEAE-dextran\
      \ method and 5-azacytidine as described previously &#x0005b;\n     <xref ref-type=\"\
      bibr\" rid=\"pbio-0040365-b069\">\n      69\n     </xref>\n     &#x0005d;. The\
      \ efficiency of transfection was 80&#x00025;&#x02013;90&#x00025;. HEK 293T and\
      \ HeLa cells were transfected using Metafectene reagent (Biontex, Munich, Germany)\
      \ following the manufacturer's protocol. The efficiency of transfection was\
      \ 80&#x00025;.\n    </p>\n   </sec>\n   <sec id=\"s4f\">\n    <title>\n    \
      \ Cholesterol and phospholipid efflux from RAW 264.7 cells.\n    </title>\n\
      \    <p>\n     RAW 264.7 cells were incubated in labeling medium containing\
      \ &#x0005b;\n     <sup>\n      3\n     </sup>\n     H&#x0005d;cholesterol (75\
      \ kBq/ml) or &#x0005b;methyl-\n     <sup>\n      14\n     </sup>\n     C&#x0005d;choline\
      \ (0.2 MBq/ml) for 48 h. Cells were then incubated for 18 h in serum-free medium\
      \ in the presence of the LXR agonist TO-901317 (final concentration 1 &#x003bc;M)\
      \ to stimulate ABCA1 expression and cholesterol efflux. Cells were then washed\
      \ with PBS and incubated for 3 h in either serum-free medium alone (blank) or\
      \ in serum-free medium supplemented with 30 &#x003bc;g/ml of lipid-free apoA-I\
      \ or 30 &#x003bc;g/ml of HDL &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"\
      pbio-0040365-b070\">\n      70\n     </xref>\n     &#x0005d;. For cholesterol\
      \ efflux analysis, aliquots of medium and cells were counted. Phospholipids\
      \ were isolated from medium and cells by thin layer chromatography (TLC) as\
      \ described previously &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b071\"\
      >\n      71\n     </xref>\n     &#x0005d;. The efflux was calculated as radioactivity\
      \ in the medium/(radioactivity in the medium &#x0002b; radioactivity remaining\
      \ in the cells) &#x000d7; 100&#x00025;. ApoA-I&#x02013;dependent efflux is efflux\
      \ to apoA-I minus efflux to blank.\n    </p>\n   </sec>\n   <sec id=\"s4g\"\
      >\n    <title>\n     Cholesterol efflux from monocyte-derived macrophages and\
      \ HeLa cells.\n    </title>\n    <p>\n     The same procedure as described above\
      \ was used except that cells were not stimulated with LXR agonist, and efflux\
      \ was allowed to proceed for 12 h rather than the 3 h used for RAW 264.7 cells.\
      \ Efflux to serum-free medium supplemented with 30 &#x003bc;g/ml of human serum\
      \ albumin was used as a control.\n    </p>\n   </sec>\n   <sec id=\"s4h\">\n\
      \    <title>\n     Phospholipid biosynthesis.\n    </title>\n    <p>\n     RAW\
      \ 264.7 cells were incubated in serum-free medium containing &#x0005b;methyl-\n\
      \     <sup>\n      14\n     </sup>\n     C&#x0005d;choline (0.2 MBq/ml) for\
      \ 2 h. Cells were washed, and lipids were extracted and separated by TLC &#x0005b;\n\
      \     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b071\">\n      71\n     </xref>\n\
      \     &#x0005d;. Phospholipid biosynthesis was defined as incorporation of &#x0005b;\n\
      \     <sup>\n      14\n     </sup>\n     C&#x0005d;choline into phospholipids\
      \ per mg of cell protein per 2 h.\n    </p>\n   </sec>\n   <sec id=\"s4i\">\n\
      \    <title>\n     Cholesteryl ester and triglyceride biosynthesis and content.\n\
      \    </title>\n    <p>\n     RAW 264.7 cells were incubated with or without\
      \ AcLDL (50 &#x003bc;g/ml) in the presence of 30 &#x003bc;g/ml of lipid-free\
      \ apoA-I or 5&#x00025; normolipidemic human plasma for 2 h at 37 &#x000b0;C.\
      \ Cells were then incubated for 2 h with 37 kBq/ml &#x0005b;\n     <sup>\n \
      \     14\n     </sup>\n     C&#x0005d;oleic acid (presented to the cells as\
      \ a BSA&#x02013;sodium oleate complex). Cells were washed, lipids extracted\
      \ and &#x0005b;\n     <sup>\n      14\n     </sup>\n     C&#x0005d;oleic acid\
      \ incorporation into cholesteryl esters and triglyceride was measured after\
      \ separation of the extracts by TLC &#x0005b;\n     <xref ref-type=\"bibr\"\
      \ rid=\"pbio-0040365-b072\">\n      72\n     </xref>\n     &#x0005d;. Cellular\
      \ free and total cholesterol content were measured using enzymatic assay (Roche,\
      \ Basel, Switzerland). Free cholesterol content was calculated as a difference\
      \ between total and esterified cholesterol.\n    </p>\n   </sec>\n   <sec id=\"\
      s4j\">\n    <title>\n     AcLDL uptake.\n    </title>\n    <p>\n     AcLDL was\
      \ labeled with\n     <sup>\n      125\n     </sup>\n     I using Iodobeads (Pierce\
      \ Biotechnology, Rockford, Illinois, United States) according to the manufacturer'\
      \ instructions, the final specific radioactivity was 100 cpm/ng protein. Cells\
      \ were incubated with &#x0005b;\n     <sup>\n      125\n     </sup>\n     I&#x0005d;AcLDL\
      \ at the final concentration 5 &#x003bc;g/ml in the presence or absence of 100-fold\
      \ excess of unlabeled AcLDL for 2 h at 37 &#x000b0;C. The amount of degraded\
      \ &#x0005b;\n     <sup>\n      125\n     </sup>\n     I&#x0005d;AcLDL in the\
      \ medium was determined as non-iodine trichloroacetic acid&#x02013;soluble radioactivity.\
      \ Cells were then washed and counted, and specific AcLDL uptake was calculated\
      \ as a sum of cell-associated and degraded &#x0005b;\n     <sup>\n      125\n\
      \     </sup>\n     I&#x0005d;AcLDL after subtraction of non-specific binding\
      \ and degradation (i.e., measured in the presence of unlabeled AcLDL).\n   \
      \ </p>\n   </sec>\n   <sec id=\"s4k\">\n    <title>\n     ApoA-I binding, internalization,\
      \ and degradation.\n    </title>\n    <p>\n     Human apoA-I was labeled with\n\
      \     <sup>\n      125\n     </sup>\n     I using Iodobeads; the final specific\
      \ radioactivity was 200-cpm/ng protein. Cells were incubated with &#x0005b;\n\
      \     <sup>\n      125\n     </sup>\n     I&#x0005d;apoA-I at the final concentration\
      \ 2 &#x003bc;g/ml in the presence or absence of a 100-fold excess of unlabeled\
      \ apoA-I for 2 h at 37 &#x000b0;C. The amount of degraded &#x0005b;\n     <sup>\n\
      \      125\n     </sup>\n     I&#x0005d;apoA-I in the medium was determined\
      \ as non-iodine trichloroacetic acid&#x02013;soluble radioactivity. Cells were\
      \ then washed, treated with 0.05&#x00025; trypsin for 5 min at 37 &#x000b0;C\
      \ to remove surface-bound &#x0005b;\n     <sup>\n      125\n     </sup>\n  \
      \   I&#x0005d;apoA-I, and centrifuged. Radioactivity in supernatant (binding)\
      \ and pellet (internalization) was counted, and specific apoA-I binding, internalization,\
      \ and degradation were calculated after subtraction of non-specific values measured\
      \ in the presence of unlabeled apoA-I.\n    </p>\n   </sec>\n   <sec id=\"s4l\"\
      >\n    <title>\n     Co-immunoprecipitation of Nef and ABCA1.\n    </title>\n\
      \    <p>\n     HeLa cells were co-transfected with ABCA1-FLAG and Nef. At 48-h\
      \ post-transfection, cells were homogenized in PBS, and batch immunoprecipitations\
      \ using M2 affinity gel (Sigma) were carried out according to the manufacturer's\
      \ protocol. Immunoprecipitate was analyzed by Western blotting using polyclonal\
      \ anti-ABCA1 (Novus Biologicals) and anti-Nef (AIDS Research and Reference Reagent\
      \ Program) antibodies.\n    </p>\n   </sec>\n   <sec id=\"s4m\">\n    <title>\n\
      \     Oil Red O Staining.\n    </title>\n    <p>\n     Human monocyte-derived\
      \ macrophages and RAW 264.7 cells (stimulated with LXR agonist) were incubated\
      \ with AcLDL (50 &#x003bc;g/ml) in RPMI 1640 supplemented with 1&#x00025; Nutridoma\
      \ (Roche) and 30 &#x003bc;g/ml of lipid-free apoA-I for 18 h. After washing\
      \ with PBS, cells were fixed in 3.7&#x00025; formaldehyde for 2 min, washed\
      \ with water, and incubated at room temperature for 1 h with Oil Red O working\
      \ solution (Fisher Biotech, West Perth, Australia). The Oil Red O solution was\
      \ removed by aspiration, the cells were washed with water, and 0.02&#x00025;\
      \ sodium azide was added to the cells. The cells were observed using a reflecting\
      \ light microscope (90&#x000d7; magnification) fitted with a camera.\n    </p>\n\
      \   </sec>\n   <sec id=\"s4n\">\n    <title>\n     Fluorescent Microscopy.\n\
      \    </title>\n    <p>\n     For visualization of ABCA1 localization, approximately\
      \ 10\n     <sup>\n      6\n     </sup>\n     monocyte-derived macrophages were\
      \ plated into each well of a 24-well plate containing polylysine-coated coverslips\
      \ (Becton Dickinson Labware, Bedford, Massachusetts, United States) and infected\
      \ with VSV-G pseudotyped WT or Nef-deleted HIV-1 viruses, or left uninfected.\
      \ At 5-d post-infection, coverslips with adherent macrophages were removed from\
      \ the wells and washed with PBS, and cells were fixed with 4&#x00025; formaldehyde\
      \ (in PBS) for 20 min at room temperature. After fixing, cells were washed three\
      \ times with PBS and incubated for 1 h at room temperature in 4&#x00025; goat\
      \ serum (in PBS). After washing in PBS, rabbit polyclonal antibody to ABCA1\
      \ (Novus Biologicals) and mouse monoclonal antibody to p24 &#x0005b;\n     <xref\
      \ ref-type=\"bibr\" rid=\"pbio-0040365-b073\">\n      73\n     </xref>\n   \
      \  &#x0005d; were added in 4&#x00025; goat serum, 0.1&#x00025; BSA, and 0.1&#x00025;\
      \ Saponin. Anti-ABCA1 antibody was added at a 1:500 dilution and anti-p24 antibody,\
      \ at 1:100. Following a 2-h incubation at room temperature, the coverslips were\
      \ washed with PBS and incubated with Cy-5&#x02013;conjugated anti-rabbit and\
      \ FITC-conjugated anti-mouse secondary antibodies (Jackson ImmunoResearch, West\
      \ Grove, Pennsylvania, United States) for 1 h at room temperature. Coverslips\
      \ were mounted onto slides using Prolong (Molecular Probes, Eugene, Oregon,\
      \ United States) and allowed to dry overnight. Visualization of stained cells\
      \ was accomplished using a Bio-Rad MRC 1024 confocal laser scanning microscope\
      \ and software (Bio-Rad, Hercules, California, United States).\n    </p>\n \
      \   <p>\n     RAW 264.7 cells (LXR agonist-stimulated) were grown on collagen-coated\
      \ coverslips and transfected with Nef-expressing construct or an empty vector.\
      \ Cells were cultured for 48 h prior to immunostaining, washed with PBS, fixed\
      \ with 4&#x00025; formaldehyde, and quenched with 50 mM NH\n     <sub>\n   \
      \   4\n     </sub>\n     Cl. After permeabilization with 0.5&#x00025; Triton\
      \ X-100, cells were incubated with the monoclonal anti-ABCA1 antibody NDF4C2\
      \ for 1 h, washed with PBS, and incubated in the dark with a secondary goat\
      \ anti-mouse FITC-labeled antibody for 1 h. For co-localization analysis, monoclonal\
      \ anti-ABCA1 and polyclonal anti-Nef antibody were used, followed by Cy5-conjugated\
      \ anti-mouse (staining ABCA1 in blue) and FITC-conjugated anti-rabbit (staining\
      \ Nef in green) antibodies. Cells were washed again with PBS and, after mounting\
      \ onto glass slides, were studied using Zeiss META confocal microscope (Zeiss,\
      \ Oberkochen, Germany). Image analysis was performed using the LSM 510 software\
      \ of the Zeiss microscope which analyzes the distribution of the fluorescence\
      \ along cell section.\n    </p>\n   </sec>\n   <sec id=\"s4o\">\n    <title>\n\
      \     Transmission electron microscopy.\n    </title>\n    <p>\n     Macrophages\
      \ infected with HIV-1\n     <sub>\n      ADA\n     </sub>\n     were fixed in\
      \ 2.5&#x00025; neutral-buffered glutaraldehyde, pelleted, gelled into agar,\
      \ post-fixed in 1&#x00025; OsO\n     <sub>\n      4\n     </sub>\n     , block-stained\
      \ in uranyl acetate, dehydrated in graded ethanol and propylene oxide, and embedded\
      \ in Spurr's resin. Thin sections were stained with uranylacetate and lead citrate,\
      \ and examined on a LEO EM10 electron microscope (LEO Electron Microscopy, Thornwood,\
      \ New Jersey, United States) at 60 kV.\n    </p>\n   </sec>\n   <sec id=\"s4p\"\
      >\n    <title>\n     Real-Time RT-PCR.\n    </title>\n    <p>\n     cDNA was\
      \ prepared from total cellular RNA from human monocyte-derived macrophages and\
      \ analyzed by QPCR using IQ Sybr Green Supermix from Bio-Rad according to the\
      \ manufacturer's recommendations with the following primers (300 nM of each\
      \ primer per sample): ABCA1 sense, 5&#x02032;-GAGCCTCCCCAGGAGTCG-3&#x02032;;\
      \ ABCA1 antisense, 5&#x02032;-CAAACATGTCAGCTGTTACTGGAAG-3&#x02032;; &#x003b2;-actin\
      \ sense, 5&#x02032;- GCCGTACCACTGGCATCGTG-3&#x02032;; &#x003b2;-actin antisense,\
      \ 5&#x02032;-GTGGTGGTGAAGCTGTA-3&#x02032;. Primers were ordered from Integration\
      \ DNA Technologies (Coralville, Iowa, United States). Serial dilutions of ABCA1-pTRE\
      \ &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b035\">\n     \
      \ 35\n     </xref>\n     &#x0005d; and &#x003b2;-actin cDNA (QPCR Plasmid Standard\
      \ from Invitrogen, Carlsbad, California, United States) plasmids were used to\
      \ calculate the copy number of ABCA1 and &#x003b2;-actin cDNA per sample, and\
      \ results were adjusted according to &#x003b2;-actin cDNA levels. The abundance\
      \ of ABCA1-specific RNA in RAW cells was determined as described previously\
      \ &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b072\">\n     \
      \ 72\n     </xref>\n     &#x0005d;.\n    </p>\n   </sec>\n   <sec id=\"s4q\"\
      >\n    <title>\n     Autopsies.\n    </title>\n    <p>\n     Segments of the\
      \ aortic wall were removed at autopsy from four HAART-treated AIDS patients\
      \ (males, aged 39, 40, 44, and 47 y) at the Institute of Forensic Medicine,\
      \ Sydney, Australia. The specimens were fixed in formalin and embedded in paraffin.\
      \ Parallel sections were immunostained with the p24 antibody to detect HIV-1,\
      \ and anti-CD68 antibody to identify macrophages. Single and double (using DAKO-DOUBLESTAIN\
      \ Kit System 40; Dako, Glostrup, Denmark) immunostaining was carried out as\
      \ described previously &#x0005b;\n     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b074\"\
      >\n      74\n     </xref>\n     &#x0005d;. Sections of lymph nodes excised from\
      \ the AIDS patients served as a positive control.\n    </p>\n   </sec>\n   <sec\
      \ id=\"s4r\">\n    <title>\n     Infectivity assay.\n    </title>\n    <p>\n\
      \     Virus infectivity was analyzed using P4-CCR5 indicator cells &#x0005b;\n\
      \     <xref ref-type=\"bibr\" rid=\"pbio-0040365-b075\">\n      75\n     </xref>\n\
      \     &#x0005d; that express &#x003b2;-galactosidase under control of HIV-1\
      \ LTR. Briefly, cells were seeded into a 96-well plate at a density of 7,500\
      \ cells per well and allowed to adhere overnight. The medium was then removed\
      \ and replaced with virus in suspension (normalized according to RT activity)\
      \ or with fresh medium as a control. Infection was allowed to proceed for 48\
      \ h at 37 &#x000b0;C, then the virus was removed, and 100 &#x003bc;l of lysis\
      \ buffer (&#x003b2;-Galactosidase Enzyme Assay System; Promega, Madison, Wisconsin,\
      \ United States) was added. The plate was then frozen overnight at &#x02212;70\
      \ &#x000b0;C to ensure efficient lysis. Upon thawing, 50 &#x003bc;l of lysate\
      \ was placed into a new 96-well plate, and 50 &#x003bc;l of 2&#x000d7; Assay\
      \ Buffer was added. The plate was incubated at 37 &#x000b0;C for 1.5 h and optical\
      \ density (OD) readings were taken at 420 nm.\n    </p>\n   </sec>\n   <sec\
      \ id=\"s4s\">\n    <title>\n     Analysis of virion-associated cholesterol.\n\
      \    </title>\n    <p>\n     Seven days post-infection with HIV-ADA, &#x0005b;\n\
      \     <sup>\n      3\n     </sup>\n     H&#x0005d;cholesterol was added to the\
      \ cultures at a final concentration of 75 kBq/ml. At 24 h after addition of\
      \ cholesterol, the labeled medium was removed, the cells were washed with PBS,\
      \ and the new medium was added with or without 500 nM of LXR agonist, TO-901317\
      \ (Sigma). Culture supernatants were collected every 3 d over the period of\
      \ 2 wk and pooled; virions were pelleted by ultracentrifugation and normalized\
      \ according to p24 value, and the amount of incorporated &#x0005b;\n     <sup>\n\
      \      3\n     </sup>\n     H&#x0005d;cholesterol was counted on a beta-counter.\n\
      \    </p>\n   </sec>\n   <sec id=\"s4t\">\n    <title>\n     Statistical analysis.\n\
      \    </title>\n    <p>\n     All experiments were reproduced two to four times,\
      \ and representative experiments are shown. The Student\n     <italic>\n   \
      \   t\n     </italic>\n     test was used to determine statistical significance\
      \ of the differences.\n    </p>\n   </sec>\n   <sec sec-type=\"supplementary-material\"\
      \ id=\"s5\">\n    <title>\n     Supporting Information\n    </title>\n   </sec>\n\
      \   <sec id=\"s5a\">\n    <title>\n     Accession Numbers\n    </title>\n  \
      \  <p>\n     The Swiss-Prot (\n     <ext-link ext-link-type=\"uri\" xlink:href=\"\
      http://www.ebi.ac.uk/swissprot\">\n      http://www.ebi.ac.uk/swissprot\n  \
      \   </ext-link>\n     ) accession numbers for the proteins discussed in this\
      \ paper are ABCA1 (O95477), ABCG1 (P45844), LAI-derived Nef (P03406), and SF2-derived\
      \ Nef (P03407).\n    </p>\n   </sec>\n  </body>\n  <back>\n   <ack>\n    <p>\n\
      \     We are grateful to Dr. Matija Peterlin for pHSF2Nef, pHSF2Nef&#x00394;Xho,\
      \ Nef\n     <sub>\n      SF2\n     </sub>\n     , and NefG2A\n     <sub>\n \
      \     SF2\n     </sub>\n     constructs; to Dr. Olivier Schwartz for AD8, AD8&#x00394;Nef\
      \ viruses, and Nef\n     <sub>\n      LAI\n     </sub>\n     expression construct;\
      \ to Dr. Michael Fitzgerald for ABCA1-FLAG; and to Dr. Alan Remaley for the\
      \ ABCA1-GFP and ABCG1-GFP constructs and HDL preparations. We thank Stephanie\
      \ J. Inder for assistance in the collection of autopsy specimens. The following\
      \ reagents were obtained through the AIDS Research and Reference Reagent Program,\
      \ Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID),\
      \ NIH: pHEF-VSVG from Dr. Lung-Ji Chang; monoclonal anti-Nef antibodies EH1\
      \ from Dr. James Hoxie; rabbit polyclonal anti-Nef antiserum from Dr. Ronald\
      \ Swanstrom; monoclonal antibody to HIV-1 p24 (AG3.0) from Dr. Jonathan Allan;\
      \ HIV-1 strain 92US660 from the Multi-Center AIDS Cohort Study and the NIAID\
      \ Division of AIDS (DAIDS); HIV-1 strain Yu-2 from Beatrice Hahn and George\
      \ Shaw; and P4-CCR5 cells from Dr. Nathaniel Landau and Dr. Pierre Charneau.\n\
      \    </p>\n    <p>\n     ZM and MPM are predoctoral students in the Biochemistry\
      \ &#x00026; Molecular Biology and Immunology Programs, respectively, of the\
      \ Institute for Biomedical Sciences at the George Washington University. This\
      \ work is part of their dissertations to be presented to the above programs\
      \ in partial fulfillment of the requirements for the Ph.D. degree.\n    </p>\n\
      \   </ack>\n   <glossary>\n    <title>\n     Abbreviations\n    </title>\n \
      \   <def-list>\n     <def-item>\n      <term>\n       ABCA1\n      </term>\n\
      \      <def>\n       <p>\n        ATP-binding cassette transporter A1\n    \
      \   </p>\n      </def>\n     </def-item>\n     <def-item>\n      <term>\n  \
      \     AcLDL\n      </term>\n      <def>\n       <p>\n        acetylated low-density\
      \ lipoprotein\n       </p>\n      </def>\n     </def-item>\n     <def-item>\n\
      \      <term>\n       apoA-I\n      </term>\n      <def>\n       <p>\n     \
      \   apolipoprotein A-I\n       </p>\n      </def>\n     </def-item>\n     <def-item>\n\
      \      <term>\n       CAD\n      </term>\n      <def>\n       <p>\n        coronary\
      \ artery disease\n       </p>\n      </def>\n     </def-item>\n     <def-item>\n\
      \      <term>\n       DC-SIGN\n      </term>\n      <def>\n       <p>\n    \
      \    dendritic cell-specific ICAM-3-grabbing nonintegrin\n       </p>\n    \
      \  </def>\n     </def-item>\n     <def-item>\n      <term>\n       HAART\n \
      \     </term>\n      <def>\n       <p>\n        highly active antiretroviral\
      \ therapy\n       </p>\n      </def>\n     </def-item>\n     <def-item>\n  \
      \    <term>\n       HDL\n      </term>\n      <def>\n       <p>\n        high-density\
      \ lipoprotein\n       </p>\n      </def>\n     </def-item>\n     <def-item>\n\
      \      <term>\n       LDL\n      </term>\n      <def>\n       <p>\n        low-density\
      \ lipoprotein\n       </p>\n      </def>\n     </def-item>\n     <def-item>\n\
      \      <term>\n       LXR\n      </term>\n      <def>\n       <p>\n        liver\
      \ X receptor\n       </p>\n      </def>\n     </def-item>\n     <def-item>\n\
      \      <term>\n       MHC\n      </term>\n      <def>\n       <p>\n        major\
      \ histocompatibility complex\n       </p>\n      </def>\n     </def-item>\n\
      \     <def-item>\n      <term>\n       PI\n      </term>\n      <def>\n    \
      \   <p>\n        protease inhibitor\n       </p>\n      </def>\n     </def-item>\n\
      \     <def-item>\n      <term>\n       RT\n      </term>\n      <def>\n    \
      \   <p>\n        reverse transcription\n       </p>\n      </def>\n     </def-item>\n\
      \     <def-item>\n      <term>\n       SD\n      </term>\n      <def>\n    \
      \   <p>\n        standard deviation\n       </p>\n      </def>\n     </def-item>\n\
      \     <def-item>\n      <term>\n       SR-B1\n      </term>\n      <def>\n \
      \      <p>\n        scavenger receptor B1\n       </p>\n      </def>\n     </def-item>\n\
      \     <def-item>\n      <term>\n       VSV\n      </term>\n      <def>\n   \
      \    <p>\n        vesicular stomatitis virus\n       </p>\n      </def>\n  \
      \   </def-item>\n     <def-item>\n      <term>\n       WT\n      </term>\n \
      \     <def>\n       <p>\n        wild type\n       </p>\n      </def>\n    \
      \ </def-item>\n     <def-item>\n      <term>\n       &#x00394;Nef\n      </term>\n\
      \      <def>\n       <p>\n        Nef deficient\n       </p>\n      </def>\n\
      \     </def-item>\n    </def-list>\n   </glossary>\n   <ref-list>\n    <title>\n\
      \     References\n    </title>\n    <ref id=\"pbio-0040365-b001\">\n     <citation\
      \ citation-type=\"journal\">\n      <person-group person-group-type=\"author\"\
      >\n       <name>\n        <surname>\n         Maziere\n        </surname>\n\
      \        <given-names>\n         JC\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Landureau\n        </surname>\n\
      \        <given-names>\n         JC\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Giral\n        </surname>\n    \
      \    <given-names>\n         P\n        </given-names>\n       </name>\n   \
      \    <name>\n        <surname>\n         Auclair\n        </surname>\n     \
      \   <given-names>\n         M\n        </given-names>\n       </name>\n    \
      \   <name>\n        <surname>\n         Fall\n        </surname>\n        <given-names>\n\
      \         L\n        </given-names>\n       </name>\n       <etal>\n       </etal>\n\
      \      </person-group>\n      <year>\n       1994\n      </year>\n      <article-title>\n\
      \       Lovastatin inhibits HIV-1 expression in H9 human T lymphocytes cultured\
      \ in cholesterol-poor medium\n      </article-title>\n      <source>\n     \
      \  Biomed Pharmacother\n      </source>\n      <volume>\n       48\n      </volume>\n\
      \      <fpage>\n       63\n      </fpage>\n      <lpage>\n       67\n      </lpage>\n\
      \      <pub-id pub-id-type=\"pmid\">\n       7522603\n      </pub-id>\n    \
      \ </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b002\">\n     <citation\
      \ citation-type=\"journal\">\n      <person-group person-group-type=\"author\"\
      >\n       <name>\n        <surname>\n         Ono\n        </surname>\n    \
      \    <given-names>\n         A\n        </given-names>\n       </name>\n   \
      \    <name>\n        <surname>\n         Freed\n        </surname>\n       \
      \ <given-names>\n         EO\n        </given-names>\n       </name>\n     \
      \ </person-group>\n      <year>\n       2001\n      </year>\n      <article-title>\n\
      \       Plasma membrane rafts play a critical role in HIV-1 assembly and release\n\
      \      </article-title>\n      <source>\n       Proc Natl Acad Sci U S A\n \
      \     </source>\n      <volume>\n       98\n      </volume>\n      <fpage>\n\
      \       13925\n      </fpage>\n      <lpage>\n       13930\n      </lpage>\n\
      \      <pub-id pub-id-type=\"pmid\">\n       11717449\n      </pub-id>\n   \
      \  </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b003\">\n     <citation\
      \ citation-type=\"journal\">\n      <person-group person-group-type=\"author\"\
      >\n       <name>\n        <surname>\n         Campbell\n        </surname>\n\
      \        <given-names>\n         SM\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Crowe\n        </surname>\n    \
      \    <given-names>\n         SM\n        </given-names>\n       </name>\n  \
      \     <name>\n        <surname>\n         Mak\n        </surname>\n        <given-names>\n\
      \         J\n        </given-names>\n       </name>\n      </person-group>\n\
      \      <year>\n       2002\n      </year>\n      <article-title>\n       Virion-associated\
      \ cholesterol is critical for the maintenance of HIV-1 structure and infectivity\n\
      \      </article-title>\n      <source>\n       AIDS\n      </source>\n    \
      \  <volume>\n       16\n      </volume>\n      <fpage>\n       2253\n      </fpage>\n\
      \      <lpage>\n       2261\n      </lpage>\n      <pub-id pub-id-type=\"pmid\"\
      >\n       12441796\n      </pub-id>\n     </citation>\n    </ref>\n    <ref\
      \ id=\"pbio-0040365-b004\">\n     <citation citation-type=\"journal\">\n   \
      \   <person-group person-group-type=\"author\">\n       <name>\n        <surname>\n\
      \         Guyader\n        </surname>\n        <given-names>\n         M\n \
      \       </given-names>\n       </name>\n       <name>\n        <surname>\n \
      \        Kiyokawa\n        </surname>\n        <given-names>\n         E\n \
      \       </given-names>\n       </name>\n       <name>\n        <surname>\n \
      \        Abrami\n        </surname>\n        <given-names>\n         L\n   \
      \     </given-names>\n       </name>\n       <name>\n        <surname>\n   \
      \      Turelli\n        </surname>\n        <given-names>\n         P\n    \
      \    </given-names>\n       </name>\n       <name>\n        <surname>\n    \
      \     Trono\n        </surname>\n        <given-names>\n         D\n       \
      \ </given-names>\n       </name>\n      </person-group>\n      <year>\n    \
      \   2002\n      </year>\n      <article-title>\n       Role for human immunodeficiency\
      \ virus type 1 membrane cholesterol in viral internalization\n      </article-title>\n\
      \      <source>\n       J Virol\n      </source>\n      <volume>\n       76\n\
      \      </volume>\n      <fpage>\n       10356\n      </fpage>\n      <lpage>\n\
      \       10364\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       12239312\n\
      \      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b005\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Zheng\n        </surname>\n\
      \        <given-names>\n         YH\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Plemenitas\n        </surname>\n\
      \        <given-names>\n         A\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Fielding\n        </surname>\n \
      \       <given-names>\n         CJ\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Peterlin\n        </surname>\n \
      \       <given-names>\n         BM\n        </given-names>\n       </name>\n\
      \      </person-group>\n      <year>\n       2003\n      </year>\n      <article-title>\n\
      \       Nef increases the synthesis of and transports cholesterol to lipid rafts\
      \ and HIV-1 progeny virions\n      </article-title>\n      <source>\n      \
      \ Proc Natl Acad Sci U S A\n      </source>\n      <volume>\n       100\n  \
      \    </volume>\n      <fpage>\n       8460\n      </fpage>\n      <lpage>\n\
      \       8465\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       12824470\n\
      \      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b006\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Barbaro\n        </surname>\n\
      \        <given-names>\n         G\n        </given-names>\n       </name>\n\
      \      </person-group>\n      <year>\n       2002\n      </year>\n      <article-title>\n\
      \       Cardiovascular manifestations of HIV infection\n      </article-title>\n\
      \      <source>\n       Circulation\n      </source>\n      <volume>\n     \
      \  106\n      </volume>\n      <fpage>\n       1420\n      </fpage>\n      <lpage>\n\
      \       1425\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       12221062\n\
      \      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b007\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         El-Sadr\n        </surname>\n\
      \        <given-names>\n         WM\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Mullin\n        </surname>\n   \
      \     <given-names>\n         CM\n        </given-names>\n       </name>\n \
      \      <name>\n        <surname>\n         Carr\n        </surname>\n      \
      \  <given-names>\n         A\n        </given-names>\n       </name>\n     \
      \  <name>\n        <surname>\n         Gibert\n        </surname>\n        <given-names>\n\
      \         C\n        </given-names>\n       </name>\n       <name>\n       \
      \ <surname>\n         Rappoport\n        </surname>\n        <given-names>\n\
      \         C\n        </given-names>\n       </name>\n       <etal>\n       </etal>\n\
      \      </person-group>\n      <year>\n       2005\n      </year>\n      <article-title>\n\
      \       Effects of HIV disease on lipid, glucose and insulin levels: Results\
      \ from a large antiretroviral-naive cohort\n      </article-title>\n      <source>\n\
      \       HIV Med\n      </source>\n      <volume>\n       6\n      </volume>\n\
      \      <fpage>\n       114\n      </fpage>\n      <lpage>\n       121\n    \
      \  </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       15807717\n      </pub-id>\n\
      \     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b008\">\n     <citation\
      \ citation-type=\"journal\">\n      <person-group person-group-type=\"author\"\
      >\n       <name>\n        <surname>\n         Escaut\n        </surname>\n \
      \       <given-names>\n         L\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Monsuez\n        </surname>\n  \
      \      <given-names>\n         JJ\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Chironi\n        </surname>\n  \
      \      <given-names>\n         G\n        </given-names>\n       </name>\n \
      \      <name>\n        <surname>\n         Merad\n        </surname>\n     \
      \   <given-names>\n         M\n        </given-names>\n       </name>\n    \
      \   <name>\n        <surname>\n         Teicher\n        </surname>\n      \
      \  <given-names>\n         E\n        </given-names>\n       </name>\n     \
      \  <etal>\n       </etal>\n      </person-group>\n      <year>\n       2003\n\
      \      </year>\n      <article-title>\n       Coronary artery disease in HIV\
      \ infected patients\n      </article-title>\n      <source>\n       Intensive\
      \ Care Med\n      </source>\n      <volume>\n       29\n      </volume>\n  \
      \    <fpage>\n       969\n      </fpage>\n      <lpage>\n       973\n      </lpage>\n\
      \      <pub-id pub-id-type=\"pmid\">\n       12739013\n      </pub-id>\n   \
      \  </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b009\">\n     <citation\
      \ citation-type=\"journal\">\n      <person-group person-group-type=\"author\"\
      >\n       <name>\n        <surname>\n         Hsue\n        </surname>\n   \
      \     <given-names>\n         PY\n        </given-names>\n       </name>\n \
      \      <name>\n        <surname>\n         Lo\n        </surname>\n        <given-names>\n\
      \         JC\n        </given-names>\n       </name>\n       <name>\n      \
      \  <surname>\n         Franklin\n        </surname>\n        <given-names>\n\
      \         A\n        </given-names>\n       </name>\n       <name>\n       \
      \ <surname>\n         Bolger\n        </surname>\n        <given-names>\n  \
      \       AF\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Martin\n        </surname>\n        <given-names>\n         JN\n \
      \       </given-names>\n       </name>\n       <etal>\n       </etal>\n    \
      \  </person-group>\n      <year>\n       2004\n      </year>\n      <article-title>\n\
      \       Progression of atherosclerosis as assessed by carotid intima-media thickness\
      \ in patients with HIV infection\n      </article-title>\n      <source>\n \
      \      Circulation\n      </source>\n      <volume>\n       109\n      </volume>\n\
      \      <fpage>\n       1603\n      </fpage>\n      <lpage>\n       1608\n  \
      \    </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       15023877\n      </pub-id>\n\
      \     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b010\">\n     <citation\
      \ citation-type=\"journal\">\n      <person-group person-group-type=\"author\"\
      >\n       <name>\n        <surname>\n         Blum\n        </surname>\n   \
      \     <given-names>\n         A\n        </given-names>\n       </name>\n  \
      \     <name>\n        <surname>\n         Hadas\n        </surname>\n      \
      \  <given-names>\n         V\n        </given-names>\n       </name>\n     \
      \  <name>\n        <surname>\n         Burke\n        </surname>\n        <given-names>\n\
      \         M\n        </given-names>\n       </name>\n       <name>\n       \
      \ <surname>\n         Yust\n        </surname>\n        <given-names>\n    \
      \     I\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Kessler\n        </surname>\n        <given-names>\n         A\n \
      \       </given-names>\n       </name>\n      </person-group>\n      <year>\n\
      \       2005\n      </year>\n      <article-title>\n       Viral load of the\
      \ human immunodeficiency virus could be an independent risk factor for endothelial\
      \ dysfunction\n      </article-title>\n      <source>\n       Clin Cardiol\n\
      \      </source>\n      <volume>\n       28\n      </volume>\n      <fpage>\n\
      \       149\n      </fpage>\n      <lpage>\n       153\n      </lpage>\n   \
      \   <pub-id pub-id-type=\"pmid\">\n       15813624\n      </pub-id>\n     </citation>\n\
      \    </ref>\n    <ref id=\"pbio-0040365-b011\">\n     <citation citation-type=\"\
      journal\">\n      <person-group person-group-type=\"author\">\n       <name>\n\
      \        <surname>\n         Lusis\n        </surname>\n        <given-names>\n\
      \         AJ\n        </given-names>\n       </name>\n      </person-group>\n\
      \      <year>\n       2000\n      </year>\n      <article-title>\n       Atherosclerosis\n\
      \      </article-title>\n      <source>\n       Nature\n      </source>\n  \
      \    <volume>\n       407\n      </volume>\n      <fpage>\n       233\n    \
      \  </fpage>\n      <lpage>\n       241\n      </lpage>\n      <pub-id pub-id-type=\"\
      pmid\">\n       11001066\n      </pub-id>\n     </citation>\n    </ref>\n  \
      \  <ref id=\"pbio-0040365-b012\">\n     <citation citation-type=\"journal\"\
      >\n      <person-group person-group-type=\"author\">\n       <name>\n      \
      \  <surname>\n         Blessing\n        </surname>\n        <given-names>\n\
      \         E\n        </given-names>\n       </name>\n       <name>\n       \
      \ <surname>\n         Kuo\n        </surname>\n        <given-names>\n     \
      \    CC\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Lin\n        </surname>\n        <given-names>\n         TM\n    \
      \    </given-names>\n       </name>\n       <name>\n        <surname>\n    \
      \     Campbell\n        </surname>\n        <given-names>\n         LA\n   \
      \     </given-names>\n       </name>\n       <name>\n        <surname>\n   \
      \      Bea\n        </surname>\n        <given-names>\n         F\n        </given-names>\n\
      \       </name>\n       <etal>\n       </etal>\n      </person-group>\n    \
      \  <year>\n       2002\n      </year>\n      <article-title>\n       Foam cell\
      \ formation inhibits growth of\n       <named-content content-type=\"genus-species\"\
      >\n        Chlamydia pneumoniae\n       </named-content>\n       but does not\
      \ attenuate\n       <named-content content-type=\"genus-species\">\n       \
      \ Chlamydia pneumoniae\n       </named-content>\n       -induced secretion of\
      \ proinflammatory cytokines\n      </article-title>\n      <source>\n      \
      \ Circulation\n      </source>\n      <volume>\n       105\n      </volume>\n\
      \      <fpage>\n       1976\n      </fpage>\n      <lpage>\n       1982\n  \
      \    </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       11997286\n      </pub-id>\n\
      \     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b013\">\n     <citation\
      \ citation-type=\"journal\">\n      <person-group person-group-type=\"author\"\
      >\n       <name>\n        <surname>\n         Grunfeld\n        </surname>\n\
      \        <given-names>\n         C\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Pang\n        </surname>\n     \
      \   <given-names>\n         M\n        </given-names>\n       </name>\n    \
      \   <name>\n        <surname>\n         Doerrler\n        </surname>\n     \
      \   <given-names>\n         W\n        </given-names>\n       </name>\n    \
      \   <name>\n        <surname>\n         Shigenaga\n        </surname>\n    \
      \    <given-names>\n         JK\n        </given-names>\n       </name>\n  \
      \     <name>\n        <surname>\n         Jensen\n        </surname>\n     \
      \   <given-names>\n         P\n        </given-names>\n       </name>\n    \
      \   <etal>\n       </etal>\n      </person-group>\n      <year>\n       1992\n\
      \      </year>\n      <article-title>\n       Lipids, lipoproteins, triglyceride\
      \ clearance, and cytokines in human immunodeficiency virus infection and the\
      \ acquired immunodeficiency syndrome\n      </article-title>\n      <source>\n\
      \       J Clin Endocrinol Metab\n      </source>\n      <volume>\n       74\n\
      \      </volume>\n      <fpage>\n       1045\n      </fpage>\n      <lpage>\n\
      \       1052\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       1373735\n\
      \      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b014\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Crook\n        </surname>\n\
      \        <given-names>\n         MA\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Mir\n        </surname>\n      \
      \  <given-names>\n         N\n        </given-names>\n       </name>\n     \
      \ </person-group>\n      <year>\n       1999\n      </year>\n      <article-title>\n\
      \       Abnormal lipids and the acquired immunodeficiency syndrome: Is there\
      \ a problem and what should we do about it?\n      </article-title>\n      <source>\n\
      \       Int J STD AIDS\n      </source>\n      <volume>\n       10\n      </volume>\n\
      \      <fpage>\n       353\n      </fpage>\n      <lpage>\n       356\n    \
      \  </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       10414876\n      </pub-id>\n\
      \     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b015\">\n     <citation\
      \ citation-type=\"journal\">\n      <person-group person-group-type=\"author\"\
      >\n       <name>\n        <surname>\n         Liang\n        </surname>\n  \
      \      <given-names>\n         JS\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Distler\n        </surname>\n  \
      \      <given-names>\n         O\n        </given-names>\n       </name>\n \
      \      <name>\n        <surname>\n         Cooper\n        </surname>\n    \
      \    <given-names>\n         DA\n        </given-names>\n       </name>\n  \
      \     <name>\n        <surname>\n         Jamil\n        </surname>\n      \
      \  <given-names>\n         H\n        </given-names>\n       </name>\n     \
      \  <name>\n        <surname>\n         Deckelbaum\n        </surname>\n    \
      \    <given-names>\n         RJ\n        </given-names>\n       </name>\n  \
      \     <etal>\n       </etal>\n      </person-group>\n      <year>\n       2001\n\
      \      </year>\n      <article-title>\n       HIV protease inhibitors protect\
      \ apolipoprotein B from degradation by the proteasome: A potential mechanism\
      \ for protease inhibitor-induced hyperlipidemia\n      </article-title>\n  \
      \    <source>\n       Nat Med\n      </source>\n      <volume>\n       7\n \
      \     </volume>\n      <fpage>\n       1327\n      </fpage>\n      <lpage>\n\
      \       1331\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       11726973\n\
      \      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b016\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Nguyen\n        </surname>\n\
      \        <given-names>\n         AT\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Gagnon\n        </surname>\n   \
      \     <given-names>\n         A\n        </given-names>\n       </name>\n  \
      \     <name>\n        <surname>\n         Angel\n        </surname>\n      \
      \  <given-names>\n         JB\n        </given-names>\n       </name>\n    \
      \   <name>\n        <surname>\n         Sorisky\n        </surname>\n      \
      \  <given-names>\n         A\n        </given-names>\n       </name>\n     \
      \ </person-group>\n      <year>\n       2000\n      </year>\n      <article-title>\n\
      \       Ritonavir increases the level of active ADD-1/SREBP-1 protein during\
      \ adipogenesis\n      </article-title>\n      <source>\n       AIDS\n      </source>\n\
      \      <volume>\n       14\n      </volume>\n      <fpage>\n       2467\n  \
      \    </fpage>\n      <lpage>\n       2473\n      </lpage>\n      <pub-id pub-id-type=\"\
      pmid\">\n       11101056\n      </pub-id>\n     </citation>\n    </ref>\n  \
      \  <ref id=\"pbio-0040365-b017\">\n     <citation citation-type=\"journal\"\
      >\n      <person-group person-group-type=\"author\">\n       <name>\n      \
      \  <surname>\n         Dressman\n        </surname>\n        <given-names>\n\
      \         J\n        </given-names>\n       </name>\n       <name>\n       \
      \ <surname>\n         Kincer\n        </surname>\n        <given-names>\n  \
      \       J\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Matveev\n        </surname>\n        <given-names>\n         SV\n\
      \        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Guo\n        </surname>\n        <given-names>\n         L\n     \
      \   </given-names>\n       </name>\n       <name>\n        <surname>\n     \
      \    Greenberg\n        </surname>\n        <given-names>\n         RN\n   \
      \     </given-names>\n       </name>\n       <etal>\n       </etal>\n      </person-group>\n\
      \      <year>\n       2003\n      </year>\n      <article-title>\n       HIV\
      \ protease inhibitors promote atherosclerotic lesion formation independent of\
      \ dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in\
      \ macrophages\n      </article-title>\n      <source>\n       J Clin Invest\n\
      \      </source>\n      <volume>\n       111\n      </volume>\n      <fpage>\n\
      \       389\n      </fpage>\n      <lpage>\n       397\n      </lpage>\n   \
      \   <pub-id pub-id-type=\"pmid\">\n       12569165\n      </pub-id>\n     </citation>\n\
      \    </ref>\n    <ref id=\"pbio-0040365-b018\">\n     <citation citation-type=\"\
      journal\">\n      <person-group person-group-type=\"author\">\n       <name>\n\
      \        <surname>\n         Klein\n        </surname>\n        <given-names>\n\
      \         D\n        </given-names>\n       </name>\n       <name>\n       \
      \ <surname>\n         Hurley\n        </surname>\n        <given-names>\n  \
      \       LB\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Quesenberry\n        </surname>\n        <given-names>\n         CP\n\
      \        </given-names>\n        <suffix>\n         Jr.\n        </suffix>\n\
      \       </name>\n       <name>\n        <surname>\n         Sidney\n       \
      \ </surname>\n        <given-names>\n         S\n        </given-names>\n  \
      \     </name>\n      </person-group>\n      <year>\n       2002\n      </year>\n\
      \      <article-title>\n       Do protease inhibitors increase the risk for\
      \ coronary heart disease in patients with HIV-1 infection?\n      </article-title>\n\
      \      <source>\n       J Acquir Immune Defic Syndr\n      </source>\n     \
      \ <volume>\n       30\n      </volume>\n      <fpage>\n       471\n      </fpage>\n\
      \      <lpage>\n       477\n      </lpage>\n      <pub-id pub-id-type=\"pmid\"\
      >\n       12154337\n      </pub-id>\n     </citation>\n    </ref>\n    <ref\
      \ id=\"pbio-0040365-b019\">\n     <citation citation-type=\"journal\">\n   \
      \   <person-group person-group-type=\"author\">\n       <name>\n        <surname>\n\
      \         Charakida\n        </surname>\n        <given-names>\n         M\n\
      \        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Donald\n        </surname>\n        <given-names>\n         AE\n \
      \       </given-names>\n       </name>\n       <name>\n        <surname>\n \
      \        Green\n        </surname>\n        <given-names>\n         H\n    \
      \    </given-names>\n       </name>\n       <name>\n        <surname>\n    \
      \     Storry\n        </surname>\n        <given-names>\n         C\n      \
      \  </given-names>\n       </name>\n       <name>\n        <surname>\n      \
      \   Clapson\n        </surname>\n        <given-names>\n         M\n       \
      \ </given-names>\n       </name>\n       <etal>\n       </etal>\n      </person-group>\n\
      \      <year>\n       2005\n      </year>\n      <article-title>\n       Early\
      \ structural and functional changes of the vasculature in HIV-infected children:\
      \ impact of disease and antiretroviral therapy\n      </article-title>\n   \
      \   <source>\n       Circulation\n      </source>\n      <volume>\n       112\n\
      \      </volume>\n      <fpage>\n       103\n      </fpage>\n      <lpage>\n\
      \       109\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       15983247\n\
      \      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b020\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         David\n        </surname>\n\
      \        <given-names>\n         MH\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Hornung\n        </surname>\n  \
      \      <given-names>\n         R\n        </given-names>\n       </name>\n \
      \      <name>\n        <surname>\n         Fichtenbaum\n        </surname>\n\
      \        <given-names>\n         CJ\n        </given-names>\n       </name>\n\
      \      </person-group>\n      <year>\n       2002\n      </year>\n      <article-title>\n\
      \       Ischemic cardiovascular disease in persons with human immunodeficiency\
      \ virus infection\n      </article-title>\n      <source>\n       Clin Infect\
      \ Dis\n      </source>\n      <volume>\n       34\n      </volume>\n      <fpage>\n\
      \       98\n      </fpage>\n      <lpage>\n       102\n      </lpage>\n    \
      \  <pub-id pub-id-type=\"pmid\">\n       11731952\n      </pub-id>\n     </citation>\n\
      \    </ref>\n    <ref id=\"pbio-0040365-b021\">\n     <citation citation-type=\"\
      journal\">\n      <person-group person-group-type=\"author\">\n       <name>\n\
      \        <surname>\n         Neumann\n        </surname>\n        <given-names>\n\
      \         T\n        </given-names>\n       </name>\n       <name>\n       \
      \ <surname>\n         Woiwoid\n        </surname>\n        <given-names>\n \
      \        T\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Neumann\n        </surname>\n        <given-names>\n         A\n \
      \       </given-names>\n       </name>\n       <name>\n        <surname>\n \
      \        Miller\n        </surname>\n        <given-names>\n         M\n   \
      \     </given-names>\n       </name>\n       <name>\n        <surname>\n   \
      \      Ross\n        </surname>\n        <given-names>\n         B\n       \
      \ </given-names>\n       </name>\n       <etal>\n       </etal>\n      </person-group>\n\
      \      <year>\n       2003\n      </year>\n      <article-title>\n       Cardiovascular\
      \ risk factors and probability for cardiovascular events in HIV-infected patients:\
      \ part I. Differences due to the acquisition of HIV-infection\n      </article-title>\n\
      \      <source>\n       Eur J Med Res\n      </source>\n      <volume>\n   \
      \    8\n      </volume>\n      <fpage>\n       229\n      </fpage>\n      <lpage>\n\
      \       235\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       12911871\n\
      \      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b022\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Varriale\n        </surname>\n\
      \        <given-names>\n         P\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Saravi\n        </surname>\n   \
      \     <given-names>\n         G\n        </given-names>\n       </name>\n  \
      \     <name>\n        <surname>\n         Hernandez\n        </surname>\n  \
      \      <given-names>\n         E\n        </given-names>\n       </name>\n \
      \      <name>\n        <surname>\n         Carbon\n        </surname>\n    \
      \    <given-names>\n         F\n        </given-names>\n       </name>\n   \
      \   </person-group>\n      <year>\n       2004\n      </year>\n      <article-title>\n\
      \       Acute myocardial infarction in patients infected with human immunodeficiency\
      \ virus\n      </article-title>\n      <source>\n       Am Heart J\n      </source>\n\
      \      <volume>\n       147\n      </volume>\n      <fpage>\n       55\n   \
      \   </fpage>\n      <lpage>\n       59\n      </lpage>\n      <pub-id pub-id-type=\"\
      pmid\">\n       14691419\n      </pub-id>\n     </citation>\n    </ref>\n  \
      \  <ref id=\"pbio-0040365-b023\">\n     <citation citation-type=\"journal\"\
      >\n      <person-group person-group-type=\"author\">\n       <name>\n      \
      \  <surname>\n         Jessup\n        </surname>\n        <given-names>\n \
      \        W\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Gelissen\n        </surname>\n        <given-names>\n         IC\n\
      \        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Gaus\n        </surname>\n        <given-names>\n         K\n    \
      \    </given-names>\n       </name>\n       <name>\n        <surname>\n    \
      \     Kritharides\n        </surname>\n        <given-names>\n         L\n \
      \       </given-names>\n       </name>\n      </person-group>\n      <year>\n\
      \       2006\n      </year>\n      <article-title>\n       Roles of ATP binding\
      \ cassette transporters A1 and G1, scavenger receptor BI and membrane lipid\
      \ domains in cholesterol export from macrophages\n      </article-title>\n \
      \     <source>\n       Curr Opin Lipidol\n      </source>\n      <volume>\n\
      \       17\n      </volume>\n      <fpage>\n       247\n      </fpage>\n   \
      \   <lpage>\n       257\n      </lpage>\n      <pub-id pub-id-type=\"pmid\"\
      >\n       16680029\n      </pub-id>\n     </citation>\n    </ref>\n    <ref\
      \ id=\"pbio-0040365-b024\">\n     <citation citation-type=\"journal\">\n   \
      \   <person-group person-group-type=\"author\">\n       <name>\n        <surname>\n\
      \         Castrillo\n        </surname>\n        <given-names>\n         A\n\
      \        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Joseph\n        </surname>\n        <given-names>\n         SB\n \
      \       </given-names>\n       </name>\n       <name>\n        <surname>\n \
      \        Vaidya\n        </surname>\n        <given-names>\n         SA\n  \
      \      </given-names>\n       </name>\n       <name>\n        <surname>\n  \
      \       Haberland\n        </surname>\n        <given-names>\n         M\n \
      \       </given-names>\n       </name>\n       <name>\n        <surname>\n \
      \        Fogelman\n        </surname>\n        <given-names>\n         AM\n\
      \        </given-names>\n       </name>\n       <etal>\n       </etal>\n   \
      \   </person-group>\n      <year>\n       2003\n      </year>\n      <article-title>\n\
      \       Crosstalk between LXR and toll-like receptor signaling mediates bacterial\
      \ and viral antagonism of cholesterol metabolism\n      </article-title>\n \
      \     <source>\n       Mol Cell\n      </source>\n      <volume>\n       12\n\
      \      </volume>\n      <fpage>\n       805\n      </fpage>\n      <lpage>\n\
      \       816\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       14580333\n\
      \      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b025\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Khovidhunkit\n       \
      \ </surname>\n        <given-names>\n         W\n        </given-names>\n  \
      \     </name>\n       <name>\n        <surname>\n         Moser\n        </surname>\n\
      \        <given-names>\n         AH\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Shigenaga\n        </surname>\n\
      \        <given-names>\n         JK\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Grunfeld\n        </surname>\n \
      \       <given-names>\n         C\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Feingold\n        </surname>\n \
      \       <given-names>\n         KR\n        </given-names>\n       </name>\n\
      \      </person-group>\n      <year>\n       2003\n      </year>\n      <article-title>\n\
      \       Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and\
      \ ABCG1 in J774 murine macrophages: Differential role of LXR\n      </article-title>\n\
      \      <source>\n       J Lipid Res\n      </source>\n      <volume>\n     \
      \  44\n      </volume>\n      <fpage>\n       1728\n      </fpage>\n      <lpage>\n\
      \       1736\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       12777468\n\
      \      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b026\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Feng\n        </surname>\n\
      \        <given-names>\n         B\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Tabas\n        </surname>\n    \
      \    <given-names>\n         I\n        </given-names>\n       </name>\n   \
      \   </person-group>\n      <year>\n       2002\n      </year>\n      <article-title>\n\
      \       ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded\
      \ macrophages. Mechanism involves enhanced ABCA1 degradation in a process requiring\
      \ full NPC1 activity\n      </article-title>\n      <source>\n       J Biol\
      \ Chem\n      </source>\n      <volume>\n       277\n      </volume>\n     \
      \ <fpage>\n       43271\n      </fpage>\n      <lpage>\n       43280\n     \
      \ </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       12215451\n      </pub-id>\n\
      \     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b027\">\n     <citation\
      \ citation-type=\"journal\">\n      <person-group person-group-type=\"author\"\
      >\n       <name>\n        <surname>\n         Aiello\n        </surname>\n \
      \       <given-names>\n         RJ\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Brees\n        </surname>\n    \
      \    <given-names>\n         D\n        </given-names>\n       </name>\n   \
      \    <name>\n        <surname>\n         Bourassa\n        </surname>\n    \
      \    <given-names>\n         PA\n        </given-names>\n       </name>\n  \
      \     <name>\n        <surname>\n         Royer\n        </surname>\n      \
      \  <given-names>\n         L\n        </given-names>\n       </name>\n     \
      \  <name>\n        <surname>\n         Lindsey\n        </surname>\n       \
      \ <given-names>\n         S\n        </given-names>\n       </name>\n      \
      \ <etal>\n       </etal>\n      </person-group>\n      <year>\n       2002\n\
      \      </year>\n      <article-title>\n       Increased atherosclerosis in hyperlipidemic\
      \ mice with inactivation of ABCA1 in macrophages\n      </article-title>\n \
      \     <source>\n       Arterioscler Thromb Vasc Biol\n      </source>\n    \
      \  <volume>\n       22\n      </volume>\n      <fpage>\n       630\n      </fpage>\n\
      \      <lpage>\n       637\n      </lpage>\n      <pub-id pub-id-type=\"pmid\"\
      >\n       11950702\n      </pub-id>\n     </citation>\n    </ref>\n    <ref\
      \ id=\"pbio-0040365-b028\">\n     <citation citation-type=\"journal\">\n   \
      \   <person-group person-group-type=\"author\">\n       <name>\n        <surname>\n\
      \         Oram\n        </surname>\n        <given-names>\n         JF\n   \
      \     </given-names>\n       </name>\n      </person-group>\n      <year>\n\
      \       2000\n      </year>\n      <article-title>\n       Tangier disease and\
      \ ABCA1\n      </article-title>\n      <source>\n       Biochim Biophys Acta\n\
      \      </source>\n      <volume>\n       1529\n      </volume>\n      <fpage>\n\
      \       321\n      </fpage>\n      <lpage>\n       330\n      </lpage>\n   \
      \   <pub-id pub-id-type=\"pmid\">\n       11111099\n      </pub-id>\n     </citation>\n\
      \    </ref>\n    <ref id=\"pbio-0040365-b029\">\n     <citation citation-type=\"\
      journal\">\n      <person-group person-group-type=\"author\">\n       <name>\n\
      \        <surname>\n         Attie\n        </surname>\n        <given-names>\n\
      \         AD\n        </given-names>\n       </name>\n       <name>\n      \
      \  <surname>\n         Kastelein\n        </surname>\n        <given-names>\n\
      \         JP\n        </given-names>\n       </name>\n       <name>\n      \
      \  <surname>\n         Hayden\n        </surname>\n        <given-names>\n \
      \        MR\n        </given-names>\n       </name>\n      </person-group>\n\
      \      <year>\n       2001\n      </year>\n      <article-title>\n       Pivotal\
      \ role of ABCA1 in reverse cholesterol transport influencing HDL levels and\
      \ susceptibility to atherosclerosis\n      </article-title>\n      <source>\n\
      \       J Lipid Res\n      </source>\n      <volume>\n       42\n      </volume>\n\
      \      <fpage>\n       1717\n      </fpage>\n      <lpage>\n       1726\n  \
      \    </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       11714841\n      </pub-id>\n\
      \     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b030\">\n     <citation\
      \ citation-type=\"journal\">\n      <person-group person-group-type=\"author\"\
      >\n       <name>\n        <surname>\n         Gendelman\n        </surname>\n\
      \        <given-names>\n         HE\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Orenstein\n        </surname>\n\
      \        <given-names>\n         JM\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Martin\n        </surname>\n   \
      \     <given-names>\n         MA\n        </given-names>\n       </name>\n \
      \      <name>\n        <surname>\n         Ferrua\n        </surname>\n    \
      \    <given-names>\n         C\n        </given-names>\n       </name>\n   \
      \    <name>\n        <surname>\n         Mitra\n        </surname>\n       \
      \ <given-names>\n         R\n        </given-names>\n       </name>\n      \
      \ <etal>\n       </etal>\n      </person-group>\n      <year>\n       1988\n\
      \      </year>\n      <article-title>\n       Efficient isolation and propagation\
      \ of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated\
      \ monocytes\n      </article-title>\n      <source>\n       J Exp Med\n    \
      \  </source>\n      <volume>\n       167\n      </volume>\n      <fpage>\n \
      \      1428\n      </fpage>\n      <lpage>\n       1441\n      </lpage>\n  \
      \    <pub-id pub-id-type=\"pmid\">\n       3258626\n      </pub-id>\n     </citation>\n\
      \    </ref>\n    <ref id=\"pbio-0040365-b031\">\n     <citation citation-type=\"\
      journal\">\n      <person-group person-group-type=\"author\">\n       <name>\n\
      \        <surname>\n         Aiken\n        </surname>\n        <given-names>\n\
      \         C\n        </given-names>\n       </name>\n      </person-group>\n\
      \      <year>\n       1997\n      </year>\n      <article-title>\n       Pseudotyping\
      \ human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular\
      \ stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses\
      \ both the requirement for Nef and the sensitivity to cyclosporin A\n      </article-title>\n\
      \      <source>\n       J Virol\n      </source>\n      <volume>\n       71\n\
      \      </volume>\n      <fpage>\n       5871\n      </fpage>\n      <lpage>\n\
      \       5877\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       9223476\n\
      \      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b032\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Oram\n        </surname>\n\
      \        <given-names>\n         JF\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Lawn\n        </surname>\n     \
      \   <given-names>\n         RM\n        </given-names>\n       </name>\n   \
      \   </person-group>\n      <year>\n       2001\n      </year>\n      <article-title>\n\
      \       ABCA1. The gatekeeper for eliminating excess tissue cholesterol\n  \
      \    </article-title>\n      <source>\n       J Lipid Res\n      </source>\n\
      \      <volume>\n       42\n      </volume>\n      <fpage>\n       1173\n  \
      \    </fpage>\n      <lpage>\n       1179\n      </lpage>\n      <pub-id pub-id-type=\"\
      pmid\">\n       11483617\n      </pub-id>\n     </citation>\n    </ref>\n  \
      \  <ref id=\"pbio-0040365-b033\">\n     <citation citation-type=\"journal\"\
      >\n      <person-group person-group-type=\"author\">\n       <name>\n      \
      \  <surname>\n         Kennedy\n        </surname>\n        <given-names>\n\
      \         MA\n        </given-names>\n       </name>\n       <name>\n      \
      \  <surname>\n         Barrera\n        </surname>\n        <given-names>\n\
      \         GC\n        </given-names>\n       </name>\n       <name>\n      \
      \  <surname>\n         Nakamura\n        </surname>\n        <given-names>\n\
      \         K\n        </given-names>\n       </name>\n       <name>\n       \
      \ <surname>\n         Baldan\n        </surname>\n        <given-names>\n  \
      \       A\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Tarr\n        </surname>\n        <given-names>\n         P\n    \
      \    </given-names>\n       </name>\n       <etal>\n       </etal>\n      </person-group>\n\
      \      <year>\n       2005\n      </year>\n      <article-title>\n       ABCG1\
      \ has a critical role in mediating cholesterol efflux to HDL and preventing\
      \ cellular lipid accumulation\n      </article-title>\n      <source>\n    \
      \   Cell Metab\n      </source>\n      <volume>\n       1\n      </volume>\n\
      \      <fpage>\n       121\n      </fpage>\n      <lpage>\n       131\n    \
      \  </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       16054053\n      </pub-id>\n\
      \     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b034\">\n     <citation\
      \ citation-type=\"journal\">\n      <person-group person-group-type=\"author\"\
      >\n       <name>\n        <surname>\n         Oram\n        </surname>\n   \
      \     <given-names>\n         JF\n        </given-names>\n       </name>\n \
      \     </person-group>\n      <year>\n       2003\n      </year>\n      <article-title>\n\
      \       HDL apolipoproteins and ABCA1: Partners in the removal of excess cellular\
      \ cholesterol\n      </article-title>\n      <source>\n       Arterioscler Thromb\
      \ Vasc Biol\n      </source>\n      <volume>\n       23\n      </volume>\n \
      \     <fpage>\n       720\n      </fpage>\n      <lpage>\n       727\n     \
      \ </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       12615680\n      </pub-id>\n\
      \     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b035\">\n     <citation\
      \ citation-type=\"journal\">\n      <person-group person-group-type=\"author\"\
      >\n       <name>\n        <surname>\n         Remaley\n        </surname>\n\
      \        <given-names>\n         AT\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Stonik\n        </surname>\n   \
      \     <given-names>\n         JA\n        </given-names>\n       </name>\n \
      \      <name>\n        <surname>\n         Demosky\n        </surname>\n   \
      \     <given-names>\n         SJ\n        </given-names>\n       </name>\n \
      \      <name>\n        <surname>\n         Neufeld\n        </surname>\n   \
      \     <given-names>\n         EB\n        </given-names>\n       </name>\n \
      \      <name>\n        <surname>\n         Bocharov\n        </surname>\n  \
      \      <given-names>\n         AV\n        </given-names>\n       </name>\n\
      \       <etal>\n       </etal>\n      </person-group>\n      <year>\n      \
      \ 2001\n      </year>\n      <article-title>\n       Apolipoprotein specificity\
      \ for lipid efflux by the human ABCAI transporter\n      </article-title>\n\
      \      <source>\n       Biochem Biophys Res Commun\n      </source>\n      <volume>\n\
      \       280\n      </volume>\n      <fpage>\n       818\n      </fpage>\n  \
      \    <lpage>\n       823\n      </lpage>\n      <pub-id pub-id-type=\"pmid\"\
      >\n       11162594\n      </pub-id>\n     </citation>\n    </ref>\n    <ref\
      \ id=\"pbio-0040365-b036\">\n     <citation citation-type=\"journal\">\n   \
      \   <person-group person-group-type=\"author\">\n       <name>\n        <surname>\n\
      \         Neufeld\n        </surname>\n        <given-names>\n         EB\n\
      \        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Remaley\n        </surname>\n        <given-names>\n         AT\n\
      \        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Demosky\n        </surname>\n        <given-names>\n         SJ\n\
      \        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Stonik\n        </surname>\n        <given-names>\n         JA\n \
      \       </given-names>\n       </name>\n       <name>\n        <surname>\n \
      \        Cooney\n        </surname>\n        <given-names>\n         AM\n  \
      \      </given-names>\n       </name>\n       <etal>\n       </etal>\n     \
      \ </person-group>\n      <year>\n       2001\n      </year>\n      <article-title>\n\
      \       Cellular localization and trafficking of the human ABCA1 transporter\n\
      \      </article-title>\n      <source>\n       J Biol Chem\n      </source>\n\
      \      <volume>\n       276\n      </volume>\n      <fpage>\n       27584\n\
      \      </fpage>\n      <lpage>\n       27590\n      </lpage>\n      <pub-id\
      \ pub-id-type=\"pmid\">\n       11349133\n      </pub-id>\n     </citation>\n\
      \    </ref>\n    <ref id=\"pbio-0040365-b037\">\n     <citation citation-type=\"\
      journal\">\n      <person-group person-group-type=\"author\">\n       <name>\n\
      \        <surname>\n         Albrecht\n        </surname>\n        <given-names>\n\
      \         C\n        </given-names>\n       </name>\n       <name>\n       \
      \ <surname>\n         Soumian\n        </surname>\n        <given-names>\n \
      \        S\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Amey\n        </surname>\n        <given-names>\n         JS\n   \
      \     </given-names>\n       </name>\n       <name>\n        <surname>\n   \
      \      Sardini\n        </surname>\n        <given-names>\n         A\n    \
      \    </given-names>\n       </name>\n       <name>\n        <surname>\n    \
      \     Higgins\n        </surname>\n        <given-names>\n         CF\n    \
      \    </given-names>\n       </name>\n       <etal>\n       </etal>\n      </person-group>\n\
      \      <year>\n       2004\n      </year>\n      <article-title>\n       ABCA1\
      \ expression in carotid atherosclerotic plaques\n      </article-title>\n  \
      \    <source>\n       Stroke\n      </source>\n      <volume>\n       35\n \
      \     </volume>\n      <fpage>\n       2801\n      </fpage>\n      <lpage>\n\
      \       2806\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       15528463\n\
      \      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b038\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Neufeld\n        </surname>\n\
      \        <given-names>\n         EB\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Stonik\n        </surname>\n   \
      \     <given-names>\n         JA\n        </given-names>\n       </name>\n \
      \      <name>\n        <surname>\n         Demosky\n        </surname>\n   \
      \     <given-names>\n         SJ\n        </given-names>\n        <suffix>\n\
      \         Jr.\n        </suffix>\n       </name>\n       <name>\n        <surname>\n\
      \         Knapper\n        </surname>\n        <given-names>\n         CL\n\
      \        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Combs\n        </surname>\n        <given-names>\n         CA\n  \
      \      </given-names>\n       </name>\n       <etal>\n       </etal>\n     \
      \ </person-group>\n      <year>\n       2004\n      </year>\n      <article-title>\n\
      \       The ABCA1 transporter modulates late endocytic trafficking: Insights\
      \ from the correction of the genetic defect in Tangier disease\n      </article-title>\n\
      \      <source>\n       J Biol Chem\n      </source>\n      <volume>\n     \
      \  279\n      </volume>\n      <fpage>\n       15571\n      </fpage>\n     \
      \ <lpage>\n       15578\n      </lpage>\n      <pub-id pub-id-type=\"pmid\"\
      >\n       14747463\n      </pub-id>\n     </citation>\n    </ref>\n    <ref\
      \ id=\"pbio-0040365-b039\">\n     <citation citation-type=\"journal\">\n   \
      \   <person-group person-group-type=\"author\">\n       <name>\n        <surname>\n\
      \         Chen\n        </surname>\n        <given-names>\n         W\n    \
      \    </given-names>\n       </name>\n       <name>\n        <surname>\n    \
      \     Wang\n        </surname>\n        <given-names>\n         N\n        </given-names>\n\
      \       </name>\n       <name>\n        <surname>\n         Tall\n        </surname>\n\
      \        <given-names>\n         AR\n        </given-names>\n       </name>\n\
      \      </person-group>\n      <year>\n       2005\n      </year>\n      <article-title>\n\
      \       A PEST deletion mutant of ABCA1 shows impaired internalization and defective\
      \ cholesterol efflux from late endosomes\n      </article-title>\n      <source>\n\
      \       J Biol Chem\n      </source>\n      <volume>\n       280\n      </volume>\n\
      \      <fpage>\n       29277\n      </fpage>\n      <lpage>\n       29281\n\
      \      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       15951431\n    \
      \  </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b040\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Wang\n        </surname>\n\
      \        <given-names>\n         N\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Silver\n        </surname>\n   \
      \     <given-names>\n         DL\n        </given-names>\n       </name>\n \
      \      <name>\n        <surname>\n         Costet\n        </surname>\n    \
      \    <given-names>\n         P\n        </given-names>\n       </name>\n   \
      \    <name>\n        <surname>\n         Tall\n        </surname>\n        <given-names>\n\
      \         AR\n        </given-names>\n       </name>\n      </person-group>\n\
      \      <year>\n       2000\n      </year>\n      <article-title>\n       Specific\
      \ binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane\
      \ morphology in cells expressing ABC1\n      </article-title>\n      <source>\n\
      \       J Biol Chem\n      </source>\n      <volume>\n       275\n      </volume>\n\
      \      <fpage>\n       33053\n      </fpage>\n      <lpage>\n       33058\n\
      \      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       10918065\n    \
      \  </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b041\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Oram\n        </surname>\n\
      \        <given-names>\n         JF\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Lawn\n        </surname>\n     \
      \   <given-names>\n         RM\n        </given-names>\n       </name>\n   \
      \    <name>\n        <surname>\n         Garvin\n        </surname>\n      \
      \  <given-names>\n         MR\n        </given-names>\n       </name>\n    \
      \   <name>\n        <surname>\n         Wade\n        </surname>\n        <given-names>\n\
      \         DP\n        </given-names>\n       </name>\n      </person-group>\n\
      \      <year>\n       2000\n      </year>\n      <article-title>\n       ABCA1\
      \ Is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion\
      \ from macrophages\n      </article-title>\n      <source>\n       J Biol Chem\n\
      \      </source>\n      <volume>\n       275\n      </volume>\n      <fpage>\n\
      \       34508\n      </fpage>\n      <lpage>\n       34511\n      </lpage>\n\
      \      <pub-id pub-id-type=\"pmid\">\n       10918070\n      </pub-id>\n   \
      \  </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b042\">\n     <citation\
      \ citation-type=\"journal\">\n      <person-group person-group-type=\"author\"\
      >\n       <name>\n        <surname>\n         Denis\n        </surname>\n  \
      \      <given-names>\n         M\n        </given-names>\n       </name>\n \
      \      <name>\n        <surname>\n         Haidar\n        </surname>\n    \
      \    <given-names>\n         B\n        </given-names>\n       </name>\n   \
      \    <name>\n        <surname>\n         Marcil\n        </surname>\n      \
      \  <given-names>\n         M\n        </given-names>\n       </name>\n     \
      \  <name>\n        <surname>\n         Bouvier\n        </surname>\n       \
      \ <given-names>\n         M\n        </given-names>\n       </name>\n      \
      \ <name>\n        <surname>\n         Krimbou\n        </surname>\n        <given-names>\n\
      \         L\n        </given-names>\n       </name>\n       <etal>\n       </etal>\n\
      \      </person-group>\n      <year>\n       2004\n      </year>\n      <article-title>\n\
      \       Molecular and cellular physiology of apolipoprotein A-I lipidation by\
      \ the ATP-binding cassette transporter A1 (ABCA1)\n      </article-title>\n\
      \      <source>\n       J Biol Chem\n      </source>\n      <volume>\n     \
      \  279\n      </volume>\n      <fpage>\n       7384\n      </fpage>\n      <lpage>\n\
      \       7394\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       14660648\n\
      \      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b043\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Le Goff\n        </surname>\n\
      \        <given-names>\n         W\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Peng\n        </surname>\n     \
      \   <given-names>\n         DQ\n        </given-names>\n       </name>\n   \
      \    <name>\n        <surname>\n         Settle\n        </surname>\n      \
      \  <given-names>\n         M\n        </given-names>\n       </name>\n     \
      \  <name>\n        <surname>\n         Brubaker\n        </surname>\n      \
      \  <given-names>\n         G\n        </given-names>\n       </name>\n     \
      \  <name>\n        <surname>\n         Morton\n        </surname>\n        <given-names>\n\
      \         RE\n        </given-names>\n       </name>\n       <etal>\n      \
      \ </etal>\n      </person-group>\n      <year>\n       2004\n      </year>\n\
      \      <article-title>\n       Cyclosporin A traps ABCA1 at the plasma membrane\
      \ and inhibits ABCA1-mediated lipid efflux to apolipoprotein A-I\n      </article-title>\n\
      \      <source>\n       Arterioscler Thromb Vasc Biol\n      </source>\n   \
      \   <volume>\n       24\n      </volume>\n      <fpage>\n       2155\n     \
      \ </fpage>\n      <lpage>\n       2161\n      </lpage>\n      <pub-id pub-id-type=\"\
      pmid\">\n       15358601\n      </pub-id>\n     </citation>\n    </ref>\n  \
      \  <ref id=\"pbio-0040365-b044\">\n     <citation citation-type=\"journal\"\
      >\n      <person-group person-group-type=\"author\">\n       <name>\n      \
      \  <surname>\n         Coleman\n        </surname>\n        <given-names>\n\
      \         SH\n        </given-names>\n       </name>\n       <name>\n      \
      \  <surname>\n         Madrid\n        </surname>\n        <given-names>\n \
      \        R\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Van Damme\n        </surname>\n        <given-names>\n         N\n\
      \        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Mitchell\n        </surname>\n        <given-names>\n         RS\n\
      \        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Bouchet\n        </surname>\n        <given-names>\n         J\n \
      \       </given-names>\n       </name>\n       <etal>\n       </etal>\n    \
      \  </person-group>\n      <year>\n       2006\n      </year>\n      <article-title>\n\
      \       Modulation of cellular protein trafficking by human immunodeficiency\
      \ virus type 1 Nef: Role of the acidic residue in the ExxxLL motif\n      </article-title>\n\
      \      <source>\n       J Virol\n      </source>\n      <volume>\n       80\n\
      \      </volume>\n      <fpage>\n       1837\n      </fpage>\n      <lpage>\n\
      \       1849\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       16439540\n\
      \      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b045\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Garcia\n        </surname>\n\
      \        <given-names>\n         JV\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Miller\n        </surname>\n   \
      \     <given-names>\n         AD\n        </given-names>\n       </name>\n \
      \     </person-group>\n      <year>\n       1991\n      </year>\n      <article-title>\n\
      \       Serine phosphorylation-independent downregulation of cell-surface CD4\
      \ by nef\n      </article-title>\n      <source>\n       Nature\n      </source>\n\
      \      <volume>\n       350\n      </volume>\n      <fpage>\n       508\n  \
      \    </fpage>\n      <lpage>\n       511\n      </lpage>\n      <pub-id pub-id-type=\"\
      pmid\">\n       2014052\n      </pub-id>\n     </citation>\n    </ref>\n   \
      \ <ref id=\"pbio-0040365-b046\">\n     <citation citation-type=\"journal\">\n\
      \      <person-group person-group-type=\"author\">\n       <name>\n        <surname>\n\
      \         Kasper\n        </surname>\n        <given-names>\n         MR\n \
      \       </given-names>\n       </name>\n       <name>\n        <surname>\n \
      \        Roeth\n        </surname>\n        <given-names>\n         JF\n   \
      \     </given-names>\n       </name>\n       <name>\n        <surname>\n   \
      \      Williams\n        </surname>\n        <given-names>\n         M\n   \
      \     </given-names>\n       </name>\n       <name>\n        <surname>\n   \
      \      Filzen\n        </surname>\n        <given-names>\n         TM\n    \
      \    </given-names>\n       </name>\n       <name>\n        <surname>\n    \
      \     Fleis\n        </surname>\n        <given-names>\n         RI\n      \
      \  </given-names>\n       </name>\n       <etal>\n       </etal>\n      </person-group>\n\
      \      <year>\n       2005\n      </year>\n      <article-title>\n       HIV-1\
      \ Nef disrupts antigen presentation early in the secretory pathway\n      </article-title>\n\
      \      <source>\n       J Biol Chem\n      </source>\n      <volume>\n     \
      \  280\n      </volume>\n      <fpage>\n       12840\n      </fpage>\n     \
      \ <lpage>\n       12848\n      </lpage>\n      <pub-id pub-id-type=\"pmid\"\
      >\n       15653685\n      </pub-id>\n     </citation>\n    </ref>\n    <ref\
      \ id=\"pbio-0040365-b047\">\n     <citation citation-type=\"journal\">\n   \
      \   <person-group person-group-type=\"author\">\n       <name>\n        <surname>\n\
      \         Sparrow\n        </surname>\n        <given-names>\n         CP\n\
      \        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Baffic\n        </surname>\n        <given-names>\n         J\n  \
      \      </given-names>\n       </name>\n       <name>\n        <surname>\n  \
      \       Lam\n        </surname>\n        <given-names>\n         MH\n      \
      \  </given-names>\n       </name>\n       <name>\n        <surname>\n      \
      \   Lund\n        </surname>\n        <given-names>\n         EG\n        </given-names>\n\
      \       </name>\n       <name>\n        <surname>\n         Adams\n        </surname>\n\
      \        <given-names>\n         AD\n        </given-names>\n       </name>\n\
      \       <etal>\n       </etal>\n      </person-group>\n      <year>\n      \
      \ 2002\n      </year>\n      <article-title>\n       A potent synthetic LXR\
      \ agonist is more effective than cholesterol loading at inducing ABCA1 mRNA\
      \ and stimulating cholesterol efflux\n      </article-title>\n      <source>\n\
      \       J Biol Chem\n      </source>\n      <volume>\n       277\n      </volume>\n\
      \      <fpage>\n       10021\n      </fpage>\n      <lpage>\n       10027\n\
      \      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       11790770\n    \
      \  </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b048\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Liao\n        </surname>\n\
      \        <given-names>\n         Z\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Cimakasky\n        </surname>\n\
      \        <given-names>\n         LM\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Hampton\n        </surname>\n  \
      \      <given-names>\n         R\n        </given-names>\n       </name>\n \
      \      <name>\n        <surname>\n         Nguyen\n        </surname>\n    \
      \    <given-names>\n         DH\n        </given-names>\n       </name>\n  \
      \     <name>\n        <surname>\n         Hildreth\n        </surname>\n   \
      \     <given-names>\n         JE\n        </given-names>\n       </name>\n \
      \     </person-group>\n      <year>\n       2001\n      </year>\n      <article-title>\n\
      \       Lipid rafts and HIV pathogenesis: Host membrane cholesterol is required\
      \ for infection by HIV type 1\n      </article-title>\n      <source>\n    \
      \   AIDS Res Hum Retroviruses\n      </source>\n      <volume>\n       17\n\
      \      </volume>\n      <fpage>\n       1009\n      </fpage>\n      <lpage>\n\
      \       1019\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       11485618\n\
      \      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b049\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Chen\n        </surname>\n\
      \        <given-names>\n         W\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Sun\n        </surname>\n      \
      \  <given-names>\n         Y\n        </given-names>\n       </name>\n     \
      \  <name>\n        <surname>\n         Welch\n        </surname>\n        <given-names>\n\
      \         C\n        </given-names>\n       </name>\n       <name>\n       \
      \ <surname>\n         Gorelik\n        </surname>\n        <given-names>\n \
      \        A\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Leventhal\n        </surname>\n        <given-names>\n         AR\n\
      \        </given-names>\n       </name>\n       <etal>\n       </etal>\n   \
      \   </person-group>\n      <year>\n       2001\n      </year>\n      <article-title>\n\
      \       Preferential ATP-binding cassette transporter A1-mediated cholesterol\
      \ efflux from late endosomes/lysosomes\n      </article-title>\n      <source>\n\
      \       J Biol Chem\n      </source>\n      <volume>\n       276\n      </volume>\n\
      \      <fpage>\n       43564\n      </fpage>\n      <lpage>\n       43569\n\
      \      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       11559713\n    \
      \  </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b050\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Schwartz\n        </surname>\n\
      \        <given-names>\n         O\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Marechal\n        </surname>\n \
      \       <given-names>\n         V\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Le Gall\n        </surname>\n  \
      \      <given-names>\n         S\n        </given-names>\n       </name>\n \
      \      <name>\n        <surname>\n         Lemonnier\n        </surname>\n \
      \       <given-names>\n         F\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Heard\n        </surname>\n    \
      \    <given-names>\n         JM\n        </given-names>\n       </name>\n  \
      \    </person-group>\n      <year>\n       1996\n      </year>\n      <article-title>\n\
      \       Endocytosis of major histocompatibility complex class I molecules is\
      \ induced by the HIV-1 Nef protein\n      </article-title>\n      <source>\n\
      \       Nat Med\n      </source>\n      <volume>\n       2\n      </volume>\n\
      \      <fpage>\n       338\n      </fpage>\n      <lpage>\n       342\n    \
      \  </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       8612235\n      </pub-id>\n\
      \     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b051\">\n     <citation\
      \ citation-type=\"journal\">\n      <person-group person-group-type=\"author\"\
      >\n       <name>\n        <surname>\n         Swigut\n        </surname>\n \
      \       <given-names>\n         T\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Shohdy\n        </surname>\n   \
      \     <given-names>\n         N\n        </given-names>\n       </name>\n  \
      \     <name>\n        <surname>\n         Skowronski\n        </surname>\n \
      \       <given-names>\n         J\n        </given-names>\n       </name>\n\
      \      </person-group>\n      <year>\n       2001\n      </year>\n      <article-title>\n\
      \       Mechanism for down-regulation of CD28 by Nef\n      </article-title>\n\
      \      <source>\n       EMBO J\n      </source>\n      <volume>\n       20\n\
      \      </volume>\n      <fpage>\n       1593\n      </fpage>\n      <lpage>\n\
      \       1604\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       11285224\n\
      \      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b052\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Sol-Foulon\n        </surname>\n\
      \        <given-names>\n         N\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Moris\n        </surname>\n    \
      \    <given-names>\n         A\n        </given-names>\n       </name>\n   \
      \    <name>\n        <surname>\n         Nobile\n        </surname>\n      \
      \  <given-names>\n         C\n        </given-names>\n       </name>\n     \
      \  <name>\n        <surname>\n         Boccaccio\n        </surname>\n     \
      \   <given-names>\n         C\n        </given-names>\n       </name>\n    \
      \   <name>\n        <surname>\n         Engering\n        </surname>\n     \
      \   <given-names>\n         A\n        </given-names>\n       </name>\n    \
      \   <etal>\n       </etal>\n      </person-group>\n      <year>\n       2002\n\
      \      </year>\n      <article-title>\n       HIV-1 Nef-induced upregulation\
      \ of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread\n\
      \      </article-title>\n      <source>\n       Immunity\n      </source>\n\
      \      <volume>\n       16\n      </volume>\n      <fpage>\n       145\n   \
      \   </fpage>\n      <lpage>\n       155\n      </lpage>\n      <pub-id pub-id-type=\"\
      pmid\">\n       11825573\n      </pub-id>\n     </citation>\n    </ref>\n  \
      \  <ref id=\"pbio-0040365-b053\">\n     <citation citation-type=\"journal\"\
      >\n      <person-group person-group-type=\"author\">\n       <name>\n      \
      \  <surname>\n         Arora\n        </surname>\n        <given-names>\n  \
      \       VK\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Fredericksen\n        </surname>\n        <given-names>\n        \
      \ BL\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Garcia\n        </surname>\n        <given-names>\n         JV\n \
      \       </given-names>\n       </name>\n      </person-group>\n      <year>\n\
      \       2002\n      </year>\n      <article-title>\n       Nef: Agent of cell\
      \ subversion\n      </article-title>\n      <source>\n       Microbes Infect\n\
      \      </source>\n      <volume>\n       4\n      </volume>\n      <fpage>\n\
      \       189\n      </fpage>\n      <lpage>\n       199\n      </lpage>\n   \
      \   <pub-id pub-id-type=\"pmid\">\n       11880052\n      </pub-id>\n     </citation>\n\
      \    </ref>\n    <ref id=\"pbio-0040365-b054\">\n     <citation citation-type=\"\
      journal\">\n      <person-group person-group-type=\"author\">\n       <name>\n\
      \        <surname>\n         Caldwell\n        </surname>\n        <given-names>\n\
      \         GA\n        </given-names>\n       </name>\n       <name>\n      \
      \  <surname>\n         Wang\n        </surname>\n        <given-names>\n   \
      \      SH\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Naider\n        </surname>\n        <given-names>\n         F\n  \
      \      </given-names>\n       </name>\n       <name>\n        <surname>\n  \
      \       Becker\n        </surname>\n        <given-names>\n         JM\n   \
      \     </given-names>\n       </name>\n      </person-group>\n      <year>\n\
      \       1994\n      </year>\n      <article-title>\n       Consequences of altered\
      \ isoprenylation targets on a-factor export and bioactivity\n      </article-title>\n\
      \      <source>\n       Proc Natl Acad Sci USA\n      </source>\n      <volume>\n\
      \       91\n      </volume>\n      <fpage>\n       1275\n      </fpage>\n  \
      \    <lpage>\n       1279\n      </lpage>\n      <pub-id pub-id-type=\"pmid\"\
      >\n       8108401\n      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"\
      pbio-0040365-b055\">\n     <citation citation-type=\"journal\">\n      <person-group\
      \ person-group-type=\"author\">\n       <name>\n        <surname>\n        \
      \ Riddler\n        </surname>\n        <given-names>\n         SA\n        </given-names>\n\
      \       </name>\n       <name>\n        <surname>\n         Smit\n        </surname>\n\
      \        <given-names>\n         E\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Cole\n        </surname>\n     \
      \   <given-names>\n         SR\n        </given-names>\n       </name>\n   \
      \    <name>\n        <surname>\n         Li\n        </surname>\n        <given-names>\n\
      \         R\n        </given-names>\n       </name>\n       <name>\n       \
      \ <surname>\n         Chmiel\n        </surname>\n        <given-names>\n  \
      \       JS\n        </given-names>\n       </name>\n       <etal>\n       </etal>\n\
      \      </person-group>\n      <year>\n       2003\n      </year>\n      <article-title>\n\
      \       Impact of HIV infection and HAART on serum lipids in men\n      </article-title>\n\
      \      <source>\n       JAMA\n      </source>\n      <volume>\n       289\n\
      \      </volume>\n      <fpage>\n       2978\n      </fpage>\n      <lpage>\n\
      \       82\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       12799406\n\
      \      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b056\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Khovidhunkit\n       \
      \ </surname>\n        <given-names>\n         W\n        </given-names>\n  \
      \     </name>\n       <name>\n        <surname>\n         Kim\n        </surname>\n\
      \        <given-names>\n         MS\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Memon\n        </surname>\n    \
      \    <given-names>\n         RA\n        </given-names>\n       </name>\n  \
      \     <name>\n        <surname>\n         Shigenaga\n        </surname>\n  \
      \      <given-names>\n         JK\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Moser\n        </surname>\n    \
      \    <given-names>\n         AH\n        </given-names>\n       </name>\n  \
      \     <etal>\n       </etal>\n      </person-group>\n      <year>\n       2004\n\
      \      </year>\n      <article-title>\n       Thematic review series: The pathogenesis\
      \ of atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein\
      \ metabolism mechanisms and consequences to the host\n      </article-title>\n\
      \      <source>\n       J Lipid Res\n      </source>\n      <volume>\n     \
      \  45\n      </volume>\n      <fpage>\n       1169\n      </fpage>\n      <lpage>\n\
      \       1196\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       15102878\n\
      \      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b057\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Shor-Posner\n        </surname>\n\
      \        <given-names>\n         G\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Basit\n        </surname>\n    \
      \    <given-names>\n         A\n        </given-names>\n       </name>\n   \
      \    <name>\n        <surname>\n         Lu\n        </surname>\n        <given-names>\n\
      \         Y\n        </given-names>\n       </name>\n       <name>\n       \
      \ <surname>\n         Cabrejos\n        </surname>\n        <given-names>\n\
      \         C\n        </given-names>\n       </name>\n       <name>\n       \
      \ <surname>\n         Chang\n        </surname>\n        <given-names>\n   \
      \      J\n        </given-names>\n       </name>\n       <etal>\n       </etal>\n\
      \      </person-group>\n      <year>\n       1993\n      </year>\n      <article-title>\n\
      \       Hypocholesterolemia is associated with immune dysfunction in early human\
      \ immunodeficiency virus-1 infection\n      </article-title>\n      <source>\n\
      \       Am J Med\n      </source>\n      <volume>\n       94\n      </volume>\n\
      \      <fpage>\n       515\n      </fpage>\n      <lpage>\n       519\n    \
      \  </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       7605397\n      </pub-id>\n\
      \     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b058\">\n     <citation\
      \ citation-type=\"journal\">\n      <person-group person-group-type=\"author\"\
      >\n       <name>\n        <surname>\n         Gianturco\n        </surname>\n\
      \        <given-names>\n         SH\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Ramprasad\n        </surname>\n\
      \        <given-names>\n         MP\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Song\n        </surname>\n     \
      \   <given-names>\n         R\n        </given-names>\n       </name>\n    \
      \   <name>\n        <surname>\n         Li\n        </surname>\n        <given-names>\n\
      \         R\n        </given-names>\n       </name>\n       <name>\n       \
      \ <surname>\n         Brown\n        </surname>\n        <given-names>\n   \
      \      ML\n        </given-names>\n       </name>\n       <etal>\n       </etal>\n\
      \      </person-group>\n      <year>\n       1998\n      </year>\n      <article-title>\n\
      \       Apolipoprotein B-48 or its apolipoprotein B-100 equivalent mediates\
      \ the binding of triglyceride-rich lipoproteins to their unique human monocyte-macrophage\
      \ receptor\n      </article-title>\n      <source>\n       Arterioscler Thromb\
      \ Vasc Biol\n      </source>\n      <volume>\n       18\n      </volume>\n \
      \     <fpage>\n       968\n      </fpage>\n      <lpage>\n       976\n     \
      \ </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       9633939\n      </pub-id>\n\
      \     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b059\">\n     <citation\
      \ citation-type=\"journal\">\n      <person-group person-group-type=\"author\"\
      >\n       <name>\n        <surname>\n         Stein\n        </surname>\n  \
      \      <given-names>\n         JH\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Klein\n        </surname>\n    \
      \    <given-names>\n         MA\n        </given-names>\n       </name>\n  \
      \     <name>\n        <surname>\n         Bellehumeur\n        </surname>\n\
      \        <given-names>\n         JL\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         McBride\n        </surname>\n  \
      \      <given-names>\n         PE\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Wiebe\n        </surname>\n    \
      \    <given-names>\n         DA\n        </given-names>\n       </name>\n  \
      \     <etal>\n       </etal>\n      </person-group>\n      <year>\n       2001\n\
      \      </year>\n      <article-title>\n       Use of human immunodeficiency\
      \ virus-1 protease inhibitors is associated with atherogenic lipoprotein changes\
      \ and endothelial dysfunction\n      </article-title>\n      <source>\n    \
      \   Circulation\n      </source>\n      <volume>\n       104\n      </volume>\n\
      \      <fpage>\n       257\n      </fpage>\n      <lpage>\n       262\n    \
      \  </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       11457741\n      </pub-id>\n\
      \     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b060\">\n     <citation\
      \ citation-type=\"journal\">\n      <person-group person-group-type=\"author\"\
      >\n       <name>\n        <surname>\n         Badiou\n        </surname>\n \
      \       <given-names>\n         S\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Merle\n        </surname>\n    \
      \    <given-names>\n         DB\n        </given-names>\n       </name>\n  \
      \     <name>\n        <surname>\n         Dupuy\n        </surname>\n      \
      \  <given-names>\n         AM\n        </given-names>\n       </name>\n    \
      \   <name>\n        <surname>\n         Baillat\n        </surname>\n      \
      \  <given-names>\n         V\n        </given-names>\n       </name>\n     \
      \  <name>\n        <surname>\n         Cristol\n        </surname>\n       \
      \ <given-names>\n         JP\n        </given-names>\n       </name>\n     \
      \  <etal>\n       </etal>\n      </person-group>\n      <year>\n       2003\n\
      \      </year>\n      <article-title>\n       Decrease in LDL size in HIV-positive\
      \ adults before and after lopinavir/ritonavir-containing regimen: An index of\
      \ atherogenicity?\n      </article-title>\n      <source>\n       Atherosclerosis\n\
      \      </source>\n      <volume>\n       168\n      </volume>\n      <fpage>\n\
      \       107\n      </fpage>\n      <lpage>\n       113\n      </lpage>\n   \
      \   <pub-id pub-id-type=\"pmid\">\n       12732393\n      </pub-id>\n     </citation>\n\
      \    </ref>\n    <ref id=\"pbio-0040365-b061\">\n     <citation citation-type=\"\
      journal\">\n      <person-group person-group-type=\"author\">\n       <name>\n\
      \        <surname>\n         Chait\n        </surname>\n        <given-names>\n\
      \         A\n        </given-names>\n       </name>\n       <name>\n       \
      \ <surname>\n         Brazg\n        </surname>\n        <given-names>\n   \
      \      RL\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Tribble\n        </surname>\n        <given-names>\n         DL\n\
      \        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Krauss\n        </surname>\n        <given-names>\n         RM\n \
      \       </given-names>\n       </name>\n      </person-group>\n      <year>\n\
      \       1993\n      </year>\n      <article-title>\n       Susceptibility of\
      \ small, dense, low-density lipoproteins to oxidative modification in subjects\
      \ with the atherogenic lipoprotein phenotype, pattern B\n      </article-title>\n\
      \      <source>\n       Am J Med\n      </source>\n      <volume>\n       94\n\
      \      </volume>\n      <fpage>\n       350\n      </fpage>\n      <lpage>\n\
      \       356\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       8475928\n\
      \      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b062\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         St Pierre\n        </surname>\n\
      \        <given-names>\n         AC\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Ruel\n        </surname>\n     \
      \   <given-names>\n         IL\n        </given-names>\n       </name>\n   \
      \    <name>\n        <surname>\n         Cantin\n        </surname>\n      \
      \  <given-names>\n         B\n        </given-names>\n       </name>\n     \
      \  <name>\n        <surname>\n         Dagenais\n        </surname>\n      \
      \  <given-names>\n         GR\n        </given-names>\n       </name>\n    \
      \   <name>\n        <surname>\n         Bernard\n        </surname>\n      \
      \  <given-names>\n         PM\n        </given-names>\n       </name>\n    \
      \   <etal>\n       </etal>\n      </person-group>\n      <year>\n       2001\n\
      \      </year>\n      <article-title>\n       Comparison of various electrophoretic\
      \ characteristics of LDL particles and their relationship to the risk of ischemic\
      \ heart disease\n      </article-title>\n      <source>\n       Circulation\n\
      \      </source>\n      <volume>\n       104\n      </volume>\n      <fpage>\n\
      \       2295\n      </fpage>\n      <lpage>\n       2299\n      </lpage>\n \
      \     <pub-id pub-id-type=\"pmid\">\n       11696468\n      </pub-id>\n    \
      \ </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b063\">\n     <citation\
      \ citation-type=\"journal\">\n      <person-group person-group-type=\"author\"\
      >\n       <name>\n        <surname>\n         Aquaro\n        </surname>\n \
      \       <given-names>\n         S\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Bagnarelli\n        </surname>\n\
      \        <given-names>\n         P\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Guenci\n        </surname>\n   \
      \     <given-names>\n         T\n        </given-names>\n       </name>\n  \
      \     <name>\n        <surname>\n         De Luca\n        </surname>\n    \
      \    <given-names>\n         A\n        </given-names>\n       </name>\n   \
      \    <name>\n        <surname>\n         Clementi\n        </surname>\n    \
      \    <given-names>\n         M\n        </given-names>\n       </name>\n   \
      \    <etal>\n       </etal>\n      </person-group>\n      <year>\n       2002\n\
      \      </year>\n      <article-title>\n       Long-term survival and virus production\
      \ in human primary macrophages infected by human immunodeficiency virus\n  \
      \    </article-title>\n      <source>\n       J Med Virol\n      </source>\n\
      \      <volume>\n       68\n      </volume>\n      <fpage>\n       479\n   \
      \   </fpage>\n      <lpage>\n       488\n      </lpage>\n      <pub-id pub-id-type=\"\
      pmid\">\n       12376954\n      </pub-id>\n     </citation>\n    </ref>\n  \
      \  <ref id=\"pbio-0040365-b064\">\n     <citation citation-type=\"journal\"\
      >\n      <person-group person-group-type=\"author\">\n       <name>\n      \
      \  <surname>\n         Leinonen\n        </surname>\n        <given-names>\n\
      \         M\n        </given-names>\n       </name>\n       <name>\n       \
      \ <surname>\n         Saikku\n        </surname>\n        <given-names>\n  \
      \       P\n        </given-names>\n       </name>\n      </person-group>\n \
      \     <year>\n       2002\n      </year>\n      <article-title>\n       Evidence\
      \ for infectious agents in cardiovascular disease and atherosclerosis\n    \
      \  </article-title>\n      <source>\n       Lancet Infect Dis\n      </source>\n\
      \      <volume>\n       2\n      </volume>\n      <fpage>\n       11\n     \
      \ </fpage>\n      <lpage>\n       17\n      </lpage>\n      <pub-id pub-id-type=\"\
      pmid\">\n       11892489\n      </pub-id>\n     </citation>\n    </ref>\n  \
      \  <ref id=\"pbio-0040365-b065\">\n     <citation citation-type=\"journal\"\
      >\n      <person-group person-group-type=\"author\">\n       <name>\n      \
      \  <surname>\n         Morre\n        </surname>\n        <given-names>\n  \
      \       SA\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Stooker\n        </surname>\n        <given-names>\n         W\n \
      \       </given-names>\n       </name>\n       <name>\n        <surname>\n \
      \        Lagrand\n        </surname>\n        <given-names>\n         WK\n \
      \       </given-names>\n       </name>\n       <name>\n        <surname>\n \
      \        van den Brule\n        </surname>\n        <given-names>\n        \
      \ AJ\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Niessen\n        </surname>\n        <given-names>\n         HW\n\
      \        </given-names>\n       </name>\n      </person-group>\n      <year>\n\
      \       2000\n      </year>\n      <article-title>\n       Microorganisms in\
      \ the aetiology of atherosclerosis\n      </article-title>\n      <source>\n\
      \       J Clin Pathol\n      </source>\n      <volume>\n       53\n      </volume>\n\
      \      <fpage>\n       647\n      </fpage>\n      <lpage>\n       654\n    \
      \  </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       11041053\n      </pub-id>\n\
      \     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b066\">\n     <citation\
      \ citation-type=\"journal\">\n      <person-group person-group-type=\"author\"\
      >\n       <name>\n        <surname>\n         Streblow\n        </surname>\n\
      \        <given-names>\n         DN\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Orloff\n        </surname>\n   \
      \     <given-names>\n         SL\n        </given-names>\n       </name>\n \
      \      <name>\n        <surname>\n         Nelson\n        </surname>\n    \
      \    <given-names>\n         JA\n        </given-names>\n       </name>\n  \
      \    </person-group>\n      <year>\n       2001\n      </year>\n      <article-title>\n\
      \       Do pathogens accelerate atherosclerosis?\n      </article-title>\n \
      \     <source>\n       J Nutr\n      </source>\n      <volume>\n       131\n\
      \      </volume>\n      <fpage>\n       2798S\n      </fpage>\n      <lpage>\n\
      \       2804S\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       11584110\n\
      \      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b067\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Schmidtmayerova\n    \
      \    </surname>\n        <given-names>\n         H\n        </given-names>\n\
      \       </name>\n       <name>\n        <surname>\n         Nuovo\n        </surname>\n\
      \        <given-names>\n         GJ\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Bukrinsky\n        </surname>\n\
      \        <given-names>\n         M\n        </given-names>\n       </name>\n\
      \      </person-group>\n      <year>\n       1997\n      </year>\n      <article-title>\n\
      \       Cell proliferation is not required for productive HIV-1 infection of\
      \ macrophages\n      </article-title>\n      <source>\n       Virology\n   \
      \   </source>\n      <volume>\n       232\n      </volume>\n      <fpage>\n\
      \       379\n      </fpage>\n      <lpage>\n       84\n      </lpage>\n    \
      \  <pub-id pub-id-type=\"pmid\">\n       9191852\n      </pub-id>\n     </citation>\n\
      \    </ref>\n    <ref id=\"pbio-0040365-b068\">\n     <citation citation-type=\"\
      journal\">\n      <person-group person-group-type=\"author\">\n       <name>\n\
      \        <surname>\n         Chang\n        </surname>\n        <given-names>\n\
      \         LJ\n        </given-names>\n       </name>\n       <name>\n      \
      \  <surname>\n         Urlacher\n        </surname>\n        <given-names>\n\
      \         V\n        </given-names>\n       </name>\n       <name>\n       \
      \ <surname>\n         Iwakuma\n        </surname>\n        <given-names>\n \
      \        T\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Cui\n        </surname>\n        <given-names>\n         Y\n     \
      \   </given-names>\n       </name>\n       <name>\n        <surname>\n     \
      \    Zucali\n        </surname>\n        <given-names>\n         J\n       \
      \ </given-names>\n       </name>\n      </person-group>\n      <year>\n    \
      \   1999\n      </year>\n      <article-title>\n       Efficacy and safety analyses\
      \ of a recombinant human immunodeficiency virus type 1 derived vector system\n\
      \      </article-title>\n      <source>\n       Gene Ther\n      </source>\n\
      \      <volume>\n       6\n      </volume>\n      <fpage>\n       715\n    \
      \  </fpage>\n      <lpage>\n       728\n      </lpage>\n      <pub-id pub-id-type=\"\
      pmid\">\n       10505094\n      </pub-id>\n     </citation>\n    </ref>\n  \
      \  <ref id=\"pbio-0040365-b069\">\n     <citation citation-type=\"journal\"\
      >\n      <person-group person-group-type=\"author\">\n       <name>\n      \
      \  <surname>\n         Escher\n        </surname>\n        <given-names>\n \
      \        G\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Hoang\n        </surname>\n        <given-names>\n         A\n   \
      \     </given-names>\n       </name>\n       <name>\n        <surname>\n   \
      \      Georges\n        </surname>\n        <given-names>\n         S\n    \
      \    </given-names>\n       </name>\n       <name>\n        <surname>\n    \
      \     Tchoua\n        </surname>\n        <given-names>\n         U\n      \
      \  </given-names>\n       </name>\n       <name>\n        <surname>\n      \
      \   El Osta\n        </surname>\n        <given-names>\n         A\n       \
      \ </given-names>\n       </name>\n       <etal>\n       </etal>\n      </person-group>\n\
      \      <year>\n       2005\n      </year>\n      <article-title>\n       Demethylation\
      \ using the epigenetic modifier, 5-azacytidine, increases the efficiency of\
      \ transient transfection of macrophages\n      </article-title>\n      <source>\n\
      \       J Lipid Res\n      </source>\n      <volume>\n       46\n      </volume>\n\
      \      <fpage>\n       356\n      </fpage>\n      <lpage>\n       365\n    \
      \  </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       15520456\n      </pub-id>\n\
      \     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b070\">\n     <citation\
      \ citation-type=\"journal\">\n      <person-group person-group-type=\"author\"\
      >\n       <name>\n        <surname>\n         Sviridov\n        </surname>\n\
      \        <given-names>\n         D\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Pyle\n        </surname>\n     \
      \   <given-names>\n         LE\n        </given-names>\n       </name>\n   \
      \    <name>\n        <surname>\n         Fidge\n        </surname>\n       \
      \ <given-names>\n         N\n        </given-names>\n       </name>\n      </person-group>\n\
      \      <year>\n       1996\n      </year>\n      <article-title>\n       Efflux\
      \ of cellular cholesterol and phospholipid to apolipoprotein A-I mutants\n \
      \     </article-title>\n      <source>\n       J Biol Chem\n      </source>\n\
      \      <volume>\n       271\n      </volume>\n      <fpage>\n       33277\n\
      \      </fpage>\n      <lpage>\n       33283\n      </lpage>\n      <pub-id\
      \ pub-id-type=\"pmid\">\n       8969186\n      </pub-id>\n     </citation>\n\
      \    </ref>\n    <ref id=\"pbio-0040365-b071\">\n     <citation citation-type=\"\
      journal\">\n      <person-group person-group-type=\"author\">\n       <name>\n\
      \        <surname>\n         Sviridov\n        </surname>\n        <given-names>\n\
      \         D\n        </given-names>\n       </name>\n       <name>\n       \
      \ <surname>\n         Hoang\n        </surname>\n        <given-names>\n   \
      \      A\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Huang\n        </surname>\n        <given-names>\n         W\n   \
      \     </given-names>\n       </name>\n       <name>\n        <surname>\n   \
      \      Sasaki\n        </surname>\n        <given-names>\n         J\n     \
      \   </given-names>\n       </name>\n      </person-group>\n      <year>\n  \
      \     2002\n      </year>\n      <article-title>\n       Structure-function\
      \ studies of apoA-I variants: Site-directed mutagenesis and natural mutations\n\
      \      </article-title>\n      <source>\n       J Lipid Res\n      </source>\n\
      \      <volume>\n       43\n      </volume>\n      <fpage>\n       1283\n  \
      \    </fpage>\n      <lpage>\n       1292\n      </lpage>\n      <pub-id pub-id-type=\"\
      pmid\">\n       12177172\n      </pub-id>\n     </citation>\n    </ref>\n  \
      \  <ref id=\"pbio-0040365-b072\">\n     <citation citation-type=\"journal\"\
      >\n      <person-group person-group-type=\"author\">\n       <name>\n      \
      \  <surname>\n         Fu\n        </surname>\n        <given-names>\n     \
      \    Y\n        </given-names>\n       </name>\n       <name>\n        <surname>\n\
      \         Hoang\n        </surname>\n        <given-names>\n         A\n   \
      \     </given-names>\n       </name>\n       <name>\n        <surname>\n   \
      \      Escher\n        </surname>\n        <given-names>\n         G\n     \
      \   </given-names>\n       </name>\n       <name>\n        <surname>\n     \
      \    Parton\n        </surname>\n        <given-names>\n         RG\n      \
      \  </given-names>\n       </name>\n       <name>\n        <surname>\n      \
      \   Krozowski\n        </surname>\n        <given-names>\n         Z\n     \
      \   </given-names>\n       </name>\n       <etal>\n       </etal>\n      </person-group>\n\
      \      <year>\n       2004\n      </year>\n      <article-title>\n       Expression\
      \ of caveolin-1 enhances cholesterol efflux in hepatic cells\n      </article-title>\n\
      \      <source>\n       J Biol Chem\n      </source>\n      <volume>\n     \
      \  279\n      </volume>\n      <fpage>\n       14140\n      </fpage>\n     \
      \ <lpage>\n       14146\n      </lpage>\n      <pub-id pub-id-type=\"pmid\"\
      >\n       14729661\n      </pub-id>\n     </citation>\n    </ref>\n    <ref\
      \ id=\"pbio-0040365-b073\">\n     <citation citation-type=\"journal\">\n   \
      \   <person-group person-group-type=\"author\">\n       <name>\n        <surname>\n\
      \         Simm\n        </surname>\n        <given-names>\n         M\n    \
      \    </given-names>\n       </name>\n       <name>\n        <surname>\n    \
      \     Shahabuddin\n        </surname>\n        <given-names>\n         M\n \
      \       </given-names>\n       </name>\n       <name>\n        <surname>\n \
      \        Chao\n        </surname>\n        <given-names>\n         W\n     \
      \   </given-names>\n       </name>\n       <name>\n        <surname>\n     \
      \    Allan\n        </surname>\n        <given-names>\n         JS\n       \
      \ </given-names>\n       </name>\n       <name>\n        <surname>\n       \
      \  Volsky\n        </surname>\n        <given-names>\n         DJ\n        </given-names>\n\
      \       </name>\n      </person-group>\n      <year>\n       1995\n      </year>\n\
      \      <article-title>\n       Aberrant Gag protein composition of a human immunodeficiency\
      \ virus type 1 vif mutant produced in primary lymphocytes\n      </article-title>\n\
      \      <source>\n       J Virol\n      </source>\n      <volume>\n       69\n\
      \      </volume>\n      <fpage>\n       4582\n      </fpage>\n      <lpage>\n\
      \       4586\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       7769728\n\
      \      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"pbio-0040365-b074\"\
      >\n     <citation citation-type=\"journal\">\n      <person-group person-group-type=\"\
      author\">\n       <name>\n        <surname>\n         Bobryshev\n        </surname>\n\
      \        <given-names>\n         YV\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Lord\n        </surname>\n     \
      \   <given-names>\n         RS\n        </given-names>\n       </name>\n   \
      \   </person-group>\n      <year>\n       1998\n      </year>\n      <article-title>\n\
      \       Mapping of vascular dendritic cells in atherosclerotic arteries suggests\
      \ their involvement in local immune-inflammatory reactions\n      </article-title>\n\
      \      <source>\n       Cardiovasc Res\n      </source>\n      <volume>\n  \
      \     37\n      </volume>\n      <fpage>\n       799\n      </fpage>\n     \
      \ <lpage>\n       810\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n\
      \       9659465\n      </pub-id>\n     </citation>\n    </ref>\n    <ref id=\"\
      pbio-0040365-b075\">\n     <citation citation-type=\"journal\">\n      <person-group\
      \ person-group-type=\"author\">\n       <name>\n        <surname>\n        \
      \ Charneau\n        </surname>\n        <given-names>\n         P\n        </given-names>\n\
      \       </name>\n       <name>\n        <surname>\n         Mirambeau\n    \
      \    </surname>\n        <given-names>\n         G\n        </given-names>\n\
      \       </name>\n       <name>\n        <surname>\n         Roux\n        </surname>\n\
      \        <given-names>\n         P\n        </given-names>\n       </name>\n\
      \       <name>\n        <surname>\n         Paulous\n        </surname>\n  \
      \      <given-names>\n         S\n        </given-names>\n       </name>\n \
      \      <name>\n        <surname>\n         Buc\n        </surname>\n       \
      \ <given-names>\n         H\n        </given-names>\n       </name>\n      \
      \ <etal>\n       </etal>\n      </person-group>\n      <year>\n       1994\n\
      \      </year>\n      <article-title>\n       HIV-1 reverse transcription. A\
      \ termination step at the center of the genome\n      </article-title>\n   \
      \   <source>\n       J Mol Biol\n      </source>\n      <volume>\n       241\n\
      \      </volume>\n      <fpage>\n       651\n      </fpage>\n      <lpage>\n\
      \       662\n      </lpage>\n      <pub-id pub-id-type=\"pmid\">\n       7520946\n\
      \      </pub-id>\n     </citation>\n    </ref>\n   </ref-list>\n   <sec sec-type=\"\
      display-objects\">\n    <title>\n     Figures and Tables\n    </title>\n   \
      \ <fig id=\"pbio-0040365-g001\" position=\"float\">\n     <label>\n      Figure\
      \ 1\n     </label>\n     <caption>\n      <title>\n       HIV-1 Nef Impairs\
      \ Cholesterol Efflux from Macrophages\n      </title>\n      <p>\n       (A)\
      \ Monocyte-derived macrophages were inoculated with indicated HIV-1 strains\
      \ equalized according to RT activity and cultivated for 21 d (RT activity in\
      \ the culture supernatants on day 21 is shown beneath the bars). Mock-infected\
      \ cells were incubated with virus-free medium. Specific cholesterol efflux to\
      \ apoA-I (30 &#x003bc;g/ml) was performed for 12 h and analyzed as described\
      \ in\n       <xref ref-type=\"sec\" rid=\"s4\">\n        Materials and Methods\n\
      \       </xref>\n       . Results are presented as percentage of efflux from\
      \ mock-infected cells (taken as 100&#x00025;) and are mean &#x000b1; standard\
      \ deviation (SD) of triplicate determinations. An asterisk (&#x0002a;) indicates\n\
      \       <italic>\n        p\n       </italic>\n       &#x0003c; 0.001\n    \
      \  </p>\n      <p>\n       (B) Monocyte-derived macrophages were inoculated\
      \ with VSV-G-pseudotyped HIV-1 SF2 either deficient in Nef (SF2.&#x00394;Nef)\
      \ or carrying WT Nef (SF2.wt). Specific cholesterol efflux to apoA-I (30 &#x003bc;g/ml)\
      \ was analyzed on day 6 after inoculation using the same procedure as described\
      \ in (A). p24 concentration in the culture medium is shown beneath the bars.\
      \ Results are presented as percentage of efflux from mock-infected cells (taken\
      \ as 100&#x00025;) and are mean &#x000b1; SD of triplicate determinations. An\
      \ asterisk (&#x0002a;) indicates\n       <italic>\n        p\n       </italic>\n\
      \       &#x0003c; 0.001.\n      </p>\n      <p>\n       (C) RAW 264.7 cells\
      \ were transfected with plasmids expressing indicated Nef variants or an empty\
      \ vector (mock-transfection). Twenty-four hours after transfection, LXR agonist,\
      \ TO-901317 (1 &#x003bc;mol/L), was added. Cholesterol efflux to apoA-I (30\
      \ &#x003bc;g/ml) was performed for 3 h with cells 48 h after transfection as\
      \ described in\n       <xref ref-type=\"sec\" rid=\"s4\">\n        Materials\
      \ and Methods\n       </xref>\n       . Means &#x000b1; SD of quadruplicate\
      \ determinations are shown. An asterisk (&#x0002a;) indicates\n       <italic>\n\
      \        p\n       </italic>\n       &#x0003c; 0.001.\n      </p>\n      <p>\n\
      \       (D) Immunoblotting of RAW 264.7 cells transfected with empty vector\
      \ (mock), WT Nef derived from HIV-1 strain SF2 (Nef.wt), or Nef.G2A mutant,\
      \ and stained with anti-Nef antibodies.\n      </p>\n     </caption>\n     <graphic\
      \ xlink:href=\"pbio.0040365.g001\">\n     </graphic>\n    </fig>\n    <fig id=\"\
      pbio-0040365-g002\" position=\"float\">\n     <label>\n      Figure 2\n    \
      \ </label>\n     <caption>\n      <title>\n       Nef Targets ABCA1-Dependent\
      \ Cholesterol Efflux\n      </title>\n      <p>\n       (A) Cholesterol efflux\
      \ to HDL (30 &#x003bc;g/ml) was measured from HIV-1 ADA-infected and mock-infected\
      \ macrophages used also to measure efflux to apoA-I in\n       <xref ref-type=\"\
      fig\" rid=\"pbio-0040365-g001\">\n        Figure 1\n       </xref>\n       A.\n\
      \      </p>\n      <p>\n       (B) Impairment of phospholipid efflux in Nef-transfected\
      \ RAW 264.7 cells. RAW 264.7 cells were transfected with plasmid expressing\
      \ HIV-1 SF2-derived Nef or empty vector (mock-transfection). Phospholipid efflux\
      \ to apoA-I (30 &#x003bc;g/ml) was measured as described in\n       <xref ref-type=\"\
      sec\" rid=\"s4\">\n        Methods\n       </xref>\n       . Means &#x000b1;\
      \ SD of quadruplicate determinations are shown. An asterisk (&#x0002a;) indicates\n\
      \       <italic>\n        p\n       </italic>\n       &#x0003c; 0.001.\n   \
      \   </p>\n      <p>\n       (C) Nef does not decrease cholesterol efflux in\
      \ RAW 264.7 cells not treated with LXR agonist. Experiment was performed using\
      \ HIV-1 SF2-derived Nef as described in\n       <xref ref-type=\"fig\" rid=\"\
      pbio-0040365-g001\">\n        Figure 1\n       </xref>\n       C, except that\
      \ LXR agonist was not added.\n      </p>\n      <p>\n       (D) Cholesterol\
      \ efflux to apoA-I from HeLa cells. HeLa cells were either mock-transfected\
      \ (mock) or co-transfected with ABCA1 and empty vector (ABCA1), or vector expressing\
      \ Nef derived from HIV-1 SF2 (ABCA1 &#x0002b; NefSF2) or LAI strains (ABCA1\
      \ &#x0002b; NefLAI); cholesterol efflux to apoA-I was analyzed. An asterisk\
      \ (&#x0002a;) indicates\n       <italic>\n        p\n       </italic>\n    \
      \   &#x0003c; 0.001 (versus cells without ABCA1); a number sign (&#x00023;)\
      \ indicates\n       <italic>\n        p\n       </italic>\n       &#x0003c;\
      \ 0.001 (versus cells without Nef). Expression of Nef determined by Western\
      \ blot is shown beneath the bars.\n      </p>\n      <p>\n       (E) Cholesterol\
      \ efflux to HDL from HeLa cells. Experiment was performed as in (D), except\
      \ that ABCG1 was used instead of ABCA1, and HDL (30 &#x003bc;g/ml) instead of\
      \ apoA-I was used as cholesterol acceptor. An asterisk (&#x0002a;) indicates\n\
      \       <italic>\n        p\n       </italic>\n       &#x0003c; 0.01 (versus\
      \ cells without ABCG1).\n      </p>\n     </caption>\n     <graphic xlink:href=\"\
      pbio.0040365.g002\">\n     </graphic>\n    </fig>\n    <fig id=\"pbio-0040365-g003\"\
      \ position=\"float\">\n     <label>\n      Figure 3\n     </label>\n     <caption>\n\
      \      <title>\n       Nef Induces Down-Modulation of ABCA1\n      </title>\n\
      \      <p>\n       (A) Human monocyte-derived macrophages were infected with\
      \ HIV-1 ADA or mock-infected and cultured for 14 d (RT in culture supernatant\
      \ was 4,000 cpm/&#x003bc;l). ABCA1, ABCG1, SR-B1, and &#x003b2;-actin (loading\
      \ control) were analyzed by Western blotting.\n      </p>\n      <p>\n     \
      \  (B) RAW 264.7 cells were transfected with vector expressing HIV-1 SF2-derived\
      \ Nef (either WT or carrying a G2A mutation) or empty vector (mock). Twenty-four\
      \ hours after transfection, cells were stimulated with TO-901317 (1 &#x003bc;M)\
      \ and 24 h later, were analyzed by Western blotting for ABCA1 and &#x003b2;-actin\
      \ (loading control).\n      </p>\n      <p>\n       (C) ABCA1 RNA from HIV-infected\
      \ macrophages used for Western blotting in (A) was analyzed by real-time RT-PCR.\
      \ Results were adjusted according to &#x003b2;-actin signal and are presented\
      \ in arbitrary units; an asterisk (&#x0002a;) indicates\n       <italic>\n \
      \       p\n       </italic>\n       &#x0003c; 0.01 (versus mock).\n      </p>\n\
      \      <p>\n       (D) RNA was extracted from non-activated RAW 264.7 cells\
      \ (control), mock-transfected RAW cells activated with LXR agonist TO-901317\
      \ (LXR), or cells transfected with SF2-derived Nef and activated with TO-901317\
      \ (LXR&#x0002b;NefSF2), and analyzed by real-time RT-PCR. Results were adjusted\
      \ according to 28S RNA signal and are presented in arbitrary units; an asterisk\
      \ (&#x0002a;) indicates\n       <italic>\n        p\n       </italic>\n    \
      \   &#x0003c; 0.01 (versus LXR agonist-treated, mock-transfected cells).\n \
      \     </p>\n     </caption>\n     <graphic xlink:href=\"pbio.0040365.g003\"\
      >\n     </graphic>\n    </fig>\n    <fig id=\"pbio-0040365-g004\" position=\"\
      float\">\n     <label>\n      Figure 4\n     </label>\n     <caption>\n    \
      \  <title>\n       The Effect of Nef on ABCA1 Localization\n      </title>\n\
      \      <p>\n       (A&#x02013;D) On day 5 after infection with VSV-G-pseudotyped\
      \ Nef-expressing (B and D) or &#x00394;Nef (A and C) HIV-1 SF2, cells were co-stained\
      \ with anti-p24 mouse monoclonal and anti-ABCA1 rabbit polyclonal antibodies,\
      \ followed by FITC-conjugated anti-mouse (A and B) and Cy5-conjugated anti-rabbit\
      \ IgG (C and D). Arrows point to cells with re-localized ABCA1. The scale bars\
      \ represent 20 &#x003bc;m.\n      </p>\n      <p>\n       (E&#x02013;G) Distribution\
      \ of ABCA1 revealed by staining with monoclonal anti-ABCA1 antibody and FITC-conjugated\
      \ anti-mouse IgG in RAW 264.7 cells transfected with empty vector (E), WT Nef\
      \ derived from SF2 HIV-1 (\n       <italic>\n        Nef.wt,\n       </italic>\n\
      \       panel &#x0005b;F&#x0005d;), or SF2 Nef carrying a G2A mutation (\n \
      \      <italic>\n        Nef.G2A\n       </italic>\n       , &#x0005b;G&#x0005d;).\
      \ Insets in (E and F) show cross-section of the image reconstituted from serial\
      \ sectioning. Scale bars represent 20 &#x003bc;m.\n      </p>\n      <p>\n \
      \      (H) &#x0005b;\n       <sup>\n        125\n       </sup>\n       -I&#x0005d;apoA-I\
      \ binding (left panel) and internalization (right panel) in RAW 264.7 macrophages\
      \ transfected with HIV-1 SF2-derived Nef. An asterisk (&#x0002a;) indicates\n\
      \       <italic>\n        p\n       </italic>\n       &#x0003c; 0.01.\n    \
      \  </p>\n     </caption>\n     <graphic xlink:href=\"pbio.0040365.g004\">\n\
      \     </graphic>\n    </fig>\n    <fig id=\"pbio-0040365-g005\" position=\"\
      float\">\n     <label>\n      Figure 5\n     </label>\n     <caption>\n    \
      \  <title>\n       Nef Interacts with ABCA1\n      </title>\n      <p>\n   \
      \    (A) ABCA1 was immunoprecipitated using anti-FLAG M2 affinity gel from HeLa\
      \ cells co-transfected with ABCA1-FLAG and an empty vector (mock), WT SF2 Nef\
      \ (Nef.wt), or myristoylation-defective mutant Nef.G2A. Immunoprecipitates were\
      \ analyzed by Western blotting for Nef (upper panel) or ABCA1 (middle panel)\
      \ using specific antibodies. Bottom panel shows Nef expression in lysates of\
      \ cells used for immunoprecipitation.\n      </p>\n      <p>\n       (B) Experiment\
      \ was performed as in\n       <xref ref-type=\"fig\" rid=\"pbio-0040365-g004\"\
      >\n        Figure 4\n       </xref>\n       E, except that cells were incubated\
      \ with monoclonal anti-ABCA1 and polyclonal anti-Nef antibody, followed by FITC-conjugated\
      \ anti-rabbit and Cy5-conjugated anti-mouse antibodies. Since all transfected\
      \ cells show re-localization of ABCA1 (\n       <xref ref-type=\"fig\" rid=\"\
      pbio-0040365-g004\">\n        Figure 4\n       </xref>\n       E), a typical\
      \ single cell is shown here. Images were analyzed using software on the Zeiss\
      \ LSM 510 microscope. The scale bar represents 20 &#x003bc;m.\n      </p>\n\
      \      <p>\n       (C) Fluorescence profile of the image in\n       <xref ref-type=\"\
      fig\" rid=\"pbio-0040365-g005\">\n        Figure 5\n       </xref>\n       B\
      \ was analyzed using the LSM 510 software. The top panel shows the distributions\
      \ of the ABCA1 and HIV-1 Nef proteins in blue and green, respectively. The same\
      \ analysis in the lower panel was performed for ABCA1 (blue) and Nef.G2A (green).\
      \ The co-localization of WT Nef and ABCA1 at the plasma membrane is indicated\
      \ by overlapping green and blue peaks at either end of the graph in the top\
      \ panel.\n      </p>\n     </caption>\n     <graphic xlink:href=\"pbio.0040365.g005\"\
      >\n     </graphic>\n    </fig>\n    <fig id=\"pbio-0040365-g006\" position=\"\
      float\">\n     <label>\n      Figure 6\n     </label>\n     <caption>\n    \
      \  <title>\n       Accumulation of Lipids in Cells Infected with HIV-1 or Transfected\
      \ with Nef\n      </title>\n      <p>\n       (A&#x02013;C) Oil Red O staining\
      \ of HIV-infected macrophages. Uninfected (A) macrophages or cells infected\
      \ with VSV-G&#x02013;pseudotyped Nef-positive (B) or &#x00394;Nef (C) HIV-1\
      \ SF2 variants were loaded with cholesterol on day 3 after infection by incubating\
      \ with AcLDL in the presence of apoA-I, and lipids were stained with Oil Red\
      \ O 24 h later. p24 concentration in the culture supernatant on day 3 after\
      \ infection was 4.7 ng/ml for cells inoculated with Nef-positive virus and 9.8\
      \ ng/ml for the culture inoculated with &#x00394;Nef HIV-1.\n      </p>\n  \
      \    <p>\n       (D&#x02013;F) Electron microscopy of cholesterol-loaded uninfected\
      \ macrophages (D) and cells infected with Nef-positive (E) and &#x00394;Nef\
      \ (F) HIV-1 AD8 performed 14 d after infection. Uninfected cells have small\
      \ numbers of electron-lucent lipid vacuoles (arrows). The cytoplasm of cells\
      \ infected with Nef-positive virus is filled with electron-dense lipid vacuoles\
      \ (arrows). Cells infected with &#x00394;Nef virus have small numbers of electron-lucent\
      \ lipid vacuoles (arrows), similar in number to those in uninfected cells. The\
      \ scale bars represent 5 &#x003bc;m.\n      </p>\n      <p>\n       (G) The\
      \ effect of Nef on cholesteryl ester synthesis. The rate of cholesteryl ester\
      \ synthesis in RAW 264.7 cells transfected with an empty vector (mock-transfected)\
      \ or Nef-expressing construct and incubated with or without AcLDL in the presence\
      \ of apoA-I or 5&#x00025; human plasma is presented as mean &#x000b1; SD of\
      \ quadruplicate determinations. An asterisk (&#x0002a;) indicates\n       <italic>\n\
      \        p\n       </italic>\n       &#x0003c; 0.02.\n      </p>\n      <p>\n\
      \       (H) and (I) RAW 264.7 cells were transfected with empty vector (H) or\
      \ Nef-expressing construct (I), stimulated with LXR agonist, incubated with\
      \ AcLDL and lipid-free apoA-I, fixed with formaldehyde, and stained with Oil\
      \ Red O.\n      </p>\n     </caption>\n     <graphic xlink:href=\"pbio.0040365.g006\"\
      >\n     </graphic>\n    </fig>\n    <fig id=\"pbio-0040365-g007\" position=\"\
      float\">\n     <label>\n      Figure 7\n     </label>\n     <caption>\n    \
      \  <title>\n       Analysis of Lipids in RAW 264.7 Macrophages Transfected with\
      \ Nef\n      </title>\n      <p>\n       (A) Cholesteryl ester content after\
      \ 24 h incubation with AcLDL (50 &#x003bc;g/ml) determined by enzymatic assay;\
      \ an asterisk (&#x0002a;) indicates\n       <italic>\n        p\n       </italic>\n\
      \       &#x0003c; 0.01.\n      </p>\n      <p>\n       (B) Free cholesterol\
      \ content after 24 h incubation with AcLDL (50 &#x003bc;g/ml) determined by\
      \ enzymatic assay; an asterisk (&#x0002a;) indicates\n       <italic>\n    \
      \    p\n       </italic>\n       &#x0003c; 0.05.\n      </p>\n      <p>\n  \
      \     (C) Triglyceride biosynthesis after 24 h incubation with AcLDL (50 &#x003bc;g/ml)\
      \ measured as incorporation of &#x0005b;\n       <sup>\n        14\n       </sup>\n\
      \       C&#x0005d;oleic acid into triglycerides as described in\n       <xref\
      \ ref-type=\"sec\" rid=\"s4\">\n        Materials and Methods\n       </xref>\n\
      \       .\n      </p>\n      <p>\n       (D) Uptake of AcLDL was calculated\
      \ as a sum of\n       <sup>\n        125\n       </sup>\n       I-AcLDL specifically\
      \ taken up and degraded by cells.\n      </p>\n      <p>\n       (E) Phospholipid\
      \ biosynthesis measured as incorporation of &#x0005b;\n       <sup>\n      \
      \  14\n       </sup>\n       C&#x0005d;choline into phospholipid fraction as\
      \ described in\n       <xref ref-type=\"sec\" rid=\"s4\">\n        Materials\
      \ and Methods\n       </xref>\n       ; an asterisk (&#x0002a;) indicates\n\
      \       <italic>\n        p\n       </italic>\n       &#x0003c; 0.01.\n    \
      \  </p>\n     </caption>\n     <graphic xlink:href=\"pbio.0040365.g007\">\n\
      \     </graphic>\n    </fig>\n    <fig id=\"pbio-0040365-g008\" position=\"\
      float\">\n     <label>\n      Figure 8\n     </label>\n     <caption>\n    \
      \  <title>\n       Identification of HIV-1&#x02013;Positive Macrophages in Atherosclerotic\
      \ Plaques of HIV-Infected Subjects.\n      </title>\n      <p>\n       Single\
      \ (A&#x02013;D) and double (E and F) immunostaining of aortic wall segments.\n\
      \      </p>\n      <p>\n       (A) p24 staining. A low-magnification image showing\
      \ the presence of p24\n       <sup>\n        &#x0002b;\n       </sup>\n    \
      \   cells in an area adjacent to the plaque lipid core. The scale bar represents\
      \ 100 &#x003bc;m.\n      </p>\n      <p>\n       (B) Detail of (A). p24\n  \
      \     <sup>\n        &#x0002b;\n       </sup>\n       cells show a characteristic\
      \ morphology of foam cells. The scale bar represents 10 &#x003bc;m.\n      </p>\n\
      \      <p>\n       (C) CD68 staining. CD68\n       <sup>\n        &#x0002b;\n\
      \       </sup>\n       cells were identified in a parallel consecutive section\
      \ to that shown in (A). The scale bar represents 100 &#x003bc;m.\n      </p>\n\
      \      <p>\n       (D) Negative control (staining with an irrelevant primary\
      \ antibody). The scale bar represents 100 &#x003bc;m.\n      </p>\n      <p>\n\
      \       (E) Double immunostaining showing the co-localization of p24 (brown)\
      \ with CD68 (rose). Immunostaining included a combination of a rabbit polyclonal\
      \ anti-p24 antibody in the peroxidase&#x02013;anti-peroxidase system with DAB\
      \ chromogen yielding a brown reaction product, and a mouse monoclonal antibody\
      \ to CD68 in the alkaline phosphatase&#x02013;anti-alkaline phosphatase system\
      \ with Fast Red chromogen, resulting in a rose precipitate. Counterstaining\
      \ was with Mayer's hematoxylin. The scale bar represents 50 &#x003bc;m.\n  \
      \    </p>\n      <p>\n       (F) A detail of (E). The scale bar represents 15\
      \ &#x003bc;m.\n      </p>\n     </caption>\n     <graphic xlink:href=\"pbio.0040365.g008\"\
      >\n     </graphic>\n    </fig>\n    <fig id=\"pbio-0040365-g009\" position=\"\
      float\">\n     <label>\n      Figure 9\n     </label>\n     <caption>\n    \
      \  <title>\n       Cholesterol Efflux and Infectivity of HIV Virions\n     \
      \ </title>\n      <p>\n       Human monocyte-derived macrophages were infected\
      \ with HIV-1 ADA or mock-infected, and 7 d after infection were treated or not\
      \ treated with LXR agonist, TO-901317 (500 nM), for seven more days.\n     \
      \ </p>\n      <p>\n       (A) Cholesterol efflux to apoA-I was measured on day\
      \ 21 after infection. An asterisk (&#x0002a;) indicates\n       <italic>\n \
      \       p\n       </italic>\n       &#x0003c; 0.01 (versus uninfected cells\
      \ not treated with TO-901317); a number sign (&#x00023;) indicates\n       <italic>\n\
      \        p\n       </italic>\n       &#x0003c; 0.01 (versus HIV-infected cells\
      \ not treated with TO-901317).\n      </p>\n      <p>\n       (B) Virions were\
      \ collected from culture supernatants of LXR agonist-treated and untreated (control)\
      \ cells on day 10 and day 14 (pooled together), adjusted according to p24 content,\
      \ and analyzed for infectivity on indicator P4-CCR5 cells. Experiment was performed\
      \ in triplicate, and results (mean &#x000b1; SD) are presented as percent infectivity\
      \ of virions produced by control cells; an asterisk (&#x0002a;) indicates\n\
      \       <italic>\n        p\n       </italic>\n       &#x0003c; 0.001.\n   \
      \   </p>\n      <p>\n       (C) Incorporation of &#x0005b;\n       <sup>\n \
      \       3\n       </sup>\n       H&#x0005d;cholesterol into virions produced\
      \ by LXR agonist-treated and untreated (control) cells was measured in triplicate,\
      \ and results (mean &#x000b1; SD) are presented relative to cholesterol in the\
      \ virions produced by control cells; an asterisk (&#x0002a;) indicates\n   \
      \    <italic>\n        p\n       </italic>\n       &#x0003c; 0.001.\n      </p>\n\
      \     </caption>\n     <graphic xlink:href=\"pbio.0040365.g009\">\n     </graphic>\n\
      \    </fig>\n   </sec>\n   <fn-group>\n    <fn id=\"ack3\" fn-type=\"conflict\"\
      >\n     <p>\n      <bold>\n       Competing interests.\n      </bold>\n    \
      \  The authors have declared that no competing interests exist.\n     </p>\n\
      \    </fn>\n    <fn id=\"ack1\" fn-type=\"con\">\n     <p>\n      <bold>\n \
      \      Author contributions.\n      </bold>\n      AD, YVB, MB, and DS conceived\
      \ and designed the experiments. ZM, HR, MPM, TP, LD, NM, YF, JMO, and YVB performed\
      \ the experiments. ZM, MPM, TP, AD, JMO, YVB, MB, and DS analyzed the data.\
      \ MB and DS wrote the paper.\n     </p>\n    </fn>\n    <fn id=\"ack2\" fn-type=\"\
      financial-disclosure\">\n     <p>\n      <bold>\n       Funding.\n      </bold>\n\
      \      This work was supported in part by the National Institutes of Health\
      \ (NIH) grants R03 TW006238 and R21 DK072926 (MB and DS), a grant from the Campbell\
      \ Foundation (MB), grants from the American Heart Association (MB and ZM), and\
      \ grants &#x00023;317810 and &#x00023;317811 from the National Health and Medical\
      \ Research Council of Australia (DS) and Australian Postgraduate Award &#x00023;1549\
      \ (HR).\n     </p>\n    </fn>\n   </fn-group>\n  </back>\n </article>\n</pmc-articleset>\n"
    PMID: 17076584
    PubMedXML: null
  model: Interaction.article
  pk: 5
[]
- fields:
    HasMut: false
    Interactions: []
    PMCID: PMC2212381
    PMCXML: "<?xml version='1.0' encoding='utf-8'?>\n<!DOCTYPE pmc-articleset PUBLIC\
      \ \"-//PMC//DTD ARTICLE SET 2.0//EN\" \"http://www.pubmedcentral.nih.gov/pmcdoc/dtd/nlm_lib/articleset/nlm-articleset-2.0.dtd\"\
      >\n<pmc-articleset>\n <article article-type=\"research-article\" xmlns:mml=\"\
      http://www.w3.org/1998/Math/MathML\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\
      >\n  <!--The publisher of this article does not allow downloading of the full\
      \ text in XML form.-->\n  <front>\n   <journal-meta>\n    <journal-id journal-id-type=\"\
      nlm-ta\">\n     J Exp Med\n    </journal-id>\n    <journal-title>\n     The\
      \ Journal of Experimental Medicine\n    </journal-title>\n    <issn pub-type=\"\
      ppub\">\n     0022-1007\n    </issn>\n    <issn pub-type=\"epub\">\n     1540-9538\n\
      \    </issn>\n    <publisher>\n     <publisher-name>\n      The Rockefeller\
      \ University Press\n     </publisher-name>\n    </publisher>\n   </journal-meta>\n\
      \   <article-meta>\n    <article-id pub-id-type=\"pmc\">\n     2212381\n   \
      \ </article-id>\n    <article-id pub-id-type=\"pmid\">\n     9841925\n    </article-id>\n\
      \    <article-categories>\n     <subj-group subj-group-type=\"heading\">\n \
      \     <subject>\n       Articles\n      </subject>\n     </subj-group>\n   \
      \ </article-categories>\n    <title-group>\n     <article-title>\n      Establishment\
      \ of a Functional Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcription\
      \ Complex Involves the Cytoskeleton\n     </article-title>\n    </title-group>\n\
      \    <contrib-group>\n     <contrib contrib-type=\"author\">\n      <name>\n\
      \       <surname>\n        Bukrinskaya\n       </surname>\n       <given-names>\n\
      \        Alissa\n       </given-names>\n      </name>\n      <xref ref-type=\"\
      aff\" rid=\"N0x1b3ccd0N0x1db78a0\">\n       &#x0002a;\n      </xref>\n     \
      \ <xref ref-type=\"aff\" rid=\"N0x1b3ccd0N0x1db78a0\">\n       &#x02021;\n \
      \     </xref>\n     </contrib>\n     <contrib contrib-type=\"author\">\n   \
      \   <name>\n       <surname>\n        Brichacek\n       </surname>\n       <given-names>\n\
      \        Beda\n       </given-names>\n      </name>\n      <xref ref-type=\"\
      aff\" rid=\"N0x1b3ccd0N0x1db78a0\">\n       &#x0002a;\n      </xref>\n     </contrib>\n\
      \     <contrib contrib-type=\"author\">\n      <name>\n       <surname>\n  \
      \      Mann\n       </surname>\n       <given-names>\n        Angela\n     \
      \  </given-names>\n      </name>\n      <xref ref-type=\"aff\" rid=\"N0x1b3ccd0N0x1db78a0\"\
      >\n       &#x0002a;\n      </xref>\n     </contrib>\n     <contrib contrib-type=\"\
      author\">\n      <name>\n       <surname>\n        Stevenson\n       </surname>\n\
      \       <given-names>\n        Mario\n       </given-names>\n      </name>\n\
      \      <xref ref-type=\"aff\" rid=\"N0x1b3ccd0N0x1db78a0\">\n       &#x0002a;\n\
      \      </xref>\n     </contrib>\n    </contrib-group>\n    <aff id=\"N0x1b3ccd0N0x1db78a0\"\
      >\n     From the\n     <label>\n      &#x0002a;\n     </label>\n     Program\
      \ in Molecular Medicine, University of Massachusetts Medical Center, Worcester,\
      \  Massachusetts 01605; and the\n     <label>\n      &#x02021;\n     </label>\n\
      \     D.I. Ivanovsky Institute of Virology, Academy of Medical Science,  Moscow\
      \ 123098, Russia\n    </aff>\n    <author-notes>\n     <fn>\n      <p>\n   \
      \    Address correspondence to Mario Stevenson, Department of Molecular Genetics\
      \ and Microbiology, Program in Molecular Medicine, University of Massachusetts\
      \ Medical Center, 373 Plantation St., Worcester,  MA 01605. Phone: 508-856-4582;\
      \ Fax: 508-856-4075.\n      </p>\n     </fn>\n    </author-notes>\n    <pub-date\
      \ pub-type=\"ppub\">\n     <day>\n      7\n     </day>\n     <month>\n     \
      \ 12\n     </month>\n     <year>\n      1998\n     </year>\n    </pub-date>\n\
      \    <volume>\n     188\n    </volume>\n    <issue>\n     11\n    </issue>\n\
      \    <fpage>\n     2113\n    </fpage>\n    <lpage>\n     2125\n    </lpage>\n\
      \    <history>\n     <date date-type=\"received\">\n      <day>\n       20\n\
      \      </day>\n      <month>\n       7\n      </month>\n      <year>\n     \
      \  1998\n      </year>\n     </date>\n     <date date-type=\"rev-recd\">\n \
      \     <day>\n       9\n      </day>\n      <month>\n       9\n      </month>\n\
      \      <year>\n       1998\n      </year>\n     </date>\n    </history>\n  \
      \  <copyright-year>\n     1998\n    </copyright-year>\n    <abstract>\n    \
      \ <p>\n      After interaction of human immunodeficiency virus type 1 (HIV-1)\
      \ virions with cell surface  receptors, a series of poorly characterized events\
      \ results in establishment of a viral reverse transcription complex in the host\
      \ cell cytoplasm. This process is coordinated in such a way that reverse transcription\
      \ is initiated shortly after formation of the viral reverse transcription complex.\
      \  However, the mechanism through which virus entry and initiation of reverse\
      \ transcription are  coordinated and how these events are compartmentalized\
      \ in the infected cell are not known. In  this study, we demonstrate that viral\
      \ reverse transcription complexes associate rapidly with the  host cell cytoskeleton\
      \ during HIV-1 infection and that reverse transcription occurs almost entirely\
      \ in the cytoskeletal compartment. Interruption of actin polymerization before\
      \ virus infection reduced association of viral reverse transcription complexes\
      \ with the cytoskeleton. In addition, efficient reverse transcription was dependent\
      \ on intact actin microfilaments. The  localization of reverse transcription\
      \ to actin microfilaments was mediated by the interaction of  a reverse transcription\
      \ complex component (gag MA) with actin but not vimentin (intermediate filaments)\
      \ or tubulin (microtubules). In addition, fusion, but not endocytosis-mediated\
      \  HIV-1 infectivity, was impaired when actin depolymerizing agents were added\
      \ to target cells  before infection but not when added after infection. These\
      \ results point to a previously unsuspected role for the host cell cytoskeleton\
      \ in HIV-1 entry and suggest that components of the  cytoskeleton promote establishment\
      \ of the reverse transcription complex in the host cell and  also the process\
      \ of reverse transcription within this complex.\n     </p>\n    </abstract>\n\
      \    <kwd-group>\n     <kwd>\n      HIV-1 entry\n     </kwd>\n     <kwd>\n \
      \     reverse transcription\n     </kwd>\n     <kwd>\n      cytoskeleton\n \
      \    </kwd>\n    </kwd-group>\n   </article-meta>\n  </front>\n </article>\n\
      </pmc-articleset>\n"
    PMID: 9841925
    PubMedXML: null
  model: Interaction.article
  pk: 6
[]
- fields:
    HasMut: true
    Interactions: [665, 671, 679, 690, 698, 706, 2474, 4393]
    PMCID: PMC368750
    PMCXML: "<?xml version='1.0' encoding='utf-8'?>\n<!DOCTYPE pmc-articleset PUBLIC\
      \ \"-//PMC//DTD ARTICLE SET 2.0//EN\" \"http://www.pubmedcentral.nih.gov/pmcdoc/dtd/nlm_lib/articleset/nlm-articleset-2.0.dtd\"\
      >\n<pmc-articleset>\n <article xmlns:xlink=\"http://www.w3.org/1999/xlink\"\
      \ article-type=\"research-article\">\n  <!--The publisher of this article does\
      \ not allow downloading of the full text in XML form.-->\n  <front>\n   <journal-meta>\n\
      \    <journal-id journal-id-type=\"nlm-ta\">\n     J Virol\n    </journal-id>\n\
      \    <journal-id journal-id-type=\"publisher-id\">\n     jvi\n    </journal-id>\n\
      \    <journal-title>\n     Journal of Virology\n    </journal-title>\n    <issn\
      \ pub-type=\"ppub\">\n     0022-538X\n    </issn>\n    <issn pub-type=\"epub\"\
      >\n     1098-5514\n    </issn>\n    <publisher>\n     <publisher-name>\n   \
      \   American Society for Microbiology\n     </publisher-name>\n    </publisher>\n\
      \   </journal-meta>\n   <article-meta>\n    <article-id pub-id-type=\"pmc\"\
      >\n     368750\n    </article-id>\n    <article-id pub-id-type=\"pmid\">\n \
      \    14694110\n    </article-id>\n    <article-id pub-id-type=\"publisher-id\"\
      >\n     1160\n    </article-id>\n    <article-id pub-id-type=\"doi\">\n    \
      \ 10.1128/JVI.78.2.779-789.2004\n    </article-id>\n    <article-categories>\n\
      \     <subj-group subj-group-type=\"heading\">\n      <subject>\n       Virus-Cell\
      \ Interactions\n      </subject>\n     </subj-group>\n    </article-categories>\n\
      \    <title-group>\n     <article-title>\n      Human Immunodeficiency Virus\
      \ Type 1 Tat Regulates Endothelial Cell Actin Cytoskeletal Dynamics through\
      \ PAK1 Activation and Oxidant Production\n     </article-title>\n    </title-group>\n\
      \    <contrib-group>\n     <contrib contrib-type=\"author\">\n      <name>\n\
      \       <surname>\n        Wu\n       </surname>\n       <given-names>\n   \
      \     Ru Feng\n       </given-names>\n      </name>\n      <xref ref-type=\"\
      aff\" rid=\"aff1\">\n       1\n      </xref>\n     </contrib>\n     <contrib\
      \ contrib-type=\"author\">\n      <name>\n       <surname>\n        Gu\n   \
      \    </surname>\n       <given-names>\n        Ying\n       </given-names>\n\
      \      </name>\n      <xref ref-type=\"aff\" rid=\"aff1\">\n       1\n     \
      \ </xref>\n     </contrib>\n     <contrib contrib-type=\"author\">\n      <name>\n\
      \       <surname>\n        Xu\n       </surname>\n       <given-names>\n   \
      \     You Cheng\n       </given-names>\n      </name>\n      <xref ref-type=\"\
      aff\" rid=\"aff1\">\n       1\n      </xref>\n     </contrib>\n     <contrib\
      \ contrib-type=\"author\">\n      <name>\n       <surname>\n        Mitola\n\
      \       </surname>\n       <given-names>\n        Stefania\n       </given-names>\n\
      \      </name>\n      <xref ref-type=\"aff\" rid=\"aff1\">\n       2\n     \
      \ </xref>\n     </contrib>\n     <contrib contrib-type=\"author\">\n      <name>\n\
      \       <surname>\n        Bussolino\n       </surname>\n       <given-names>\n\
      \        Federico\n       </given-names>\n      </name>\n      <xref ref-type=\"\
      aff\" rid=\"aff1\">\n       2\n      </xref>\n     </contrib>\n     <contrib\
      \ contrib-type=\"author\">\n      <name>\n       <surname>\n        Terada\n\
      \       </surname>\n       <given-names>\n        Lance S.\n       </given-names>\n\
      \      </name>\n      <xref ref-type=\"aff\" rid=\"aff1\">\n       1\n     \
      \ </xref>\n      <xref ref-type=\"corresp\" rid=\"cor1\">\n       &#x0002a;\n\
      \      </xref>\n     </contrib>\n    </contrib-group>\n    <aff id=\"aff1\"\
      >\n     The University of Texas Southwestern Medical Center and the Dallas Veterans\
      \ Administration Medical Center, Dallas, Texas,\n     <label>\n      1\n   \
      \  </label>\n     The Institute for Cancer Research and Treatment and University\
      \ of Turin, Turin, Italy\n     <label>\n      2\n     </label>\n    </aff>\n\
      \    <author-notes>\n     <fn id=\"cor1\">\n      <label>\n       &#x0002a;\n\
      \      </label>\n      <p>\n       Corresponding author. Mailing address: Dallas\
      \ VAMC, MC151, 4500 S. Lancaster Rd., Dallas, TX 75216. Phone: (214) 857-0405.\
      \ Fax: (214) 857-0340. E-mail:\n       <email>\n        lance.terada&#x00040;med.va.gov\n\
      \       </email>\n       .\n      </p>\n     </fn>\n    </author-notes>\n  \
      \  <pub-date pub-type=\"ppub\">\n     <month>\n      1\n     </month>\n    \
      \ <year>\n      2004\n     </year>\n    </pub-date>\n    <volume>\n     78\n\
      \    </volume>\n    <issue>\n     2\n    </issue>\n    <fpage>\n     779\n \
      \   </fpage>\n    <lpage>\n     789\n    </lpage>\n    <history>\n     <date\
      \ date-type=\"received\">\n      <day>\n       16\n      </day>\n      <month>\n\
      \       6\n      </month>\n      <year>\n       2003\n      </year>\n     </date>\n\
      \     <date date-type=\"accepted\">\n      <day>\n       28\n      </day>\n\
      \      <month>\n       9\n      </month>\n      <year>\n       2003\n      </year>\n\
      \     </date>\n    </history>\n    <copyright-statement>\n     Copyright &#x000a9;\
      \ 2004, American Society for Microbiology\n    </copyright-statement>\n    <copyright-year>\n\
      \     2004\n    </copyright-year>\n    <abstract>\n     <p>\n      Human immunodeficiency\
      \ virus type 1 Tat exerts prominent angiogenic effects which may lead to a variety\
      \ of vasculopathic conditions in AIDS patients. Because endothelial cells undergo\
      \ prominent cytoskeletal rearrangement during angiogenesis, we investigated\
      \ the specific effects of Tat on the endothelial cell actin cytoskeleton. Glutathione\n\
      \      <italic>\n       S\n      </italic>\n      -transferase (GST)-Tat, at\
      \ a level of 200 ng/ml (equivalent to 52 ng of Tat/ml), caused stress fiber\
      \ disassembly, peripheral retraction, and ruffle formation in human umbilical\
      \ vein endothelial cells (HUVEC) and human lung microvascular endothelial cells.\
      \ At 600 ng of GST-Tat/ml (157 ng of Tat/ml), actin structures were lost, and\
      \ severe cytoskeletal collapse occurred. In contrast, GST-Tat harboring mutations\
      \ within either the cysteine-rich or basic domains exerted minimal effects on\
      \ the endothelial cytoskeleton. HUVEC expressing a DsRed-Tat fusion protein\
      \ displayed similar actin rearrangements, followed by actin collapse, whereas\
      \ neighboring nontransfected cells retained normal actin structures. Because\
      \ active mutants of p21-activated kinase 1 (PAK1) induce identical changes in\
      \ actin dynamics, we hypothesized that Tat exerts its cytoskeletal effects through\
      \ PAK1. GST-Tat activated PAK1 within 5 min, and adenovirus delivery of a kinase-dead\
      \ PAK1 [PAK1(K298A)] completely prevented cytoskeletal collapse induced by GST-Tat\
      \ or DsRed-Tat and also blocked downstream activation of c-Jun N-terminal kinase.\
      \ Further, GST-Tat increased phosphorylation of the NADPH oxidase subunit p47\n\
      \      <sup>\n       <italic>\n        phox\n       </italic>\n      </sup>\n\
      \      and caused its rapid redistribution to membrane ruffles. PAK1(K298A)\
      \ blocked p47\n      <sup>\n       <italic>\n        phox\n       </italic>\n\
      \      </sup>\n      phosphorylation, and interference with NADPH oxidase function\
      \ through superoxide scavenging or through expression of a transdominant inhibitor,\
      \ p67(V204A), prevented GST-Tat-induced alterations in the actin cytoskeleton.\
      \ We conclude that Tat induces actin cytoskeletal rearrangements through PAK1\
      \ and downstream activation of the endothelial NADPH oxidase.\n     </p>\n \
      \   </abstract>\n   </article-meta>\n  </front>\n </article>\n</pmc-articleset>\n"
    PMID: 14694110
    PubMedXML: null
  model: Interaction.article
  pk: 11
- fields: {HIVGene: 3, HumanGene: 7, InteractionType: 6}
  model: Interaction.interaction
  pk: 665
- fields: {HIVGene: 3, HumanGene: 9, InteractionType: 6}
  model: Interaction.interaction
  pk: 671
- fields: {HIVGene: 3, HumanGene: 10, InteractionType: 6}
  model: Interaction.interaction
  pk: 679
- fields: {HIVGene: 3, HumanGene: 12, InteractionType: 6}
  model: Interaction.interaction
  pk: 690
- fields: {HIVGene: 3, HumanGene: 13, InteractionType: 6}
  model: Interaction.interaction
  pk: 698
- fields: {HIVGene: 3, HumanGene: 15, InteractionType: 6}
  model: Interaction.interaction
  pk: 706
- fields: {HIVGene: 3, HumanGene: 638, InteractionType: 4}
  model: Interaction.interaction
  pk: 2474
- fields: {HIVGene: 3, HumanGene: 1440, InteractionType: 27}
  model: Interaction.interaction
  pk: 4393
- fields:
    Article: 11
    Mutation: [2]
    PMID: null
    ParNum: 1
    SentNum: 10
    Text: Further, GST-Tat increased phosphorylation of the NADPH oxidase subunit
      p47phoxand caused its rapid redistribution to membrane ruffles. PAK1(K298A)
      blocked p47phoxphosphorylation, and interference with NADPH oxidase function
      through superoxide scavenging or through expression of a transdominant inhibitor,
      p67(V204A), prevented GST-Tat-induced alterations in the actin cytoskeleton.
  model: Interaction.sentence
  pk: 72
- fields: {Gene: null, Mut: K298A}
  model: Interaction.mutation
  pk: 2
[]
- fields:
    Article: 11
    Mutation: [1]
    PMID: null
    ParNum: 1
    SentNum: 8
    Text: Because active mutants of p21-activated kinase 1 (PAK1) induce identical
      changes in actin dynamics, we hypothesized that Tat exerts its cytoskeletal
      effects through PAK1. GST-Tat activated PAK1 within 5 min, and adenovirus delivery
      of a kinase-dead PAK1 [PAK1(K298A)] completely prevented cytoskeletal collapse
      induced by GST-Tat or DsRed-Tat and also blocked downstream activation of c-Jun
      N-terminal kinase.
  model: Interaction.sentence
  pk: 71
- fields: {Gene: null, Mut: K298A}
  model: Interaction.mutation
  pk: 1
[]
- fields:
    HasMut: false
    Interactions: []
    PMCID: PMC190843
    PMCXML: "<?xml version='1.0' encoding='utf-8'?>\n<!DOCTYPE pmc-articleset PUBLIC\
      \ \"-//PMC//DTD ARTICLE SET 2.0//EN\" \"http://www.pubmedcentral.nih.gov/pmcdoc/dtd/nlm_lib/articleset/nlm-articleset-2.0.dtd\"\
      >\n<pmc-articleset>\n <article xmlns:xlink=\"http://www.w3.org/1999/xlink\"\
      \ article-type=\"research-article\">\n  <!--The publisher of this article does\
      \ not allow downloading of the full text in XML form.-->\n  <?from_PubMed??>\n\
      \  <front>\n   <journal-meta>\n    <journal-id journal-id-type=\"nlm-ta\">\n\
      \     J Virol\n    </journal-id>\n    <journal-title>\n     Journal of Virology\n\
      \    </journal-title>\n    <issn pub-type=\"ppub\">\n     0022-538X\n    </issn>\n\
      \    <issn pub-type=\"epub\">\n     1098-5514\n    </issn>\n   </journal-meta>\n\
      \   <article-meta>\n    <article-id pub-id-type=\"pmc\">\n     190843\n    </article-id>\n\
      \    <article-id pub-id-type=\"pmid\">\n     8892894\n    </article-id>\n  \
      \  <article-categories>\n     <subj-group subj-group-type=\"heading\">\n   \
      \   <subject>\n       Research Article\n      </subject>\n     </subj-group>\n\
      \    </article-categories>\n    <title-group>\n     <article-title>\n      Cytoskeletal\
      \ proteins inside human immunodeficiency virus type 1 virions.\n     </article-title>\n\
      \    </title-group>\n    <contrib-group>\n     <contrib contrib-type=\"author\"\
      >\n      <name>\n       <surname>\n        Ott\n       </surname>\n       <given-names>\n\
      \        D E\n       </given-names>\n      </name>\n     </contrib>\n     <contrib\
      \ contrib-type=\"author\">\n      <name>\n       <surname>\n        Coren\n\
      \       </surname>\n       <given-names>\n        L V\n       </given-names>\n\
      \      </name>\n     </contrib>\n     <contrib contrib-type=\"author\">\n  \
      \    <name>\n       <surname>\n        Kane\n       </surname>\n       <given-names>\n\
      \        B P\n       </given-names>\n      </name>\n     </contrib>\n     <contrib\
      \ contrib-type=\"author\">\n      <name>\n       <surname>\n        Busch\n\
      \       </surname>\n       <given-names>\n        L K\n       </given-names>\n\
      \      </name>\n     </contrib>\n     <contrib contrib-type=\"author\">\n  \
      \    <name>\n       <surname>\n        Johnson\n       </surname>\n       <given-names>\n\
      \        D G\n       </given-names>\n      </name>\n     </contrib>\n     <contrib\
      \ contrib-type=\"author\">\n      <name>\n       <surname>\n        Sowder\n\
      \       </surname>\n       <given-names>\n        R C\n       </given-names>\n\
      \       <suffix>\n        2nd\n       </suffix>\n      </name>\n     </contrib>\n\
      \     <contrib contrib-type=\"author\">\n      <name>\n       <surname>\n  \
      \      Chertova\n       </surname>\n       <given-names>\n        E N\n    \
      \   </given-names>\n      </name>\n     </contrib>\n     <contrib contrib-type=\"\
      author\">\n      <name>\n       <surname>\n        Arthur\n       </surname>\n\
      \       <given-names>\n        L O\n       </given-names>\n      </name>\n \
      \    </contrib>\n     <contrib contrib-type=\"author\">\n      <name>\n    \
      \   <surname>\n        Henderson\n       </surname>\n       <given-names>\n\
      \        L E\n       </given-names>\n      </name>\n     </contrib>\n    </contrib-group>\n\
      \    <aff>\n     AIDS Vaccine Program, National Cancer Institute, Frederick\
      \ Cancer Research and Development Center, Maryland 21702-1201, USA. ott@avpvx1.ncifcrf.gov.\n\
      \    </aff>\n    <pub-date pub-type=\"ppub\">\n     <month>\n      11\n    \
      \ </month>\n     <year>\n      1996\n     </year>\n    </pub-date>\n    <volume>\n\
      \     70\n    </volume>\n    <issue>\n     11\n    </issue>\n    <fpage>\n \
      \    7734\n    </fpage>\n    <lpage>\n     7743\n    </lpage>\n    <abstract>\n\
      \     <p>\n      We have identified three types of cytoskeletal proteins inside\
      \ human immunodeficiency virus type 1 (HIV-1) virions by analyzing subtilisin-digested\
      \ particles. HIV-1 virions were digested with protease, and the treated particles\
      \ were isolated by sucrose density centrifugation. This method removes both\
      \ exterior viral proteins and proteins associated with microvesicles that contaminate\
      \ virion preparations. Since the proteins inside the virion are protected from\
      \ digestion by the viral lipid envelope, they can be isolated and analyzed after\
      \ treatment. Experiments presented here demonstrated that this procedure removed\
      \ more than 95% of the protein associated with microvesicles. Proteins in digested\
      \ HIV-1(MN) particles from infected H9 and CEM(ss) cell lines were analyzed\
      \ by high-pressure liquid chromatography, protein sequencing, and immunoblotting.\
      \ The data revealed that three types of cytoskeletal proteins are present in\
      \ virions at different concentrations relative to the molar level of Gag: actin\
      \ (approximately 10 to 15%), ezrin and moesin (approximately 2%), and cofilin\
      \ (approximately 2 to 10%). Our analysis of proteins within virus particles\
      \ detected proteolytic fragments of alpha-smooth muscle actin and moesin that\
      \ were cleaved at sites which might be recognized by HIV-1 protease. These cleavage\
      \ products are not present in microvesicles from uninfected cells. Therefore,\
      \ these processed proteins are most probably produced by HIV-1 protease digestion.\
      \ The presence of these fragments, as well as the incorporation of a few specific\
      \ cytoskeletal proteins into virions, suggests an active interaction between\
      \ cytoskeletal and viral proteins.\n     </p>\n    </abstract>\n   </article-meta>\n\
      \  </front>\n </article>\n</pmc-articleset>\n"
    PMID: 8892894
    PubMedXML: null
  model: Interaction.article
  pk: 15
[]
- fields:
    HasMut: false
    Interactions: []
    PMCID: PMC104434
    PMCXML: "<?xml version='1.0' encoding='utf-8'?>\n<!DOCTYPE pmc-articleset PUBLIC\
      \ \"-//PMC//DTD ARTICLE SET 2.0//EN\" \"http://www.pubmedcentral.nih.gov/pmcdoc/dtd/nlm_lib/articleset/nlm-articleset-2.0.dtd\"\
      >\n<pmc-articleset>\n <article article-type=\"research-article\" xmlns:mml=\"\
      http://www.w3.org/1998/Math/MathML\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\
      >\n  <!--The publisher of this article does not allow downloading of the full\
      \ text in XML form.-->\n  <front>\n   <journal-meta>\n    <journal-id journal-id-type=\"\
      nlm-ta\">\n     J Virol\n    </journal-id>\n    <journal-id journal-id-type=\"\
      publisher-id\">\n     J VIROL\n    </journal-id>\n    <journal-title>\n    \
      \ Journal of Virology\n    </journal-title>\n    <issn pub-type=\"ppub\">\n\
      \     0022-538X\n    </issn>\n    <issn pub-type=\"epub\">\n     1098-5514\n\
      \    </issn>\n    <publisher>\n     <publisher-name>\n      American Society\
      \ for Microbiology\n     </publisher-name>\n    </publisher>\n   </journal-meta>\n\
      \   <article-meta>\n    <article-id pub-id-type=\"pmc\">\n     104434\n    </article-id>\n\
      \    <article-id pub-id-type=\"pmid\">\n     9971772\n    </article-id>\n  \
      \  <article-id pub-id-type=\"publisher-id\">\n     0502\n    </article-id>\n\
      \    <article-categories>\n     <subj-group subj-group-type=\"heading\">\n \
      \     <subject>\n       Structure and Assembly\n      </subject>\n     </subj-group>\n\
      \    </article-categories>\n    <title-group>\n     <article-title>\n      Actin\
      \ Associates with the Nucleocapsid Domain of the  Human Immunodeficiency Virus\
      \ Gag Polyprotein\n     </article-title>\n    </title-group>\n    <contrib-group>\n\
      \     <contrib contrib-type=\"author\">\n      <name>\n       <surname>\n  \
      \      Wilk\n       </surname>\n       <given-names>\n        Thomas\n     \
      \  </given-names>\n      </name>\n     </contrib>\n     <contrib contrib-type=\"\
      author\">\n      <name>\n       <surname>\n        Gowen\n       </surname>\n\
      \       <given-names>\n        Brent\n       </given-names>\n      </name>\n\
      \      <xref ref-type=\"author-notes\" rid=\"FN151\">\n       &#x02020;\n  \
      \    </xref>\n     </contrib>\n     <contrib contrib-type=\"author\">\n    \
      \  <name>\n       <surname>\n        Fuller\n       </surname>\n       <given-names>\n\
      \        Stephen D.\n       </given-names>\n      </name>\n      <xref ref-type=\"\
      author-notes\" rid=\"FN150\">\n       &#x0002a;\n      </xref>\n     </contrib>\n\
      \    </contrib-group>\n    <aff id=\"N0x8bee868.0x9c10618\">\n     Structural\
      \ Biology Programme, European Molecular Biology Laboratory, 69117 Heidelberg,\
      \ Germany\n    </aff>\n    <author-notes>\n     <fn id=\"FN150\">\n      <label>\n\
      \       &#x0002a;\n      </label>\n      <p>\n       Corresponding author. Mailing\
      \ address: Structural Biology Programme, European Molecular Biology Laboratory,\
      \ Postfach 10.2209, 69117 Heidelberg, Germany. Phone: 49-6221-387-265. Fax:\
      \ 49-6221-387-306. E-mail:\n       <email>\n        Fuller@EMBL-Heidelberg.DE\n\
      \       </email>\n       .\n      </p>\n     </fn>\n     <fn id=\"FN151\">\n\
      \      <label>\n       &#x02020;\n      </label>\n      <p>\n       Present\
      \ address: Cryo-TEM Facility, Department of Biochemistry, Imperial College of\
      \ Science, Technology, and Medicine, London, United Kingdom SW7 2AZ.\n     \
      \ </p>\n     </fn>\n    </author-notes>\n    <pub-date pub-type=\"ppub\">\n\
      \     <month>\n      3\n     </month>\n     <year>\n      1999\n     </year>\n\
      \    </pub-date>\n    <volume>\n     73\n    </volume>\n    <issue>\n     3\n\
      \    </issue>\n    <fpage>\n     1931\n    </fpage>\n    <lpage>\n     1940\n\
      \    </lpage>\n    <history>\n     <date date-type=\"received\">\n      <day>\n\
      \       1\n      </day>\n      <month>\n       4\n      </month>\n      <year>\n\
      \       1998\n      </year>\n     </date>\n     <date date-type=\"accepted\"\
      >\n      <day>\n       7\n      </day>\n      <month>\n       12\n      </month>\n\
      \      <year>\n       1998\n      </year>\n     </date>\n    </history>\n  \
      \  <copyright-statement>\n     Copyright &#x000a9; 1999, American Society for\
      \ Microbiology\n    </copyright-statement>\n    <copyright-year>\n     1999\n\
      \    </copyright-year>\n    <abstract>\n     <p>\n      Recently, it was shown\
      \ that actin molecules are present in human immunodeficiency virus type 1 (HIV-1)\
      \ particles. We have examined the basis for incorporation and the location of\
      \ actin molecules within HIV-1 and murine retrovirus particles. Our results\
      \ show that the retroviral Gag polyprotein is sufficient for actin uptake. Immunolabeling\
      \ studies demonstrate that actin molecules localize to a specific radial position\
      \ within the immature particle, clearly displaced from the matrix domain underneath\
      \ the viral membrane but in proximity to the nucleocapsid (NC) domain of the\
      \ Gag polyprotein. When virus or subviral Gag particles were disrupted with\
      \ nonionic detergent, actin molecules remained associated with the disrupted\
      \ particles. Actin molecules remained in a stable complex with the NC cleavage\
      \ product (or an NC-RNA complex) after treatment of the disrupted HIV-1 particles\
      \ with recombinant HIV-1 protease. In contrast, matrix and capsid molecules\
      \ were released. The same result was obtained when mature HIV-1 particles were\
      \ disrupted with detergent. Taken together, these results indicate that actin\
      \ molecules are associated with the NC domain of the viral polyprotein.\n  \
      \   </p>\n    </abstract>\n   </article-meta>\n  </front>\n </article>\n</pmc-articleset>\n"
    PMID: 9971772
    PubMedXML: null
  model: Interaction.article
  pk: 16
[]
